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Abstract 
Understanding the processes that control how we develop from a fertilized 
embryo to a functional adult is paramount for treating the diseases that result when 
these processes are disrupted at any stage of life. My dissertation investigates the cis-
regulatory logic underlying how cell signaling pathways utilize the genome to create and 
maintain the wide variety of cell types and tissues needed for proper development and 
survival.  
Surprisingly few cell signaling pathways are used throughout embryonic 
development; I have chosen to focus on Hedgehog (Hh) signaling, a pathway used in 
such diverse cellular contexts as digit specification, brain development, lung function, 
and reproductive maintenance (Ingham and McMahon, 2001). Disruption of this 
pathway results in developmental defects (Lipinski et al., 2010; Schachter and Krauss, 
2008) and cancer (Barakat et al., 2010; Hahn et al., 1996; Johnson et al., 1996; 
McMahon et al., 2003). It is essential to understand the mechanisms by which Hh 
signaling functions to treat these diseases more effectively. One relatively unexplored 
mechanism of Hh function is how its signal is transduced at the level of DNA, 
specifically through the regulation of gene expression. In this thesis, I explore the 
mechanisms that mediate tissue-specific, Hh-dependent gene regulation, and uncover 
an ancient cis-regulatory logic shared between flies and mice that has significant 
implications for the maintenance and evolution of cellular communication. I 
experimentally demonstrate that multiple enhancer elements, which control tissue-
 ix 
specific gene expression, rely on sub-optimal DNA sequences for binding of GLI 
proteins, the transcriptional effectors of Hh signaling. These sequences are essential to 
control gene expression in response to Hh and can influence the function of the 
pathway in a variety of cellular contexts. I also characterize several new transcriptional 
regulators of Hh signaling and introduce new tools to the field that allow for in depth 
analysis of the regulatory landscape of Hh target genes at any stage of development.  
My work presented here addresses a significant gap in our knowledge of how the 
Hh signaling pathway functions at the cis-regulatory level and describes a framework by 
which new advances can be made on this topic in the future. 
 
 1 
Chapter 1  
 
Introduction 
1.1 Non-coding DNA and a brief history of enhancers 
DNA is the genetic material that holds a code which determine the characteristics 
defining who we are; from the color of our eyes to the number of toes on our feet (Avery 
et al., 1944). Unfortunately, it is also the culprit behind many inherited genetic disorders, 
developmental defects, and environmentally acquired diseases, like cancer. Similar to 
how a set of blueprints can be read by architects, biologists have the ability to read 
DNA, although the code has not yet been completely cracked. We know that at the 
heart of these blueprints there are four molecules:  Adenine (A), Thymine (T), Guanine 
(G), and Cytosine (C). These molecules are called nucleotides and are arranged in a 
particular order (Watson and Crick, 1953). Under the correct conditions, certain 
stretches of DNA, called genes, are processed into RNA via transcription, which then 
can then be translated into proteins. It is critical that transcription occurs at the correct 
time, at the appropriate levels, and in the right contexts throughout development. The 
field of gene regulation is dedicated to understanding how genes are expressed in this 
way, but we are far from a complete understanding of how the genome functions 
(Dahm, 2005). My dissertation focuses on how a single genome regulates gene 
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expression so that that we develop normally and maintain healthy cellular processes 
well into adulthood. 
The ability to quickly and efficiently sequence entire genomes has provided a 
wealth of data that has been instrumental for understanding how the genome works 
(Shendure and Ji, 2008). Prior to sequencing the genome, estimates based on the 
(false) premise that the average human gene was roughly 30,000bp long and that 
genes covered the entire genome led scientists to believe there could be more than one 
hundred thousand genes encoded in our DNA (Pertea and Salzberg, 2010). After 
completion, the human genome project revealed that there are only between 22,000 
and 23,000 genes in the human genome (Lander et al., 2001). Strikingly, this means 
that only ~2% of our total DNA consists of coding genes, leaving the other ~98% as 
non-coding DNA (Elgar and Vavouri, 2008). That 98% of human DNA not making genes 
serves many purposes and one of its most important functions is directing the proper 
temporal- and tissue-specific expression of genes, a process known as gene regulation 
(Levine, 2010; Levine et al., 2014). This is largely achieved through regions of DNA 
called cis-regulatory modules (CRMs). These modules are made up of patterns of 
nucleotides that can be bound by proteins called transcription factors (TFs) at the right 
time and place in development. Once bound, TFs recruit the basal transcriptional 
machinery to the coding region of a gene to make RNA, via transcription (Villicaña et al., 
2014). One type of well-studied CRM is an enhancer, named because of its ability to 
“enhance” expression of its target gene. Pioneering work in the early 1980’s 
characterized a 72 bp fragment of viral DNA that increased the transcriptional activation 
of the rabbit β-Globin gene more than 200-fold (Banerji et al., 1981). This was also a 
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significant discovery because of the physical location of this regulatory DNA relative to 
the β-Globin gene: this enhancer was found distal to the coding region, demonstrating 
that transcriptionally relevant sequences can be located at a distance from the genes 
they regulate. This landmark discovery demonstrated that non-coding regions of the 
genome play a functional role in biology. Similar work was published around this time 
demonstrating other genes were regulated by enhancers in a similar manner as β-
Globin (Benoist and Chambon, 1981; Fromm and Berg, 1983). All of these findings 
helped pave the way for enhancer biologists to better understand how genes are 
regulated at the level of DNA sequence.  
Today, we have many examples of similar kinds of complex gene regulation by 
enhancers in different contexts. While Banerji and colleagues showed that enhancers 
can work at a distance from the gene they regulate, a more striking example of this was 
later shown for the Sonic Hedgehog (Shh) gene in mice and humans. This gene is 
absolutely essential for the normal development of many different developmental 
tissues, like the spinal cord, limbs, and several organs required for survival (Bellusci et 
al., 1997; Chiang et al., 1996; Ingham and McMahon, 2001; Niswander et al., 1994). In 
the early 2000’s, a great amount of effort was dedicated to identifying a distally located 
enhancer of Shh, which resides more than 1Mb away from its coding region (Lettice et 
al., 2003). This enhancer specifically regulates Shh expression even though it is found 
in the intron of another gene completely unrelated to Shh. It is also tissue-specific, 
contributing to the regulation of Shh in just the limb for digit specification, which 
introduces yet another layer of complexity to the function of enhancers; not only do 
genes require enhancers that can be located far away from the coding region of the 
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gene, enhancers are often tissue specific. Importantly, deletion of this enhancer, while 
leaving the Shh coding region intact, abrogates normal limb development, 
demonstrating the functional contribution of non-coding sequence to developmental 
processes (Sagai et al., 2005). Follow-up studies on this distal Shh enhancer also 
uncovered similar mutations in polydactylous felines known as Hemingway’s cats 
(Lettice et al., 2008). These cats have been celebrated for having extra digits, and the 
driving force behind this malformation were single nucleotide substitutions in this 
conserved Shh enhancer, demonstrating both strong conservation between species and 
functional importance of regulatory elements in key developmental processes (Lettice et 
al., 2008).  
1.2 Enhancer structure and function  
Enhancers are able to regulate gene expression in specific tissues using 
information encoded within the sequence of DNA itself, but also rely on the available 
transcription factors in different developmental contexts. Enhancers can range in size 
and there is no limit to how large an enhancer might be (Hnisz et al., 2013; Parker et al., 
2013). The content of enhancers is an assortment of transcription factor binding sites 
arranged in a particular order to facilitate the binding of their cognate TFs (Johnson et 
al., 2008). An enhancer for the Drosophila Pax2 (dPax2) gene has been essential for 
learning more about how enhancers work at the level of DNA sequence. This relatively 
short 362bp enhancer termed sparkling, or spa, requires input from Notch, EGFR, 
Runx, Mapk, and ETS factors, making it an ideal example of a well-characterized signal-
regulated enhancer (Flores et al., 2000; Fu and Noll, 1997; Fu et al., 1998). 
Interestingly, a synthetic version of this enhancer containing just the known binding sites 
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for the required inputs of spa failed to recapitulate normal expression, thus 
demonstrating that spa required even more regulatory information than previously 
thought to activate dPax2. This again highlighted the need for multiple transcriptional 
inputs into a single regulatory element (Swanson et al., 2010a; Swanson et al., 2011). 
The other part of enhancer tissue specificity is the availability of TFs in each 
developmental context. Since all of our cells, regardless of cell type or function, have 
the same DNA, they also have the same enhancers for every gene that will ever be 
activated or repressed throughout development. There will often be high quality TF 
binding sites in regions of the genome that will remain unbound because there is no 
protein to recognize that sequence. For example, even if there is a perfect binding site 
for a leg specific TF in the eye-specific spa enhancer, that TF will not be present in the 
developing eye and that binding site will remain unoccupied (or at least unoccupied by 
that particular TF). These constraints further increase the specificity by which enhancers 
can regulate gene expression. 
1.3 Enhancer identification 
One of the big, open questions in the field of transcriptional biology is how to 
identify functional binding sites within enhancers. There are many different tools 
available to accomplish this and each has their own advantages and disadvantages. 
Since there is ample sequence data freely available across many different species, we 
can use evolutionary conservation to identify regions of DNA that are shared between 
different species, like mouse and human, for example. This comparative genomic 
bioinformatic technique has been used with varying degrees of success (Berman et al., 
2004; Gurdziel et al., 2015; Pennacchio et al., 2006); see Chapter 4 for more details). 
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By aligning genomic sequences from different organisms, we can find which specific 
sequences of DNA are conserved, suggesting that they are functionally relevant. We 
can then use any number of transcription factor binding site prediction algorithms to 
predict if TFs might be important for these enhancers (just a handful of examples are 
CIS-BP, (http://cisbp.ccbr.utoronto.ca/ ), (Weirauch and Hughes, 2010); Weeder-Web 
(Pavesi et al., 2004); and databases like Fly Factor Survey - 
http://mccb.umassmed.edu/ffs/ - curated by Michael Brodsky and Scot Wolfe). While 
these methods have the advantage of being able to rely on sequence data alone, using 
only this prediction tool is limited. The first limitation is that not all transcription factors 
are expressed in all tissues. This gets to the point of context-specific transcription 
factors, like in the case of spa discussed above. Looking at just the sequence 
information does not give us clues as to if the TF is actually expressed in the relevant 
tissue where that enhancer is required for development. The second limitation is that we 
are still learning what a transcription factor binding site (TFBS) actually is and how it 
works. Most of the data available for TFBS prediction comes from in vitro detection 
methods like SELEX, EMSAs, and Bacterial 1 Hybrid analysis (Christensen et al., 2012; 
Hallikas et al., 2006; Tuerk and Gold, 1990; Zhu et al., 2011). These methods generally 
provide a prediction of what sequence a TF might recognize, but lack information about 
the required co-factors or context restricted availability of the TFs. Furthermore, these 
binding sites that are strongly predicted for certain TFs in vitro have been shown to not 
always be favored during development (Crocker et al., 2015) as discussed in Chapter 2. 
For these reasons, additional analyses are required to more accurately predict and 
characterize enhancers.  
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There are also methods by which enhancers can be identified on a genome-wide 
basis. DNAse hypersensitivity and FAIRE-seq analyses, for example, both identify 
regions of open chromatin that predict where certain TFs can bind to DNA. DNAse 
hypersensitivity, or footprinting, takes advantage of protein binding to DNA (Galas and 
Schmitz, 1978). In this assay, protein is bound to DNA, the DNA is then sheared using 
DNAse enzyme that will digest free DNA, which is not bound by protein, leaving all 
regions bound by protein in tact. Once sequencing technology became available, these 
regions bound by protein could then be dissociated from the bound protein and 
sequenced using high throughput analysis to identify a genome’s worth of binding data. 
FAIRE-seq, or Formaldehyde-Assisted Isolation of Regulatory Elements uses the same 
principles as DNAse hypersensitivity, but with the added benefit of being able to look 
more closely at cell-type specific data (Giresi et al., 2007). These techniques can 
accurately predict enhancers, but are not able to assign function to enhancers and 
cannot delineate specific TFs that are bound to these regions of DNA. 
To more specifically identify the DNA regions bound by specific TFs, ChIP-seq is 
a very popular and efficient tool (Johnson et al., 2007). This technique relies on similar 
principles of detecting protein-DNA complexes, but takes it a step further by using a 
protein-specific antibody. By using this antibody, the protein-DNA complex can be 
isolated from specific cell-types and DNA fragments sequenced, revealing the in vivo TF 
occupancy of specific TFs. While this technique allows for more controlled identification 
of enhancers, it also relies on the specificity of the antibody, or how well it can recognize 
it’s epitope on the protein trying to be isolated (Marx, 2013). Some TFs, like the Hox 
genes as one example, are notoriously difficult to target because of protein redundancy 
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(Mann et al., 2009). Furthermore, ChIP-seq, along with DNAse and FAIRE-seq only 
provide a snapshot of what is going on in the cell at one particular timepoint and does 
not provide direct evidence for the function of these enhancers for the regulation of 
gene expression.  
To assess enhancer function on a genome-wide scale, a technique has recently 
been described called STARR-seq (Self-Transcribing Active Regulatory Region - 
sequencing) to detect enhancers by allowing them to actively transcribe themselves 
using a minimal heterologous promoter (Arnold et al., 2013). This technique takes 
advantage of enhancer function (i.e. their ability to up-regulate transcription) to 
demonstrate enhancer-promoter specificity and to drive transcription (Lorberbaum and 
Barolo, 2015; Zabidi et al., 2014). While this technique faithfully identifies many tissue-
specific enhancers and highlights that they are functional, it is limited by the requirement 
to conduct experiments in cell culture, rather than in their native developmental context.  
Another method used to study regulatory elements is an enhancer-reporter 
transgene that can be integrated into the chromosome of a model organism. This 
technology relies on easily detectable genes that are not present in the host genome 
being studied and are visualized either by a chemical reaction (lacZ) or by emitting 
detectable light (GFP, or any variety of fluorescent protein). For a brief review and 
relevant examples, see (Barolo et al., 2000; Shaner et al., 2005). To test the function of 
an enhancer in vivo, it can be cloned upstream of a promoter, which will drive the 
expression of a reporter gene. This construct can then be integrated into the genome 
using one of many transfection techniques that vary by organism. Depending on when 
and where that enhancer is normally active, it will drive expression of the reporter gene 
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at the right time and place during development. Furthermore, because the enhancer-
reporter construct is integrated into the host chromosome, it will also experience 
everything DNA normally experiences in that cell type -- including all the relevant TFs, 
co-factors, or any epigenetic regulation that might be important. Downstream 
processing using immunofluorescence, for example, can also provide important clues 
about enhancer activity. One of the major drawbacks of this technique, however, is that 
in order to be tested, an enhancer must already be identified. It is also a relatively low 
throughput method of characterizing enhancer function, but does have the advantage of 
being an in vivo readout of activity. 
In addition to those already mentioned above, there are still other methods as 
well that rely on histone marks such as methylation and acetylation to provide clues on 
a genomic scale for enhancer mapping (see ENCODE project, review here: 
Stamatoyannopoulos, 2012). Taken together, however, there is no single, simple 
method for identifying enhancers. All of these resources must be used in combination to 
identify and validate enhancers that are important for the regulation of gene expression.  
1.4 Hedgehog signaling in development  
In order to better understand the role of enhancers in gene regulation and 
developmental biology, I have opted to study these CRMs alongside cell signaling 
pathways. Amazingly, there are only a handful of cell signaling pathways used 
repeatedly throughout development (Barolo, 2002). Rather than examine all of these 
pathways, I have dedicated my efforts to understanding transcriptional regulation 
controlled by the Hedgehog signaling pathway (Hh). First identified in a forward genetic 
screen in Drosophila melanogaster (Nüsslein-Volhard and Wieschaus, 1980), Hh has 
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been extensively studied and shown to regulate amny cellular responses to signaling 
and shape morphological development (Ingham, 2016). Regardless of the tissue or 
context, Hh signaling works similarly: in the absence of Hh ligand, the 12-pass 
transmembrane receptor Patched (Ptc in flies; PTCH1 in mammals) inhibits the function 
of Smoothened (Smo) (Chen and Struhl, 1996; Ingham et al., 1991). This inhibition 
leads to the proteolytic cleavage of GLI, known as Cubitus Interruptus or Ci in flies, 
which removes the activation domain leaving GLI to act as a repressor (GLI-Repressor, 
GLI-R;) so that when it enters the nucleus GLI-R will be able to repress the transcription 
of target genes (Aza-Blanc et al., 1997; Méthot and Basler, 2001; Orenic et al., 1990). In 
the presence of the Hh ligand the inhibition of Smo by Ptc is removed, protecting the 
activation domain of GLI, allowing GLI-Activator (GLI-A) to enter the nucleus, recognize 
its binding site(s) in the appropriate enhancer, and activate transcription of target genes 
(Figure 1.1; (Briscoe and Thérond, 2013; Hui and Angers, 2011; Infante et al., 2015)). In 
all cases known from flies to mice, GLI proteins are the main transcriptional effectors of 
the pathway (Buttitta et al., 2003; Méthot and Basler, 2001; Motoyama et al., 2003).  
Two well-studied contexts that require Hh signaling in Drosophila development 
are the wing imaginal disc and the embryonic ectoderm. Imaginal discs are specialized 
structures found in the larval stages of developing Drosophila that are destined to 
develop into a specific adult appendage (Basler and Struhl, 1994; Mohler, 1988; Tabata 
and Kornberg, 1994). In order for this development to occur, imaginal discs must 
receive signaling input from many signaling pathways, including Hh. Normally, cells in 
the posterior produce the Hh ligand, which is then secreted as a morphogen across the 
anterior-posterior (A-P) axis to regulate target genes (Figure 1.2, left; (Aza-Blanc et al., 
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1997; Motzny and Holmgren, 1995)). Importantly, the transcription factor Engrailed (En) 
permits Hh expression and represses Ci in those cells, so that the pathway is not 
constitutively active, and it eventually helps to transduce the signal across the axis (Blair 
and Ralston, 1997; Eaton and Kornberg, 1990; Rodriguez and Basler, 1997). Cells 
sitting in the anterior region near that A-P axis will experience high levels of Hh 
signaling and activate the pathway, turning on Hh target genes (Figure 1.2, left hand 
panel; (Hooper and Scott, 1989; Nakano et al., 1989)). The embryonic ectoderm is 
regulated in a similar manner as the wing imaginal disc, but instead of having just one 
posterior and anterior region, there are segmentally repeated stripes that produce Hh 
where Ci is similarly repressed by En (Eaton and Kornberg, 1990; Forbes et al., 1993; 
Perrimon, 1994). Hh ligands are secreted both anteriorly and posteriorly and cells 
receiving high levels of signal in each segment will activate the pathway, turning on the 
appropriate target genes ((Briscoe and Thérond, 2013; Fietz et al., 1995; Hidalgo and 
Ingham, 1990); depicted in the right hand panel of Figure 1.2). Importantly, in 
developmental contexts regulated by Hh signaling, including the wing and embryonic 
ectoderm, one of those key target genes that must be activated is patched (ptc) 
(Alexandre et al., 1996; Forbes et al., 1993; Goodrich et al., 1996; Hooper and Scott, 
1989). Since ptc codes for the transmembrane receptor the of the pathway, it introduces 
a negative feedback mechanism that is essential to regulate the pathway in all Hh-
responsive developmental contexts (Ingham et al., 1991; Tabata and Kornberg, 1994; 
Vokes et al., 2007).  
We know that in order for Hh target genes to respond to their signal, GLI must 
recognize a particular DNA sequence, or binding site, in the target gene’s enhancer(s). 
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Much work has been done on the sequences GLI prefers to bind dating back to the 
early 1990s, when it was demonstrated that human GLI prefers the sequence 
GACCACCCA as its consensus binding site (Kinzler and Vogelstein, 1990). While these 
data were generated in human cell lines with human proteins, it was later shown that 
other mammalian GLIs and Ci recognize nearly identical sequences in both mice and 
flies (Hallikas et al., 2006), perhaps not too surprisingly, since this pathway is highly 
evolutionarily conserved (Ingham et al., 2011). Three of these consensus GLI binding 
sites (GBS) were identified in the Drosophila locus of the Hh target gene ptc. When a 
promoter proximal ptc enhancer was cloned into a reporter construct, it responded in a 
Hh-like pattern (Alexandre et al., 1996). When the region of this enhancer containing 
those three consensus GBS was deleted in a parallel experiment expression was 
greatly reduced, demonstrating their requirement for activation in the wing imaginal disc 
(an updated version of this experiment is described in Chapter 2, specifically 
mutagenizing those sites and using a GFP reporter instead of lacZ). This seemingly 
simple experiment characterized the first Hh responsive ptc enhancer, and also 
provided strong evidence that consensus GLI binding sites are critical for the regulation 
of Hh target genes. 
1.5 The importance of GLI binding site affinity  
While GLI binding sites in the promoter-proximal ptc enhancer were sufficient to 
respond to Hh signaling in the wing imaginal disc, they were not sufficient to respond in 
all Hh-regulated developmental contexts (see Chapter 2). In fact, most known Hh target 
genes in flies do not require high affinity GLI motifs to respond to Hh signaling (Ramos 
and Barolo, 2013). Rather, they require binding sites that slightly vary from the 
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consensus sequence recognized by GLI, referred to as low affinity binding sites, since 
they are recognized by GLI with a lower predicted affinity (Hallikas et al., 2006). Two 
examples of well-characterized enhancers that require low affinity GBS to respond to 
Hh signaling belong to wingless (wg) and stripe (sr). First, wg, which encodes the ligand 
for the WNT signaling pathway, is directly activated by Hh signaling in the Drosophila 
embryo via an enhancer that contains four low affinity GLI binding sites (Ohlen and 
Hooper, 1997; Ohlen et al., 1997). While no transgenic reporter animals carrying this 
enhancer were examined in these studies, cell culture experiments in embryo-derived 
cells were used with luciferase reporters to demonstrate the importance of these low 
affinity GBS. Additionally, these sites were confirmed with EMSAs to show that GLI 
could recognize those specific binding sites. This enhancer was later examined as a 
transgenic reporter construct in flies and again required low affinity GBS to properly 
respond to Hh signaling (Ramos and Barolo, 2013). Second, stripe (sr), a regulator of 
muscle development in late Drosophila embryogenesis, also requires low affinity GBS in 
its enhancer to respond to Hh signaling. A GFP-reporter transgene carrying a wildtype 
enhancer responded to Hh signaling, but when its low affinity GBS were mutagenized, 
the enhancer could no longer respond (Piepenburg et al., 2000). The Barolo lab further 
characterized both the wg and sr enhancers by improving the affinity of their low affinity 
GBS so that they match the consensus predicted GLI motif (GACCACCCA). Even with 
an affinity upgrade, we saw less activation in these contexts further demonstrating the 
importance of low affinity GBS for Hh response (Ramos and Barolo, 2013). 
There is also strong evidence supporting the requirement of low affinity GBS for 
Hh target gene regulation in mammals. For instance, work published by Oosterveen and 
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colleagues identifies a series of Hh target gene enhancers active in the neural tube that 
are regulated by GLI-repressor acting through low affinity GBS. Interestingly, GLI-
activator was not affected by changing affinities of GBS (Oosterveen et al., 2012). While 
this group found an interesting link between low affinity GBS and GLI-R activity, another 
group demonstrated that both GLI-A and -R depend upon low affinity binding sites. Hh-
responsive enhancers for FoxA2 and Nkx2.2, direct Hh transcriptional targets in the 
vertebrate neural tube, are both influenced by GBS affinity for maintaining normal 
patterning of the neural tube and preventing unwanted expansion of the floor plate in 
this Hh-regulated context (Peterson et al., 2012). Taken together, these studies strongly 
suggest that low affinity GBS are critical for generating a normal Hh response in a wide 
array of developmental contexts, tissues and animals.  
In this dissertation, I identify an array of new enhancers, describe how they are 
able to respond to signaling in different contexts, and provide several key pieces of 
evidence further supporting the importance of GBS affinity in Hh target gene regulation. 
I address the problem of enhancer identification from a bioinformatics and genomics 
standpoint and offer a solution that combines both methods to better identify Hh target 
gene enhancers. Finally, I introduce new tools to better understand how genes are 
regulated in their native genomic contexts using CRISPR/Cas9 gene editing technology. 
The chapters all work towards the same goal: to better understand how a single 






Figure 1.1 The Hedgehog (Hh) signaling pathway 
Starting in the left hand panel, in the absence of Hh ligand, Ptc inhibits Smo. This leads 
the proteolytic cleavage of Gli (or Ci in flies). This cleavage event removed the 
activation domain of Gli (yellow), generating a Gli-Repressor that enters the nucleus, 
and upon binding to its cis-regulatory element, will repress target gene transcription, of 
which ptc is a target gene. On the right hand panel, active Hh signaling is depicted. 
When Hh ligand is present, it can bind to Ptc, relieving the inhibition of Smo. This 
protects the activation domain of Gli, rendering it a transcriptional activator, so when it 
enters the nucleus, it binds to DNA to activate Hh target genes. Once again, ptc is a 





Figure 1.2 Hh signaling in the wing imaginal disc and embryonic ectoderm 
In the wing, left, Hh is expressed in posterior cells that do not express Gli. The Hh 
ligand is secreted into the anterior cells where it acts as a morphogen to activate the 
pathway (Figure 1.1) turning on target genes, of which ptc is again used as an example. 
In the embryonic ectoderm, right, Hh is expressed in the posterior of each segment in 
the embryo. It is secreted both anteriorly and posteriorly to cells that express Gli and are 
able to activate the pathway. These cells receiving high levels of Hh signal will then turn 
on Hh target genes, like ptc. 
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Chapter 2  
 
Fine Tuning Hedgehog Signaling: A cis-regulatory Strategy 




The Hedgehog signaling pathway is part of the ancient developmental-
evolutionary animal toolkit. Frequently co-opted to pattern new structures, the pathway 
is conserved among eumetazoans yet flexible and pleiotropic in its effects. The 
Hedgehog receptor, Patched, is transcriptionally activated by Hedgehog, providing 
essential negative feedback in all tissues. Our locus-wide dissections of the cis-
regulatory landscapes of fly patched and mouse Ptch1 reveal abundant, diverse 
enhancers with stage- and tissue-specific expression patterns. The seemingly simple, 
constitutive Hedgehog response of patched/Ptch1 is driven by a complex regulatory 
architecture, with batteries of context-specific enhancers engaged in promoter-specific 
interactions to tune signaling individually in each tissue, without disturbing patterning 
elsewhere. This structure—one of the oldest cis-regulatory features discovered in 
animal genomes—explains how patched/Ptch1 can drive dramatic adaptations in animal 
morphology while maintaining its essential core function. It may also suggest a general 





Like other major developmental signaling pathways, the Hedgehog (Hh) pathway 
is broadly conserved among bilaterians, from its basic signal transduction mechanism to 
the DNA-binding specificity of its effector molecules, the zinc finger transcription factors 
of the GLI family (Briscoe and Thérond, 2013; Hallikas et al., 2006). Hh signaling is 
used for cell-cell communication in many contexts during development, and is 
maintained into adulthood to control tissue homeostasis. Disruption of signaling has 
been directly linked to several human cancers such as medulloblastoma and basal cell 
carcinoma in addition to developmental disorders including spina bifida, exencephaly 
and cleft lip/palate (Barakat et al., 2010; Scales and de Sauvage, 2009; Teglund and 
Toftgård, 2010). The Hh pathway itself is highly pleiotropic, regulating many different 
cell fate decisions in different cellular contexts, but the vast majority of the direct 
transcriptional targets of Hh/GLI respond to signaling in a strictly limited, tissue- and 
stage-specific pattern (Barolo, 2002). A very small number of target genes, such as 
patched in flies and Ptch1, GLI1, and perhaps Hhip1 in vertebrates, all of which encode 
components or modifiers of the Hh pathway itself, seem to respond to Hh signaling in a 
universal, constitutive manner (or nearly so), to the extent that the expression of these 
target genes is sometimes considered diagnostic for the presence of Hh signaling 
(Epstein, 2008; Shahi et al., 2015). Although the regulation of these "universal" target 
genes, which respond to Hh/GLI in most or all signaling contexts, has been studied to 
some extent—for example, an enhancer of Drosophila patched was the first direct 
Hh/GLI target discovered in any organism (Alexandre et al., 1996)—the basis of a 
constitutive response to Hedgehog/GLI, or to any pleiotropic signaling pathway, is not 
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understood. One could imagine a simple "master" response element that is universally 
activated by a given signal in all developmental and adult stem-niche contexts where 
that signal is present. But while efforts have been made to synthesize such generic 
response elements by multimerizing binding sites, with varying degrees of success 
(Barolo, 2006), so far no such element has been found in nature. 
Here we examine the regulation of the patched gene, a universal transcriptional 
target of Hh/GLI signaling in Drosophila, and its mouse ortholog Ptch1, which has an 
equally universal response to signaling. The Hh receptor Patched (Ptc) normally inhibits 
the function of Smoothened, blocking signal transduction and favoring the production of 
the repressor isoform of the Ci/GLI transcription factor (GLIR). This inhibition is relieved 
upon binding of Hh ligand to Ptc, allowing the activator isoform (GLIA) to accumulate. 
Ptc is expressed broadly, keeping the Hh pathway silent in the absence of ligand, but it 
is also directly transcriptionally activated by GLI in all Hh-regulated tissues, where it 
moderates signal levels (Figure 2.1A). This constitutive negative feedback circuit, which 
is conserved from flies to mammals and is essential for normal development, has been 
extensively studied in Drosophila, especially in the contexts of the developing wing and 
embryonic ectoderm (Alexandre et al., 1996; Briscoe and Thérond, 2013; Chen and 
Struhl, 1996; Milenkovic et al., 1999). A previously characterized promoter-proximal 
enhancer of Drosophila patched (Alexandre et al., 1996), referred to here as ptcprox 
(Figure 2.1B), contains three optimal consensus GLI binding sites which are required to 
activate expression in Hh-responsive wing cells (Figure 2.1C-E), but was not examined 
in other developmental contexts. 
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Since patched is activated in all Hh-responsive tissues, we wondered whether 
this promoter-proximal element, with its cluster of optimal GLI sites, is capable of 
reproducing the universal Hh response pattern of its parent gene. Our previous work 
has demonstrated that high-affinity GLI motifs identical to those in ptcprox 
(GACCACCCA) can repress enhancer activity in embryos, even in Hh-responding cells 
(Ramos and Barolo, 2013; White et al., 2012). These results presented a potential 
paradox: the same GLI motifs that have been shown to repress transcription in 
embryonic stripes are also found in an enhancer of patched, a gene which is directly 
activated by Hh/GLI in those same cells. Two explanations that could reconcile these 
results were (1) that optimal GLI motifs can either activate or repress transcription in the 
same cells, depending on their cis-context, or (2) that the ptcprox element is not a 
universally Hh/GLI-responsive enhancer. To distinguish between these possibilities, we 
examined the ptcprox enhancer in the embryonic ectoderm, and found that it fails to 
respond to Hh/GLI in this context (Figure 2.1F,G). This is also consistent with reports 
that a larger 3.2 kb fragment including ptcprox is also insufficient for a complete 
embryonic response, but larger fragments that include extensive 5’ sequences are 
sufficient to drive ptc-like embryo patterns (Forbes et al., 1993; Millard and Martin, 
2008). Because the promoter-adjacent cluster of conserved, optimal GLI motifs 
produces a tissue-restricted expression pattern, it is not sufficient to explain the 
universal Hh response of the patched gene (Figure 2.1C-G), suggesting that the control 
region for embryonic stripe expression is located elsewhere in the locus. We then set 
out to identify the enhancer module responsible for ptc expression in embryonic 
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ectodermal stripes and to characterize its Hh/GLI response, hypothesizing that it may 
depend on lower-affinity GLI inputs than the ptcprox element.  
Our findings show that the seemingly simple constitutive Hh response of patched 
is controlled by an unexpectedly complex multi-modular system of enhancers spread 
across the ptc locus. The mouse Ptch1 locus seems to be regulated by a very similar 
overall structure, making this an uncommonly ancient cis-regulatory strategy in the 
animal genome, perhaps as old as the Hh-GLI-Ptc negative feedback circuit itself. We 
propose that this regulatory structure, in which many context-specific Hh-responsive 
enhancers together produce a "simple" constitutive response pattern, can explain why 
patched is an important locus for morphological divergence: it allows Hh signaling levels 
to be adjusted independently in each tissue and stage, without disturbing pathway 




2.3.1 The universal Hh response of patched is mediated by a large array of stage- 
and tissue-specific enhancers 
For this study, we created a nomenclature of sequence fragments by dividing the 
5’ intergenic sequences into regions A through Z (with A containing the ptc transcription 
start site) and the first intron into regions 1A through 1I, and then naming each 
sequence fragment after the 5’- and 3’-most regions included in that fragment (Figure 
2.3A): for example, the ptcprox enhancer, which spans fragments D, C, and B, will be 
referred to in the rest of this report as module DB. To reduce bias in our search and to 
account for the possibility of multiple embryonic enhancers, we independently tested 
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overlapping fragments of the large 5’ intergenic region and the large first intron of ptc as 
single-copy, targeted-insertion reporter transgenes in which GFP was driven by the ptc 
promoter (fragment BA) (Figure 2.3A). We focused on the 5’ intergenic and first-intron 
sequences of ptc in this functional analysis because the other four introns of ptc are 
short (<350 bp) and poorly conserved and the 3’ neighboring gene is located less than 
700 bp downstream of ptc.  
 The BA promoter fragment alone drives broad, low-level gene expression in most 
or all tissues—suggesting that the broad, non-Hh-regulated aspect of patched 
expression may be controlled by this region—but it is not able, on its own, to drive Hh-
responsive patterns in any tissue (Figures 2.3J,J’’). FAIRE-seq and DNAse-seq 
datasets (McKay and Lieb, 2013; Thomas et al., 2011) show that chromatin states in 
non-coding regions of the patched locus are highly dynamic in the Drosophila embryo 
and larval wing (Figure 2.3B; Figure 2.3.). Furthermore, the promoter-proximal 
consensus GLI sites, which are essential for ptcprox activity in the wing (Figure 2.1D-E), 
are in regions of mostly closed chromatin in the embryo, consistent with reporter data 
suggesting that Hh/GLI regulates patched via different enhancers in the embryo vs. 
wing. Every tested fragment in this 27 kb region drives expression in ptc-positive cells 
within at least one Hh-patterned tissue (e.g., Figure 2.3C-I; see also data from (Jenett et 
al., 2012; Kvon et al., 2014). These tissues represent cell types from nearly every stage 
of the Drosophila life cycle, from multiple embryonic tissues types to larval imaginal 
discs (Figure 2.3C,D,F) to adult tissues such as the gut and stem cell/niche systems in 
testes and ovaries (Figure 2.3E,G,H). Hh signaling participates in the development and 
maintenance of all of these tissues and cell types (Chen and Struhl, 1996; Michel et al., 
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2012; Sahai-Hernandez and Nystul, 2013; Takashima and Murakami, 2001; Zhang and 
Kalderon, 2001). In many tissues, such as the embryonic ectoderm, multiple ptc 
modules are active. However, no single enhancer recapitulates the complete ptc 
expression pattern (Figure 2.3C-I; Figure 2.4). Together, these findings are consistent 
with DamID data indicating that Ci, the Drosophila GLI, occupies the entire ptc locus in 
embryos (Biehs et al., 2010). Distributed, multi-modular enhancer arrangements have 
been observed at other developmental gene loci  (Barolo, 2011a), but ptc appears to be 
an unusually complex cis-regulatory locus—an idea supported by unusually dynamic 
chromatin structure (Figure 2.3B; Figure 2.4) (Thomas et al., 2011). 
 
Bypassing enhancer-promoter specificity reveals diverse sub-patterns among 
segmentation stripe enhancers of patched 
 
We find that, as in other tissues, the control of patched expression in the 
embryonic ectoderm is distributed among multiple stripe enhancers distributed across 
the locus. A small promoter element, fragment BA, which does not include the cluster of 
three optimal GLI sites (Figure 2.3A), drives broad, low-level, non-Hh-regulated 
expression (Figure 2.3J,J’), while several separable embryonic enhancers, when 
examined in vivo as GFP reporters containing the BA promoter element, drive patched-
like segment-polarity stripe patterns (Figure 2.3K-N). In order to distinguish the 
information encoded in these embryo stripe enhancers from that provided by the 
endogenous ptc promoter, we also tested several ptc stripe enhancers with a minimal 
heterologous Hsp70 TATA/Inr-containing promoter ("hspmin") driving GFP. When 
paired with the hspmin promoter, three ptc enhancers drive ptc-like responses in the 
embryonic ectoderm (Figure 2.5; Figure 2.6). The intronic element 1EH is activated in 
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stripes to the anterior and posterior of each segmental stripe of Hh-expressing cells, 
much like the ptc gene's expression pattern in this tissue, though with broader stripes 
(Figure 2.5C-D). The distal 5' enhancer VT is active in a subset of ptc-positive cells on 
the anterior side of Hh-producing stripes in each segment (Figure 2.5H), while the more 
proximal 5' enhancer LK drives expression in ptc+ cells to the posterior of each Hh 
stripe (Figure 2.5K). Conditional overexpression of the Hh ligand augmented the 
posterior-stripe expression of enhancer LK, but did not affect the context specificity of its 
expression pattern (Figure 2.7). 
2.3.2 GLI binding site affinity informs tissue specificity 
We analyzed the sequence of the embryonic stripe enhancers described above 
to identify putative binding sites for the zinc finger transcription factor Cubitus 
interruptus (Ci), the Drosophila GLI, using an in vitro binding dataset (Hallikas et al., 
2006) which corresponds well with GLI binding preferences in vivo (e.g., (Peterson et 
al., 2012) (see Methods). These Ci/GLI motifs were then altered by overlap extension 
PCR to abolish Ci binding (see Figure 2.8 for in vitro binding assays). Mutating Ci/GLI 
motifs in each embryonic stripe enhancer of ptc severely reduced its Hh responsiveness 
in vivo (Figure 2.5), demonstrating that low- to moderate-affinity GLI motifs—which 
account for most or all of the Ci/GLI sites in these modules (Figure2.8)—are required for 
strong activation in the embryonic ectoderm. Enhancer 1EH contains one optimal GBS 
(GACCACCCA), but targeted mutation of this motif did not have a strong effect on 
enhancer activity (Figure 2.5G, compare to 2.5D). 
To test whether the low affinity of GLI sites in these enhancers contributed to 
transcriptional activation, we converted two of the low-affinity motifs in both the 1EH 
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module and the VT module to optimal GACCACCCA motifs.  Because this two-site 
optimization increased Ci binding to those sites in vitro (Figure 2.8), and augmented the 
GLI1-responsiveness of the enhancer modules in mammalian cells (Figure 2.5M), we 
conclude that the sequence alteration improves Ci/GLI binding as predicted.  In vivo, 
however, the GLI-optimized 1EH and VT enhancers are significantly less active in the 
embryonic ectoderm than their wild-type counterparts (Figure 2.5F,J; compare to 
2.5D,H). Though perhaps counterintuitive, this finding is consistent with our group's 
previous reports that optimizing Ci/GLI motifs in Hh-regulated embryonic ectodermal 
enhancers of the wingless and stripe genes causes a decrease in enhancer activation in 
vivo (Ramos and Barolo, 2013; White et al., 2012). Interestingly, this effect appears to 
be tissue-/stage-dependent: optimizing two GLI motifs in the VT module decreases its 
activity in the embryonic ectoderm, as described above, but the same alteration 
conversely causes an increase of enhancer activity in the wing disc (Figure 2.5J'), 
where VT is normally weakly active (Figure 2.5H'). These results suggest that there is 
no level of GLI occupancy that allows optimal activity of this ptc enhancer in both the 
embryonic segments and the wing disc. Thus, nonconsensus GLI motifs can influence 
both the strength and the stage/tissue specificity of transcriptional responses to 
Hedgehog signaling. 
2.3.3 Multiple wing disc enhancers of patched depend on GLI motifs of varying 
affinities to synergistically activate gene expression in response to Hh 
 
The ptc response to Hh/GLI in the wing, as in the embryonic ectoderm, is 
distributed across many regions of the locus; in fact, most of the enhancers we tested in 
vivo had some activity in wing imaginal discs, though not all drove a strong or strictly 
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ptc-like expression pattern. We examined a few of these enhancers (Figure 2.9A)—all 
of which correspond to regions of accessible chromatin in wing discs (Figure 2.3B; 
(McKay and Lieb, 2013))—in greater detail with respect to their direct GLI inputs, using 
GFP reporters with a minimal TATA+Inr "hspmin" promoter. All of these wing stripe 
enhancers depend on GLI motifs for full activity in the wing imaginal disc (Figure 
2.9B,D). However, the number and quality of GLI motifs in these modules bears no 
obvious relationship to the strength of enhancer activity in Hh-responding cells. For 
example, the previously characterized wing enhancer ptcprox (referred to here as 
module DB), with its cluster of three well-conserved optimal sites, is a weaker wing 
enhancer than several other regions of the ptc locus with fewer and/or lower-affinity GLI 
motifs (Figure 2.9B-D; Figure 2.10).  Presumably this reflects a requirement for other 
transcription factor inputs into these modules, but it also demonstrates that binding site 
quality and number are not always accurate predictors of transcriptional responsiveness 
in vivo.  
When these five wing enhancers (paired with the same hspmin promoter) were 
tested for GLI responsiveness in GLI1-expressing NIH/3T3 cells as luciferase reporters, 
we found that their levels of activation were not well correlated with either their 
expression levels in wing discs or the number or quality of GLI sites (Figure 2.9E, 
compare to 2.9C,D). However, the relative change in expression upon mutation of the 
GLI motifs, both in vitro and in vivo, was usually greater in modules with higher-quality 
GLI sites such as DB and ZY, compared to modules with weaker sites such as HF and 
YU (Figure 2.9D,E). Taking these results altogether, we conclude that, while GLI motif 
quality plays a role in Hh/GLI responsiveness (positively or negatively, depending on the 
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developmental context), it is not in itself a good indicator of which enhancers will be the 
most strongly active in a given tissue. Note that of the five wing enhancers examined 
here, the two with the highest expression levels in wings (HF and YU) have relatively 
few and/or low-quality GLI motifs, which nevertheless make significant contributions to 
their activity.  
We were intrigued to learn from the above analysis that the canonical patched 
wing enhancer ptcprox/DB, with its cluster of optimal GLI motifs, drives relatively weak 
expression in vivo (though it is strongly responsive to Hh/GLI in vitro). This result led us 
to hypothesize that the high-affinity GLI sites in the DB module may require additional 
flanking sequence in order to exert a strong influence on gene expression in vivo. We 
first addressed this by testing a nested set of fragments from the -5.5 kb region 
upstream of ptc, all containing the 3 proximal optimal GBS (Figure 2.9F, top). All of the 
fragments (DB, GB, HB, and JB, in order of increasing size) drove ptc-like stripes in the 
wing, but while the anterior-posterior positions of these stripes were the same, the 
levels and dorsal-ventral extents of gene expression increased greatly with the addition 
of 5’ flanking sequence (Figure 2.9G,H). 5’ sequences containing relatively few and 
weak GLI motifs provided significant boosts to gene expression in the wing: for 
example, compare GB to DB, and HB to GB (Figure 2.9G,H,K). We next examined the 
direct contribution of the three optimal GLI sites (located within region D) to the in vivo 
activity of the nested fragments DB, GB, and JB. In all cases, mutating these three GLI 
sites (while leaving any other GLI motifs intact) significantly reduced peak gene 
expression in the wing stripe (Figure 2.9K) (Student’s t-test; p<0.0015). However, the 
relative contribution of those three sites, measured as reduction of expression of a 
 28 
3xGLI-mutant enhancer compared to wild-type, decreased as more cis-regulatory 
context was included—from a 99.9% reduction in module DB, to a 62% reduction in 
module GB, to a 26% reduction in module JB (Figure 2.9K). When taken out of their 
native sequence context and tested as a synthetic reporter, three optimal Ci/GLI sites 
are not capable of activating gene expression in the wing, though they can strongly 
synergize with other activator binding sites (Ramos and Barolo, 2013). 
By breaking down module JB into smaller, non-overlapping sub-fragments (JI, H, 
GE, and DB; see Figure 2.9F), we were able to test the individual contributions of these 
regions, with very different predicted GLI binding patterns, to gene activation. Note that 
of these fragments, only module DB contains the cluster of three optimal GLI motifs. All 
of these modules were sufficient to drive expression in the wing disc, and as with the 
more distal patched wing enhancers examined above, little or no correlation between 
predicted GLI affinity and in vivo expression levels was observed (Figure 2.9G,I). In 
general, transcriptional synergy among sub-fragments was observed in vivo, such that 
the activity of a large fragment (JB, HB, GB) was greater than the sum of the individual 
activities of its constituent sub-fragments (Figure 2.9H-J). 
The above findings suggest that, even in the wing, the promoter-proximal cluster 
of optimal GLI sites makes a relatively minor (though significant) contribution to the 
Hh/GLI response of patched, and that inputs from many additional cis-regulatory 
regions, some of which contain relatively few and/or weak GLI motifs, are integrated to 
produce the final pattern of transcriptional activation in this tissue. 
2.3.4 An unusual tissue- or stage-specific Polycomb/Trithorax response element 
(PRE) alters the output of patched enhancers  
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In addition to the multi-modular complexity of the ptc locus, we found evidence of 
higher-level control of gene expression via specialized enhancer-promoter interactions. 
Some ptc enhancers drove qualitative and quantitatively different in vivo expression 
patterns when placed in cis to a homologous vs. a heterologous promoter (e.g., Figures 
2.3M, 2.5K; see also below). In third-instar larvae, the ptc promoter and 5’ sequences 
are bound by the Polycomb group (PcG) factors Pleiohomeotic (Pho), Polyhomeotic 
(Ph), Polycomb (Pc), and Posterior sex combs (Psc), as well as the Trithorax group 
(TrxG) factor Trl/GAF (Oh et al., 2013; Schaaf et al., 2013), and are marked with the 
repressive histone modification H3K27me3 (Figure 2.11A). These are all hallmarks of 
Polycomb/Trithorax response elements (PREs), cis-regulatory sequences which 
mediate epigenetic regulation by PcG/TxG factors (Bowman et al., 2014; Kassis and 
Brown, 2013; Schaaf et al., 2013). In embryos, however, the ptc promoter lacks PRE 
signatures: compared to the PRE-containing loci en/inv, AbdB, and Ubx, the ptc 
promoter region has low PcG occupancy (except for Pho) and low H3K27me3 
(Schuettengruber et al., 2009)  (Figure 2.12).  A motif analysis of DNA sequences 
located 5’ of the ptc promoter using the CIS-BP database (Weirauch et al., 2014) 
identified conserved binding motifs for the PcG protein Pho (ortholog of vertebrate YY1) 
and the TrxG transcription factor Trl/GAF (Figure 2.11B; Figure 2.13), consistent with 
our tissue-specific ChIP-seq binding data. These motifs are frequently enriched in PREs 
and often required for their function (Kassis and Brown, 2013). We also compared the 
core promoter motifs present in our two test promoters. The ptc core promoter region 
lacks a TATA box but contains a Drosophila Initiator element (Inr) and multiple GAF-
binding GAGA motifs, as well as a pause button (PB) and a Downstream Promoter 
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Element (DPE) 3’ of the transcription start site (Figure 2.11B; Figure 2.13). The GAGA + 
Inr + [PB and/or DPE] promoter configuration is associated with RNA polymerase II 
stalling at Drosophila promoters (Hendrix et al., 2008), and embryonic GRO-seq data 
identify ptc as one of the most heavily promoter-paused genes in the Drosophila 
genome (Saunders et al., 2013). The ptc promoter is highly dissimilar from the minimal 
Hsp70 “hspmin” promoter fragment used here as an alternative heterologous promoter, 
which has a TATA + Inr motif configuration (Emanuel and Gilmour, 1993). 
When paired with the heterologous hspmin promoter, the ptc embryonic stripe 
enhancers PN and LJ activate expression in restricted subsets of the ptc segment-
polarity stripe pattern (dorsal and posterior ptc-positive cells, respectively, within each 
embryonic segment) (Figure 2.11, left). However, when paired with the native ptc 
promoter fragment BA—which alone is broadly and weakly active (like the ptc gene 
itself) but unresponsive to Hh/GLI (Figures 2.3J,J’ and 2.11C, top)—these enhancers 
drive stronger and more complete, ptc-like expression patterns in embryos (Figure 
2.11C, right). Neither the core ptc promoter, fragment A, nor the upstream element, 
fragment B, were sufficient to enhance the Hh/GLI response of module PN (Figure 
2.14A-H), suggesting that both the ptc core promoter, region A, and the promoter-
proximal fragment B are required for this enhancement. 
We next examined the promoter effects on ptc enhancer function in larval 
imaginal discs—where, in contrast to the embryo, we found strong PcG binding and the 
Polycomb-produced repressive mark H3K27me3 at and upstream of the promoter 
(Figure 2.11A; compare with Figure 2.12). Three of four tested wing-stripe enhancers 
(GC, YU, and ZY) showed reduced activity when paired with the ptcBA promoter, 
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compared to the heterologous hspmin promoter (Figure 2.11D,E). A fourth wing 
enhancer, HF, showed no difference in peak levels of activation, but had a higher 
baseline expression level across the wing when paired with ptcBA (Figure 2.11D,E).  
Taken together, our genomics and functional results suggest that interactions 
among multiple regions of the cis-regulatory apparatus, including distal enhancers, 5’ 
promoter-proximal sequences, and the core promoter are integrated to determine the 
final pattern and levels of gene expression in each tissue, in a manner that correlates 
with the presence or absence of PcG/TrxG regulation of a tissue- or stage-specific PRE. 
Interestingly, the TrxG factor GAF—which has been associated with 
transcriptional activation in addition to its role in PRE-mediated repression (Adkins et 
al., 2006)—directly occupies the intronic embryonic stripe enhancer 1EH in the embryo, 
though to a lesser extent than the ptc promoter (Figure 2.11A; Figure 2.12), probably via 
conserved GAGA motifs in that element (Figure 2.15 and Figure 2.16).  This may 
explain why the 1EH module, the most powerful embryonic stripe enhancer at the ptc 
locus, does not require the heavily GAF-occupied ptc promoter for strong activation in 
the embryo (Figure 2.14).  GAF has recently been implicated in large-scale changes in 
gene regulation during the embryo-larva transition (Blanch et al., 2015). 
2.3.5 Drosophila and vertebrate patched orthologs share a similar cis-regulatory 
strategy 
Direct transcriptional activation of ptc by Hh/GLI, for the purpose of negative 
feedback regulation, is a regulatory circuit that predates the protostome-deuterostome 
split (Alexandre et al., 1996; Goodrich et al., 1996). In light of this unusually ancient 
evolutionary linkage, we asked whether the cis-regulation of the mammalian Ptch1 gene 
resembles that of its insect ortholog. Two GLI-bound enhancers of mouse Ptch1 have 
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been reported: a high-affinity promoter-proximal neural tube module v(Vokes et al., 
2007)  and a lower-affinity intronic limb bud mesenchyme module (Lopez-Rios et al., 
2014). Our ChIP-seq analysis and previous studies (Lopez-Rios et al., 2014; Peterson 
et al., 2012; Vokes et al., 2007) identify many sites of significant GLI binding near 
mPtch1 and extending far upstream of the gene (Figure 2.17A,B). We tested seven of 
these GLI-bound regions as lacZ reporters in transgenic mice. As with enhancers of 
Drosophila ptc, we found that all tested Ptch1 modules are active in different, 
overlapping subsets of the Ptch1 expression pattern: no single module, no matter how 
strongly bound by GLI, recapitulates the complete Hh/GLI-responsive expression 
pattern of the parent gene (Figure 2.17A). Binding of GLI transcription factors to 
numerous sites in the Ptch1 locus is dynamic across several different developmental 
contexts, perhaps suggesting that enhancer modules are differentially accessible in a 
developmentally regulated manner (Figure 2.17B, red arrows). Even taken together, the 
novel enhancers that we identify here and the previously identified modules do not 
account for the complete Ptch1 pattern, suggesting that there are still more yet 
uncharacterized Ptch1 enhancers to be found—presumably with relatively lower levels 
of GLI factor binding, since the highest-occupancy ChIP-seq peaks have now been 
tested. As in fly ptc, chromatin at the mouse Ptch1 locus is H3K27-trimethylated at the 
promoter and in upstream noncoding regions (Figure 2.17C, compare with 2.11A), 
characteristic of PcG regulation (Bowman et al., 2014; Kassis and Brown, 2013).  
Mouse Ptch1 and fly patched share a general gene-expression profile (broad, 
weak basal expression plus a constitutive response to Hh/GLI), as well as a complex 
multi-enhancer organization in which the universal response to Hedgehog signaling is 
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not constituted in a master GLI response element, but distributed across many sub-
tissue-specific GLI-regulated modules (Figure 2.17A,D,E). The GLI-regulated enhancers 
discovered to date at both the Drosophila patched and vertebrate Ptch1 loci range from 
remote 5’ elements, to promoter-proximal modules with optimal GLI motifs, to intronic 
enhancers.  Hi-C topographical domain mapping and ChIP-seq occupancy data for the 
chromatin insulator/boundary factor CTCF indicate that both Ptch1 and patched are 
flanked by a nearby 3’ boundary (associated with a closely neighboring downstream 
gene) and a far more remote 5’ boundary (Dixon et al., 2012; Wang et al., 2012) (Figure 
2.17A,D,E; Figure 2.18). In both fly and mouse, all mapped enhancers fall within this 
topographical domain; they rely on GLI sites across a wide range of affinities; they 
appear to also require additional tissue-specific transcription factor inputs 
(Supplementary File 2); and they act through a PcG-bound, H3K27me3-marked 
promoter. This combination of regulatory mechanisms, ranging in scale from the single 
binding site to the locus as a whole, allows independent tuning of ptc/Ptch1 
expression—and therefore of Hh signaling levels—in individual tissues, without 
disrupting overall signaling required for normal development and adult tissue 




This chapter, which examines the regulation of an essential developmental gene 
at the locus-wide level, demonstrates for the first time how a constitutive pathway-
responsive gene is precisely regulated in diverse developmental contexts. This 
regulation consists of two major modes of control: First, ptc must be broadly active to 
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inhibit Smoothened activity, preventing the inappropriate activation of Hh target genes 
and subsequent faulty patterning, developmental defects, and disease (Barakat et al., 
2010; Scales and de Sauvage, 2009; Teglund and Toftgård, 2010). Our reporter-based 
analysis of the locus has identified a promoter-proximal 5' sequence, region B, which in 
conjunction with the core promoter acts as the likely controller of the basal, signal-
independent mode of ptc expression.  
Second, ptc must be able to respond to Hh/GLI signaling in many developmental 
and stem-niche contexts. We show here that this is not accomplished by a master 
Hh/GLI response element, but rather by a collection of GLI-regulated enhancers spread 
across the ptc gene locus. These remote, tissue- and sub-tissue-specific enhancers 
work synergistically and are integrated with additional information from promoter-
proximal sequences and the core promoter, responding to Hh signaling differently in 
each stage and tissue type. The basis for the tissue-specific activity of the numerous 
enhancers of ptc has not been directly examined yet, but in some cases we have 
identified likely candidate selector inputs by a combination of sequence motif searching 
and DNA conservation analysis (Figure 2.16; Figure 2.17D,E). 
At least in some enhancer modules, we find that the quality/affinity of GLI binding 
motifs in these enhancers is extremely important for proper patterning, to the extent that 
optimizing GLI motifs in certain enhancers can cripple enhancer activity.  Previous 
studies from our group and others have shown that low-to-moderate-affinity 
transcription factor binding sites can be important for limiting the response of a target 
gene to a pleiotropic, broadly active transcription factor or pathway (Crocker et al., 
2015; Farley et al., 2015; Swanson et al., 2011); additional references within). Our 
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results with embryonic stripe enhancers of the ptc gene, however, point to a different 
type of regulatory control by weak binding sites, in which the occupancy of a 
transcription factor is modulated to an optimal level of activation within a tissue. The fact 
that optimal activation is achieved via suboptimal GLI binding sites in the Drosophila 
embryo may reflect the fact that Ci/GLI acts both as an activator and as a repressor 
through the same binding sites. Considering that the area and duration of Hh production 
in embryonic segments is vastly lower than that in larval/pupal wings, where half of the 
organ produces Hh protein for most of the developmental period of the animal, it is to be 
expected that the GLIA:GLIR ratio may be significantly lower in Hh-responsive cells in 
the embryonic segments than in late-larval wing discs. If so, the relatively high 
concentration of GLIR in Hh-responding embryonic cells may create selective pressures 
favoring lower GLI occupancy, as we have argued previously (Parker et al., 2011; White 
et al., 2012). Alternatively (or in addition), other mechanisms, such as overlapping 
binding specificities for non-GLI transcription factors, could play a role in the sub-
optimization of GLI motifs observed here. 
Our results from transgenic mouse reporter constructs and GLI ChIP-seq 
experiments suggest that the same large-scale cis-regulatory strategy at work in the fly 
locus is also present in vertebrates—at least to the extent that many enhancers, with 
widely varying levels of GLI input, act in combination but in a tissue-specific manner to 
independently adjust Ptch1 expression levels in each cell type, giving the illusion of a 
universal response to Hh signaling but in fact representing a complex array of context-
limited responses. However, we do not mean to propose that the specific cis-regulatory 
sequences that regulate patched and its orthologs are conserved across such large 
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evolutionary distances. Individual patched enhancers show no obvious sequence 
conservation from insects to mammals—unsurprisingly, given that most ptc-expressing, 
Hh/GLI-regulated organs present in modern animals did not exist at the time of the 
protostome-deuterostome divergence. Rather, we propose that patched and its 
orthologs share an ancient regulatory structure composed of relatively young 
enhancers. Based on our motif analyses and mutational studies, we propose that 
patched enhancer evolution likely involved both tuning of GLI occupancy and the co-
option of tissue-specific inputs to produce new aspects of the patched expression 
pattern over time. This elaboration of new sub-patterns would not be necessary if 
patched/Ptch1 were regulated by a unified "master" Hedgehog response element; under 
such a simple regulatory scheme, new domains of patched expression would appear 
automatically whenever Hh signaling were activated in new contexts. By contrast, our 
analysis suggests that robust response to Hh/GLI in both embryonic segment-polarity 
stripes and in larval wing stripes may not be achievable by the same enhancer module, 
perhaps due to conflicting requirements for GLI occupancy, or perhaps for other 
reasons whose basis in cis-regulatory logic is not yet clear. 
The cis-regulatory architecture discovered here is also a remarkably ancient 
example of a direct transcriptional linkage and gene regulatory strategy in animals. 
Notch regulation of Hes/Hey genes is a circuit of comparable age, but its conservation is 
limited to the presence of CSL-family binding sites controlling orthologous target genes 
(Rebeiz et al., 2012), with no evidence of a larger shared gene-regulatory structure. 
Conversely, while the collinear structure of animal Hox gene clusters predates the 
Bilateria, the upstream regulators of Hox genes do not appear to be shared between 
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protostomes and deuterostomes (Duboule, 2007). Our results suggest that the locus-
wide multi-modular structure by which patched responds to Hh/GLI to provide feedback 
inhibition is an unusually old cis-regulatory strategy. This strategy has the potential 
advantages of transcriptional precision and robustness ascribed to regulation by 
‘shadow’ enhancers (Barolo, 2011b; Frankel et al., 2010; Perry et al., 2011; Wunderlich 
et al., 2015), but more importantly it allows for the independent modulation of signaling 
levels in a stage- and tissue-specific manner, without disturbing pathway activity in other 
contexts.  
Our model has significant implications for the evolution of cell signaling pathways 
and their target genes and tissues. For example, it helps to explain two reported cases 
of morphological divergence caused by changes at the vertebrate Ptch1 locus: 
modifications to an intronic enhancer of Ptch1 produced major developmental 
adaptations in the bovine limb (Lopez-Rios et al., 2014), while sequence variation 
upstream of Ptch1 is linked to cichlid craniofacial diversification (Roberts et al., 2011). In 
both cases, Hh signaling levels in other developmental contexts (for example, the spinal 
cord) were apparently unaffected by the adaptation, indicating that the affected 
enhancer module is stage/tissue-specific. Our conserved structure with flexible 
enhancers model of patched regulation is also consistent with the finding that, while 
zebrafish Ptch1 resembles its mouse and fly orthologs in having multiple GLI-bound 
regions, few such sites are conserved among vertebrates (Peterson et al., 2012; Wang 
et al., 2013). Thus, while the cis-regulatory structure of patched appears to have ancient 
roots, it is also highly flexible, allowing a core component of the Hedgehog pathway to 
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function as an adaptable tissue-specific modifier of pathway activity and as a substrate 
for morphological evolution. 
 
2.5 Materials and Methods 
 
Transcription factor binding site prediction and ranking 
Matrix similarity scores were calculated(Quandt et al., 1995) using in vitro Ci/GLI 
binding data (Hallikas et al., 2006). GBS were identified in silico by screening the ptc 
locus for defined motifs using GenePalette (Rebeiz and Posakony, 2004).  PBEs 
(Polycomb-core-complex Binding Elements) were defined by Mohd-Sarip et al. (Mohd-
Sarip et al., 2005). 
 
DNA sequence alignments  
Sequences and multi-species alignments were obtained from the UCSC Genome 
Browser (genome.ucsc.edu). 
 
DNA cloning and mutagenesis 
Wild-type ptc enhancers were amplified by PCR (Roche Expand High Fidelity PCR 
System) from BAC DNA (CH322-170A-12 or CH322-188E13). PCR primers are 
provided in Figure 2.19. Enhancer constructs were sub-cloned into the pENTR/D-TOPO 
plasmid (Life Technologies) by TOPO cloning. Enhancers tested with the hspmin 
promoter, taken from the D. melanogaster Hsp70 gene, were subsequently cloned into 
the pHPdesteGFP transgenesis vector via LR Cloning (Life Technologies). Enhancers 
tested with the endogenous ptc promoter were cloned by traditional methods into the 
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pStinger transgenesis vector (Barolo et al., 2000). Targeted GBS mutations were 
created by overlap-extension PCR (Swanson et al., 2010a). Promoter analysis 
described in Figure 2.11 and Figure 2.14 was done by replacing the minimal hsp70 
promoter contained in pHPdeste with the designated ptc promoter region (see Figure 
2.19 for sequences and restriction sites used). All enhancers and promoters were 
screened by restriction digest and sequencing. 
 
Drosophila transgenesis 
P-element transformation was performed as previously described (Swanson et al., 
2010a) in the w1118 strain. Site-directed transformation by embryo injection was 
performed as described by (Bischof et al., 2007), with reporter transgenes integrated 
into a ΦC31 landing site at genomic position 86Fb.  
 
Immunohistochemistry and confocal microscopy 
Drosophila embryos and third-instar imaginal discs were fixed and stained using 
standard methods (Parker et al., 2011; Ramos and Barolo, 2013; White et al., 2012). 
Adult testes and ovaries were dissected between 0-2 days after adult hatching, fixed in 
4% paraformaldehyde, washed in PBS with 0.1% TritonX, and subjected to antibody 
staining. Third-instar larval gut was dissected and fixed in the same matter as testes 
and ovaries. Primary antibodies used included rabbit anti-EGFP (Invitrogen 1:100), 
mouse anti-beta-galactosidase (Developmental Studies Hybridoma Bank 40-1a, 1:200), 
mouse anti-Engrailed (Developmental Studies Hybridoma Bank 4D9, 1:50), mouse anti-
Wingless (Developmental Studies Hybridoma Bank 4D4, 1:50). In Drosophila embryos, 
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EGFP antibodies were used to visualize reporter expression; in imaginal discs, native 
GFP fluorescence was imaged directly. Antibodies obtained from the Developmental 
Studies Hybridoma Bank were developed under the auspices of the National Institute of 
Child Health and Human Development and maintained by the Department of Biological 
Sciences, The University of Iowa (Iowa City, IA). AlexaFluor488, AlexaFluor555, and 
AlexaFluo568 conjugates with secondary antibodies from Invitrogen were used at 
1:2000 dilutions. DAPI was included in the Prolong Gold antifade mountant (Life 
technologies). Confocal images were captured on an Olympus FluoView 500 Laser 
Scanning Confocal Microscope mounted on an Olympus IX-71 inverted microscope, 
and on a Nikon A1 confocal microscope. Samples to be directly compared were fixed, 
prepared, and imaged under identical confocal microscopy conditions and settings. 
Quantitative GFP expression data from imaginal discs were collected from confocal 
images: all GFP-expressing fly stocks were crossed to the same reference line, dppD-
Ciptc, which drives DsRed expression in wing discs, as an internal normalization 
reference (Parker et al., 2011). DsRed and GFP were imaged for each disc, and GFP 
levels were normalized to peak DsRed fluorescence (Parker et al., 2011). Normalized 
GFP fluorescence data across wing discs (Figs. 4 and 5) were graphed in MATLAB (E. 
Ortiz-Soto, A.I.R. and S.B., manuscript in preparation). Two-tailed t tests for two 
samples with unequal variances were used to compare peak wing expression levels of 
GFP reporters. 
   
Cell culture assay  
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NIH/3T3 cells were cultured at 37°C, 5% CO2, 95% humidity in Dulbecco’s modified 
eagle medium (DMEM; Gibco, cat. #11965-092) containing 10% bovine calf serum 
(ATCC; cat. #30-2030) and penicillin/streptomycin/glutamine (Gibco, cat. #10378-016). 
Luciferase assays were performed by plating 2.5 x 104 cells/well in 24 well plates. The 
next day, cells were co-transfected using Lipofectamine 2000 with the DNA constructs 
indicated in each experiment in addition to ptc∆136-GL3 (Chen et al., 1999; Nybakken 
et al., 2005) and pSV-Beta-galactosidase (Promega) constructs to report Hh pathway 
activation and normalize transfections, respectively. GLI1 cDNA was added where 
relevant to activate the Hh pathway. Cells were changed to low-serum media (DMEM 
supplemented with 0.5% bovine calf serum and penicillin/streptomycin/glutamine) 48 
hours after transfection and cultured at 37°C in 5%CO2 for an additional 48 hours. Cells 
were harvested and luciferase and beta-galactosidase activities were measured using 
Luciferase Assay System (Promega, cat. # E1501) and BetaFluor -gal assay kit 
(Novagen, cat. #70979-3). Multiple assays were performed and each treatment group 
was assayed in triplicate. Two-tailed t tests for two samples with unequal variances 
were used to compare samples.   
 
Quantitation of transgenic reporter expression data 
Fluorescence data from wing confocal images were collected and quantified as 
previously described using the Matlab program Icarus (E. Ortiz-Soto, A.I.R., and S.B., 
manuscript in preparation) (Parker et al., 2011; Ramos and Barolo, 2013). Each 
experiment was performed at least two times, and fluorescence was measured from at 
least two wings per construct. 
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EMSA competition assays 
Electromobility shift competition assays were performed as previously described  
(Parker et al., 2011).  EMSA oligonucleotides sequences are provided in Figure 2.20. 
 
hedgehog misexpression in Drosophila 
Heat shock-inducible Hh (HS-hh) transgenic flies (Ingham, 1993) were crossed with flies 
harboring the ptcLK-GFP reporter transgene. Embryos were collected overnight at 25°C 
and heat shocked for 1 hour at 37°C, shifted to 25°C for 30 minutes, and fixed, stained 
and imaged as described above.  
 
Drosophila larva ChIP-seq 
Protocol for carrying out ChIP in larval tissue has been described previously (Brown and 
Kassis, 2013), with minor changes: fixed brains and imaginal discs were dissected from 
10 third instar larvae, and before incubating the sonicated chromatin with antibodies 
3.3% of each sample was saved for input reactions. ChIP was performed with 1:100 
antibody dilutions of anti-Pho, anti-Ph (a kind gift from Donna J Arndt-Jovin), anti-En 
(Santa Cruz Biotechnologies) and 1:200 dilutions of anti-H3K27me3 (Millipore, 17-622) 
antibodies. Following purification of immunoprecipitated DNA, Illumina libraries were 
prepared by using TruSeq DNA Sample Prep Kit V2 as described previously 
(ethanomics.wordpress.com/chip-seq-library-construction-using-the-illumina-truseq-
adapters/). All ChIP-seq data sets were aligned using Bowtie (version 0.12.2) to the 
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Drosophila reference genome (releases 5.22 and 6.02). All ChIP-seq experiments were 
performed with 2 biological replicates.  
 
ChIP-seq data can be accessed at this link 
http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?token=yrifkssspfuzbsp&acc=GSE76892. 
 
Mouse ChIP-seq, transgenic reporters, and beta-galactosidase staining 
E10.5 embryos were obtained from timed matings of Swiss Webster (Taconic) mice and 
micro-dissected in cold PBS to isolate the head, trunk (neural tube and somites) and 
limb buds. Each tissue was pooled separately and fixed for 30 minutes in 1% 
formaldehyde/PBS at room temp. Chromatin immunoprecipitation and embryoid body 
differentiation were performed as previously described (Peterson et al., 2012). 
Antibodies used for ChIP were goat anti-mouse GLI2 antibody (R&D Systems, AF3635) 
and H3K27me3 (Millipore, 07-449). High throughput single-end sequencing was done 
on the GAII or Hi-seq platform (Illumina) and reads were mapped using BWA (Li and 
Durbin, 2010). Sequence data for the 500 kb flanking Ptch1 corresponds to 
(chr13:63,112,841-64,166,828 (mm9) have been deposited under accession number 
GSE71199. GLI3 ChIP-seq data correspond to GSE52939. Individual enhancer regions 
were defined by the conservation block encompassing the detected GLI binding region, 
amplified by PCR and cloned into a Gateway compatible version of the reporter 
construct previously described (Vokes et al., 2007). Mouse enhancer coordinates are 
provided in Figure 2.21. Transient transgenic embryos were analyzed at E10.5 and X-
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gal stained for beta-galactosidase activity for 4h at 37C. ChIP-seq data are available 
(accession number GSE71199). 
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Figure 2.1 The promoter-proximal Hedgehog/GLI-responsive enhancer of patched is not 
sufficient to respond to Hh signaling in the embryo 
(A) Summary of the conserved Hh-GLI-Ptc pathway feedback loop. (B) Promoter-
proximal region of D. melanogaster patched (ptcprox). Optimal Ci/GLI binding sites are 
shown as red bars; sequence conservation among Drosophila species is indicated by 
the histogram at bottom. (C) Wing imaginal disc from a ptc-lacZ enhancer-trap larva, 
showing the ptc wing expression pattern. (D-E) Larval wing discs carrying ptcprox-GFP 
reporter transgenes with the minimal hsp70 promoter and either intact (D) or mutated 
(E) GLI sites. Sequences can be found in Supplementary File 1. (F) Stage 12 ptc-lacZ 







































           Ci-93ko ---A-AA--  Ci-141ko --TT-T--- 
             Ci-1 GA-------     Ci-1 ---G---T- 
 
GACTTAATAGCCGCTTTCATTGGCCAAAAGCCTGATAAAAGACCGCACACGAAGCTCTTCTTCG 
         Ci-59ko ---A-A---  
 
GAGCCAAGGCAGTCGTGGCTGTGTGGTGGTTTCGTGGGTTTGATGGTTGCTGGCTTGGTGGTTT 

































            --TT-T--- Ci-100ko 
 
GGACGAGGCCACCAAATGACGGCCCACGCCTGACCCCGACTGCGATGACCCAGGGACACTGTCG 













                 Ci-16 
GGCCAGGAGCACCGACCGTCCAGGTGTCTTTTTCGATTGGATTTTTGAAAGTGCACAATCGAGT 



































































           Ci-23ko --TT-T--- 
































































YU  chr2R:4,520,384-4,522,692 2309 bp 
!
GCCCTGTCGTCTTTGTCTTCTTTATTCCCAGCGCTCCTGGGCGATCGA  
    Ci-106ko --TT-T---     
 
CGTGTGTGGCCCTCCACATCCCATTTGCGATCGGAGCGGATTGTGGGGCATTATTGGACCCTGT 









































       --TT-T--- Ci-93ko   --TT-T--- Ci-141ko   
 
AAGCCTGATAAAAGACCGCACACGAAGCTCTTCTTCGGAGCCAAGGCAGTCGTGG 
   ---A-AA-- Ci-59ko   
 
CTGTGTGGTGGTTTCGTGGGTTTGATGGTT 










          Ci-3ko --TT-T---  
  
GTCATCTTCTTGGGTGGTCCATATTAGCCGGCCTGCTCTCTCCCCCCTTTTGATCTCAAGTGCG 








         Ci-106ko --TT-T---    
 
TGTGTGGCCCTCCACATCCCATTTGCGATCGGAGCGGATTGTGGGGCATTATTGGACCCTGTCT 

















































 ---A-AA-- Ci-1ko   
 
TGGGTGGTCCACACTGCAGCGAAAATAAACTACAGTGGCAACAACAAACCAGCAGCCAAGGCAC 
---T-TT-- Ci-1ko   
 
TTTGGGTGGTCCATGCAAAAAAAAAACAAATTACGGCATGCGAATAACAATAGAAATTAGCGCT 


























































































Figure 2.2 patched enhancer sequences with targeted GLI/Ci binding site mutations 
Sequences were taken from the dm3 build of the UCSC genome browser. Optimal Ci 
binding sites are highlighted in red, low affinity Ci binding sites are highlighted in gray 
and further annotated with a numerical ranking corresponding to the affinity predictions 
previously defined(Hallikas et al., 2006). Blue text indicates how each Ci binding site 
was mutated, for example in ptc-prox enhancer DB, the optimal Ci-1 binding site of 















 ---A-AA-- Ci-1ko   
 
TGGGTGGTCCACACTGCAGCGAAAATAAACTACAGTGGCAACAACAAACCAGCAGCCAAGGCAC 
---T-TT-- Ci-1ko   
 
TTTGGGTGGTCCATGCAAAAAAAAAACAAATTACGGCATGCGAATAACAATAGAAATTAGCGCT 





















Figure 2.3 The universal Hedgehog response of patched is mediated by a large array of 
tissue- and stage-specific enhancers 
(A) The ptc genomic locus.  DNA regions tested for in vivo enhancer activity are shown 
as oblong shapes; a sequence conservation histogram is shown below the exon map. 
(B) In vivo DNA accessibility at the ptc locus, as determined by FAIRE-seq across 
various developmental stages and tissues (McKay & Lieb, 2013); DNAse-seq data are 
shown in Figure 2—figure supplement 1. (C-I) Selected larval, adult, and embryonic 
tissues from GFP transgenic animals.  Enhancer names are as in (A). (J) Activity of the 
ptcBA promoter region in a stage 12 embryo, driving broad, low expression in the 
anterior (En-negative) compartment of each segment. (K-N) ptc-like ectodermal stripes 
driven by four separate ptc enhancers in cis to the ptcBA promoter. (K’-N’) Enlarged 
views of dashed boxes in (J-N); asterisks show stripes of En-positive, Hh-producing 
cells in the posterior compartment of each segment. GFP signals are isolated 
(greyscale) in the lower half of K'-N' to show the lack of stripe enhancer activity in the 




Figure 2.4 Individual patched enhancers exhibit tissue-restricted responses to 
Hedgehog signaling 
(A) Map of the ptc locus. Enhancers described in this figure are colored; all other tested 
enhancers are grey. Sequence conservation among 12 drosophilids is shown in black. 
(B) DNAse-seq different embryonic stages in the ptc locus (Thomas et al., 2011) (B to 
H) enhancer reporter constructs, all of which are Hh/GLI-responsive in other contexts 
(see Figure 2.3), shown here in a developmental context in which they fail to drive a ptc-





Figure 2.5 Embryonic ectoderm enhancers of patched require suboptimal GLI sites to 
respond to Hh signaling 
(A) Map of the ptc locus showing enhancers tested in this figure. (B) Scale of predicted 
relative binding affinity for Ci, used to label predicted Ci/GLI motifs in enhancer 
diagrams; the optimal motif (in red) is GACCACCCA. (C) Cartoon depiction of the 
embryo with the representative region in this figure highlighted in red, left. Stage 13 
embryo carrying the ptc-lacZ enhancer-trap, right. (D,H,K) Expression of wild-type (WT) 
1EH, VT and LK enhancers in embryos (wing imaginal disc displayed in H’) Full 
embryos for all panels can be seen in Figure 2.6. (E,I,L) GLI binding site knockout 
(GBS-KO) versions of those enhancers, (wing imaginal disc displayed in I’). In addition, 
enhancer LK also responds to Hh signaling via overexpression (Figure 2.7) (F,J) 
Optimization of two non-consensus GLI mofits (GBS-opt) in enhancers 1EH and VT 
(wing imaginal disc displayed in J’) (G) The single optimal consensus motif is mutated in 
the 1EH module (1xGBS-KO). The relative affinity of GBS were assessed by 
competitive EMSA analysis (Figure 2.8). All enhancer and GLI sites can be found in 
Figure 2.2. (M) GLI1-responsiveness of embryonic enhancers in NIH/3T3 cells, error 




Figure 2.6 Embryonic ectoderm enhancers of patched require non-consensus, 
suboptimal GLI sites to respond to Hh signaling 





Figure 2.7 patched enhancer LK responds to Hh signaling in the embryonic ectoderm 
(A) GFP expression (green) shows expression of a wild-type LK enhancer reporter in 
doubly transgenic embryos containing a hedgehog cDNA under the control of the heat-
inducible Hsp70 promoter, in the absence of heat shock. (B) Embryo of the same 
genotype as (A), but with heat shock. Hh pathway activation causes an intensification 
and expansion of enhancer activity in segment-polarity stripes to the posterior of stripes 
of normal Hh signaling, but does not produce ectopic expression in the anterior stripes 
of Hh-responsive, ptc-positive cells (labeled in red with the Hh/GLI target Wingless, 




Figure 2.8 Ci binds to non-consensus GLI motifs in patched embryonic ectoderm 
enhancers in vitro 
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(A) Diagram showing three embryonic-ectoderm enhancers of ptc and their predicted 
GBS (using the same affinity rank scale as in Figure 2.5). GBS noted with an affinity 
score were tested in these experiments. (B-D) EMSA competition assays in which cold 
(unlabeled) probes bearing GBS of noted rank compete with a radiolabeled probe 
containing the consensus GBS (GACCACCCA, rank 1) for binding to the Ci DNA-
binding domain. GBS sequences and affinity ranks are in colored boxes and the 
concentrations of competitor oligonucleotides, relative to the concentration of 




Figure 2.9 Wing enhancers of patched synergize to respond to Hh/GLI, largely via low-
affinity GBS 
(A) Map of the ptc locus showing enhancers tested in this figure. (B) Activity of WT and 
GBS-KO versions of five ptc enhancers across the wing imaginal disc. Color-inverted 
grayscale images of disc segments spanning the anterior-posterior axis; GFP 
fluorescence appears black. The relative affinity of GBS were assessed by competitive 
EMSA analysis (Figure 2.10). (C) Diagrams of five wing enhancers and their GBS; all 
enhancers are color-coded as in (A). (D) Peak wing disc GFP intensity driven by WT 
and GBS-KO wing enhancers. (E) GLI1-responsiveness of the same enhancers in 
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NIH/3T3 cells, error bars indicate s.d. Student’s t-test; *, p<0.05; **, p<0.005. (F) Tested 
enhancers ≤6 kb upstream of the patched promoter are mapped to the ptc locus with 
best predicted high- and low- affinity GBS in red and gray, see GBS affinity color scale, 
bottom. (G) promoter proximal enhancer activity in wing imaginal discs as revealed by 
transgenic larvae (inverted grayscale represents GFP expression). (H,I) Quantitation of 
GFP enhancer activity across the wing disc. (J-K) Quantitation of peak GFP 
fluorescence in transgenic wing discs carrying enhancer-GFP reporters. All enhancer 




Figure 2.10 GLI binds to low affinity motifs in wing enhancers 
(A) EMSA competition assays in which increasing concentrations of unlabeled 
oligonucleotides containing the optimal GBS from the ptcDB enhancer compete with a 
radiolabeled probe containing the consensus GBS (specifically, DB site 1) for binding to 
the Ci DNA-binding domain.  Unlabeled competitor concentrations, relative to labeled 
probe, are 0x, 50x, 100x, 250x, 500x, and 1000x, from left to right.  Far right, an 
unlabeled probe containing the mutated motif used in GBS-KO enhancers does not 
compete with the labeled probe for Ci binding. (B) Four GBS from the ptcZY enhancer 
(colored according to the affinity scale in Fig. 2), tested as unlabeled competitors 
against a labeled probe containing an optimal GBS (DB site 1, tested in the far left of 
 68 
panel [A]). Oligonucleotide concentrations are the same as in (A). Far right, GBS-KO 




Figure 2.11 Developmentally dynamic Polycomb/Trithorax Response Elements (PREs) 
near the patched promoter modulate enhancer activity differently in the embryo and 
developing wing 
(A) ChIP-seq data from larval tissues showing binding of PcG proteins, the H3K27me3 
histone mark, Engrailed, and Trithorax-like(Trl)/GAF in the neighborhood of ptc. 
Embryonic Trl/GAF binding data (bottom) are taken from (Oh et al., 2013).  For 
comparison with larval PcG/TrxG binding, see embryonic ChIP-seq data in Figure 2.12. 
(B) DNA motif analysis of the ptcBA promoter.  Additional 5' flanking sequence is 
analyzed in Figure 2.13. (C) Two embryonic ectodermal enhancers of ptc (rows) tested 
on different promoters (columns) in stage 12 transgenic embryos. Related experiments 
are presented in Figure 2.14. (D) Four wing enhancers of ptc tested on a minimal 
TATA+Inr promoter (hspmin) or the native ptc promoter (fragment BA; -317 to +121). 
(E) Quantitation of wing GFP expression across wing imaginal discs carrying the 




Figure 2.12 The patched promoter region, which is heavily bound by PcG proteins and 
H3K27me3-marked in larval discs, does not show PRE signatures in the embryo 
(A) Embryo ChIP-seq binding data are taken the Cavalli group’s Polycomb and 
Trithorax Genome Browser (Schuettengruber et al., 2009) and show the H3K4me3 
mark (which is associated with active or potentially active promoters), the TrxG factor 
Trl/GAF (Oh et al., 2013), and the PcG protein Pho are present at the ptc promoter in 
the embryo. (B-D) Classic PRE-containing loci such as en/inv, ubx and abd-B. 
Embryonic patched (in A) has low levels of H3K27 trimethylation and poor occupancy of 
the PRE-associated proteins Polycomb (Pc) and Polyhomeotic (Ph) compared to these 




Figure 2.13 Conserved PRE-associated transcription factor binding motifs in promoter-
proximal sequences of the patched gene 
Gene map and sequence conservation histogram are taken from the UCSC Genome 
Browser (genome.ucsc.edu). The cluster of optimal GBS is outlined in a black box; 
various PRE-associated transcription factor binding motifs and core promoter motifs are 




Figure 2.14 Polycomb/Trithorax Response Elements (PRE) near the patched promoter 
modulates enhancer activity 
(A-J) Two embryonic ectodermal enhancers of ptc (PN, 1EH in rows) tested on different 




Figure 2.15 Conserved TF motifs identified in ptc enhancer sequences 
Consensus motifs were obtained from the CIS-BP database (Weirauch et al., 2014). 
Enhancer nomenclature is given in Figure 2A. IUPAC naming is used in the “Consensus 
Binding Motif” colu mn (R = A/G; Y = C/T; S = G/C; W = A/T; K = G/T; M = A/C; B = 
C/G/T; D = A/G/T; H = A/C/T; V = A/C/G; N = A/C/G/T). 
  
ZY Distaless (Dll) DLX TRATWDB
ZY Tango/Spineless (Tgo/Ss) bHLH-PAS/Arnt RTCASRCR
YU Scalloped (Sd) TEAD DGHATNT
YU Engrailed (En) En YTAATKR
VT Odd-Skipped (Odd) Osr SRGTAGC
VT Engrailed (En) En YTAATKR
RP Forkhead (Fkh) Forkhead/FOXA TRDDYAAACA
RP Engrailed (En) En YTAATKR
PN Pannier (Pnr)/dGATAa GATA WGATAA
LK Sloppy Paired (Slp1) Forkhead/FOXG RWAAAYA
JB GAGA Factor/Trl (GAF) Trithorax GAGAG
JB Scalloped (Sd) TEAD DGHATNT
JB Engrailed (En) En YTAATKR
1EH GAGA Factor/Trl (GAF) Trithorax GAGAG
1EH Pleiohomeotic (Pho) YY1 GCCAT
1EH Engrailed (En) En YTAATKR
B GAGA Factor/Trl (GAF) Trithorax GAGAG
B Pleiohomeotic (Pho) YY1 GCCAT






Sequence conservation of selected TF binding motifs in enhancers of patched. Selected 
conserved Tango/Spineless (Tgo/Ss) motifs are in gray; Distaless (Dll) in light blue; Engrailed (En) in 
green;  Pannier (Pnr/dGATAe) in purple; Scalloped (Sd) in blue; Cubitus interruptus (Ci) in red; Odd-
Skipped (Odd) in dark red; Forkhead (Fkh) in dark yellow; Sloppy-paired (Slp) in blue-green; 
Pleiohomeotic (Pho) in pink, GAGA Factor (GAF/Trl) in yellow.  Blocks of sequence separated by line 
breaks are not necessarily contiguous.   
 
 
Enhancer ZY  
 
 D. melanogaster  tct----------------tcgtgggtggcccttaat------------------tcgacgtca- 
     D. simulans  tct----------------tcgtgggtggcccttaat------------------tcgacgtca- 
    D. sechellia  tct----------------tcgtgggtggcccttaat------------------tcgacgtca- 
       D. yakuba  tct----------------tcgtgggtggcccttaat------------------tcgacgtca- 
       D. erecta  tct----------------tcgtgggtggcccctaat------------------tcgacgtca- 
    D. biarmipes  tct----------------tcgtgggtggcccttaat------------------tcgtcgtca- 
  D. bipectinata  tct----------------tcgtgggtggcccttaat------------------tcgtcgtcag 
   D. eugracilis  tct----------------tcgtgggtggcccttaat------------------tcgtcgtca- 
      D. elegans  tct----------------tcgtgggtggcccttaat------------------tcgtcgtca- 
   D. takahashii  tct----------------tcgtgggtggcccttaat------------------tcgtcgtca- 
     D. rhopaloa  tct----------------tcgtgggtggcccttaat------------------tcgtcgtca- 
   D. ficusphila  tct----------------tcgtgggtggcccttaat------------------tcgtcgtca- 
D. pseudoobscura  tcttgctctccgctctgcgtcgtgggtggcatttgat------tcgtcgtcgtcgtcgtcgtca- 
   D. persimilis  tcttgctctccgctctgcgtcgtgggtggcatttgattcgtcgtcgtcgtcgtcgtcgtcgtca- 
      D. miranda  tcttgctctccgctctgcgtcgtgggtggcatttgat------tcgtcgtcgtcgtcgtcgtca- 
   D. willistoni  tct----------------tcgtgggtggcctt----------------------tcgttgtca- 
      D. virilis  tct----------------tcgtgggtggccttttat------------------tcgttgtt-- 
   D. mojavensis  -------------------tcgtgggtggtcttttat------------------tcgttgct-- 
 
 D. melanogaster  tcttcttgggtggtcca-----------------------tattagccggcctgct-------------- 
     D. simulans  tcttcttgggtggtcca-----------------------tattagccggcctgtt-------------- 
    D. sechellia  tcttcttgggtggtcca-----------------------tattagccggcctgct-------------- 
       D. yakuba  tcttcttgggtggtcca-----------------------tatttgccggcctgct-------------- 
       D. erecta  tcttcttgggtggtcca-----------------------tattagccgtcctgct-------------- 
    D. biarmipes  tcctcttgggtggtcca-----------------------tattagccggccagtt-------------- 
  D. bipectinata  tctgcttgggtggcctc-----------------------tattagccgtcccgct-------------- 
   D. eugracilis  tcttcttgggtggtcca-----------------------tattagctggccttct-------------- 
      D. elegans  tcttcttgggtggtctc-----------------------tattagccggcctgct-------------- 
     D. kikkawai  tctgcttgggtggtc-------------------------tattagccggcctgct-------------- 
   D. takahashii  tcctcttgggtggtcca-----------------------tattagccggcctgtt-------------- 
     D. rhopaloa  tcttcttgggtggtctc-----------------------tattagccggcctgct-------------- 
   D. ficusphila  tcttcttgggtggtctc-----------------------tattagccggcctgct-------------- 
D. pseudoobscura  tcatcatgggtggtc-------------------------tattagcccg-------------------- 
   D. persimilis  tcgtcatgggtggtc-------------------------tattagcccg-------------------- 
      D. miranda  tcgtcatgggtggtc-------------------------tattagcccg-------------------- 
   D. willistoni  tcgtcatgggtggtc-------------------------tattagctgcctcgcttctctatctttctc 
      D. virilis  tcgtcttgggtggtctatctcttgccagtgtgtgtctctctgt---ctcgctcact-------------- 
   D. mojavensis  tcgccttgggtggtccaactcttggcagtgtgtggctctatat-agctcgctctcg-------------- 
 
 D. melanogaster  attgatcatt-ttctcgtttgatagtgcgtgacg--t---ctctgggcag------------------cc 
     D. simulans  attgatcatt-ttctcgtttgatagtgcgtgacg--t---ctctgggcag------------------cc 
    D. sechellia  attgatcatt-ttctcgtttgatagtgcgtgacg--t---ctctgggcag------------------cc 
       D. yakuba  attgatcatt-ttctcgtttgatagtgcgtgacg--t---ctctgggcag------------------cc 
       D. erecta  attgatcatt-ttctcgtttgatagtgcgtgacg--t---ctctgggcag------------------cc 
    D. biarmipes  attgatcatt-ttctcgtttgatagtgcgtgacg--t---ctctgttcgg------------------ct 
  D. bipectinata  attgatcattcccctcgtttgatagtgcgtgacgt-t---ctccagtact------------------cc 
   D. eugracilis  attgatcatt-ttctcgtttgatagtgcgtgacg--tcgcctctggccga------------------ct 
      D. elegans  attgatcatt-ttctcgtttgatagtgcgtgacg--t---ctctgagtaga-----------------cc 
     D. kikkawai  attgatcatt-ctctcgtttgatagtgcgtgacg--a---cgcttgagagggctgccagaggagccgtcc 
   D. takahashii  attgatcatt-ttctcgtttgatagtgcgtgacg--t---ctcgggtcgg------------------ct 
     D. rhopaloa  attgatcatt-ttctcgtttgatagtgcgtgacg--t---ctctgggtagg-----------------cc 
   D. ficusphila  attgatcatt-ttctcgtttgatagtgcgtgacgtct---ctctggacag------------------cc 
D. pseudoobscura  attgatcatt-ctctcgtttgatagtgcgtgacg--t---tttagtgttg------------------ct 
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   D. persimilis  attgatcatt-ctctcgtttgatagtgcgtgacg--t---tttagtgttg------------------ct 
      D. miranda  attgatcatt-ctctcgtttgatagtgcgtgacg--t---tttagtgttg------------------ct 
   D. willistoni  attgatcatt-ttcttgtttgatagtgcgtgacg--t---tttcaactctcact--------------ct 
      D. virilis  attgatcatt-ttcttgtttgatagtgcgtgacg--t---tttcgtaatg------------------ct 






 D. melanogaster  cttctt-----ctgc------tgctcactcgc-----gctcatttattcgagcataaaattagcaattat 
     D. simulans  cttctt-----ctgc------tgctcactcgc-----gctcatttattcgagcataaaattagcaattat 
    D. sechellia  cttctt-----ctgc------tgctcactcgc-----gctcatttattcgagcataaaattagcaattat 
       D. yakuba  cttctt-----ct--------cactccctcgc-----gctcatttgttcgagcataaaattagcaattac 
       D. erecta  cttctg-----ct--------ccctcgctcgc-----gctcatttattcgagcataaaattagcaattat 
    D. biarmipes  cttcgt-----ctgc------tgctcactcgc-----gctcatttattcgagcataaaattagcaattat 
  D. bipectinata  cttcgc-----ctgc------tcttcattcgc-----gctcatttattcgagcataaaattagcaattat 
   D. eugracilis  cttcgt-----ctccgctgctggctcactcgc-----gctcatttattcgagcataaaattagcaattat 
      D. elegans  cttcgt-----ctgc------gtctcactcac-----gctcatttattcgagcataaaattagcaattat 
     D. kikkawai  ctttgc-----ctgcccttc-gtctcgctagc-----tctcatttattcgagcataaaattagcaattat 
   D. takahashii  cttcgt-----ctcc------tgctcactcgc-----gctcatttattcgagcataaaattagcaattat 
     D. rhopaloa  cttcgt-----ctgc------ggctcactcgc-----gctcatttattcgagcataaaattagcaattat 
   D. ficusphila  cttcgt-----ctgc------tgctcactcgc-----gctcatttattcgagcataaaattagcaattat 
D. pseudoobscura  cttctttactcttgg------ggcacactcacgctcagctcatttattcgagcataaaattagcaattat 
   D. persimilis  cttcttaatccttgg------ggcacactcacgctcagctcatttattcgagcataaaattagcaattat 
      D. miranda  cttctttactcttgg------ggcacactcacgctcagctcatttattcgagcataaaattagcaattat 
   D. willistoni  ctactt---------------ggggcactcag-----gctcatttattcgagcataaaattagcaattat 
      D. virilis  cttcaa-------------------------------cgttttttattcgagcataaaattagcaattat 
   D. mojavensis  cttttg-------------------------------agttttttattcgagcataaaattagcaattat 
 
 
Enhancer YU  
 
 D. melanogaster  tgttggca-acaatta-ttgcgttgttgacagcaagatagatagcaatcatttgc 
     D. simulans  tgttggca-acaatta-ttgcgttgttgacagcaagatagatagcaatcatttgc 
    D. sechellia  tgttggca-acaatta-ttgcgttgttgacagcaagatagatagcaatcatttgc 
       D. yakuba  tgttggca-acaatta-ctgtgttgttgacagcaagatagatagcaatcatttgc 
       D. erecta  tgtt-gca-acaatta-ttgtgttgttgacagcaagatagatagcaatcatttgc 
    D. biarmipes  tgtttgca-acaatta-ttgtgttgttgacagcaagatagataggaataatttgc 
  D. bipectinata  ------ct-ac-atta-ttttgatgttgacagcaagatagatagcaataatttgc 
   D. eugracilis  tgttggca-acaatta-ttgtgttgttgacagcaagatagatagcaataatttgc 
      D. elegans  -----gca-acaatta-ttgtgatgttgacagccagatagatagcaataatttgc 
     D. kikkawai  tgtcggca-acaatta-ttgtgttgttgacggccagatagatagcaataatttgc 
   D. takahashii  tgttggca-acaatta-ttgtgttgttgacagcaagatagatagcaataatttgc 
     D. rhopaloa  tgttggca-acaatta-ttgtgttgttgacagcaagatagatagcaataatttgc 
   D. ficusphila  tgttggca-acaatta-ttgtgttgttgacagcaagatagatagcaacaatttgc 
D. pseudoobscura  tgttacca-acaatta-ttccgatgttgacagcaagatagatagcaataatttgc 
   D. persimilis  tgttacca-acaatta-ttccgatgttgacagcaagatagatagcaataatttgc 
      D. miranda  tgttacca-acaatta-ttccgatgttgacagcaagatagatagcaataatttgc 
      D. virilis  tgttgcca-acaattatttgtgttgttgacagcaagacagatagcaacagcagca 
   D. mojavensis  tgttgcca-acaattatttgtgttgttgacagcaagacagatagcaacagcaaca 
 
 D. melanogaster  gtcccatcgtataattgcatatagcgccagtggaagttccggtcggttggc--tttttt 
     D. simulans  gtccgatcgtataattgcatatagcgccagtggaagttccggtcggttggc--tttttt 
    D. sechellia  gtccgatcgtataattgcatatagcgccagtggaagttccggtcggttggc--tttttt 
       D. yakuba  -tgcgatcgtataattgcatatagcgccagtggaagttccggtcggttggc--tttttg 
       D. erecta  ---cgatcggataattgcatatagcgccagtggaagttccggtcggttggc--tttttt 
    D. biarmipes  ------tcgtataattgcatatagcgccagttgaagttccggtcggttggg--tttttt 
  D. bipectinata  ------tcttataattgcatatagcgccagttgaagttccggtcggttgag--tttttg 
   D. eugracilis  ------tcgtataattgcatatagcgccagttgaagttccggtcggttggg--tttttt 
      D. elegans  ------tcgtataattgcatatagcgccagttgaagttccggtcggttggc--tttttt 
     D. kikkawai  ------tcttataattgcatatagcgccagttgaagttccggtcggttggg--tttctt 
   D. takahashii  ------tcgtataattgcatatagcgccagttgaagttccggtcggttggg--tttttt 
     D. rhopaloa  ------tcgtataattgcatatagcgccagttgaagttccggtcggttggg--tttttt 
   D. ficusphila  ------tcgtataattgcatatagcgccagttgaagttccggtccgttggg--tttttt 
D. pseudoobscura  ------tcttataattgcatatagcgccagttgcagttccggtcggttggg--tttttt 
   D. persimilis  ------tcttataattgcatatagcgccagttgcagttccggtcggttggg--tttttt 
      D. miranda  ------tcttataattgcatatagcgccagttgcagttccggtcggttgggtttttttt 
   D. willistoni  ------ttttataattgcatatagcgccagttgcagttccggtccgatgag--tttttg 
      D. virilis  ------gtttataattgcatatagcgccagttgcagttccggtccgttgag--tttttt 












  D. melanogaster  tgttgctgtgtatgtgtgattggtgaatggcatgttgccacccaagttgcca-----------gttggct 
      D. simulans  tgctgctgtgtatgtgtgattggtgaatggcatgttgccacccaagttgcca-----------gttggct 
     D. sechellia  tgctgctgtgtatgtgtgattggtgaatggcatgttgccacccaagttgcca-----------gttggct 
        D. yakuba  tgttgctgtgtatgtgtgattggtgaatggcatgttgccacccaagttgcca-----------gttggct 
        D. erecta  tgtgcctgtgtatgtgtgattggtgaatggcatgttgccacccaagttgcca-----------gttggct 
     D. biarmipes  tgtccctgtgtatgtgtgattggtgaatggcatgttgccacccaag------------------------ 
   D. bipectinata  tgtatacgagtatgtgtgattggtgaatgccatgttgccacccaagttgccaactggcaactggctggct 
    D. eugracilis  tgctcctgtgtatgtgtgattggtgaatggcatgttgccacccaagttgcca-----------gttggcc 
       D. elegans  tgttcttgtgtatgtgtgattggtgaatggcatgttgccacccaagttgcca-----------gttggct 
      D. kikkawai  tgcccttgtgtatgtgtgattggtgaatggcatgttgccacccaagttgcca-----------gttggct 
    D. takahashii  tgtccctgtgtatgtgtgattggtgaatggcatgttgccacccaagttgcca-----------gttggct 
      D. rhopaloa  tgtgcttgtgtatgtgtgattggtgaatggcatgttgccacccaagttgcca-----------gttagct 
    D. ficusphila  tgtgcttgtgtatgtgtgattggtgaatggcatgttgccacccaagttgcca-----------gttggct 
 D. pseudoobscura  agtactggtatatgtgtgattggtgaatggcatgttgccacccaagttgccaactgtgcctcggttggct 
    D. persimilis  agaactggtatatgtgtgattggtgaatggcatgttgccacccaagttgccaactgtgcctcggttggct 
       D. miranda  agtactggtatatgtgtgattggtgaatggcatgttgccacccaagttgccaactgtgcctcggttggct 
       D. virilis  tgtttgtgtgtgtgtgggattggtgaatggcatgttgccacccaagttgccaactgtgtcttggttggct 





 D. melanogaster  tggtgaatggcatgttgccacccaagttgcca-----------g 
     D. simulans  tggtgaatggcatgttgccacccaagttgcca-----------g 
    D. sechellia  tggtgaatggcatgttgccacccaagttgcca-----------g 
       D. yakuba  tggtgaatggcatgttgccacccaagttgcca-----------g 
       D. erecta  tggtgaatggcatgttgccacccaagttgcca-----------g 
    D. biarmipes  tggtgaatggcatgttgccacccaag------------------ 
  D. bipectinata  tggtgaatgccatgttgccacccaagttgccaactggcaactgg 
   D. eugracilis  tggtgaatggcatgttgccacccaagttgcca-----------g 
      D. elegans  tggtgaatggcatgttgccacccaagttgcca-----------g 
     D. kikkawai  tggtgaatggcatgttgccacccaagttgcca-----------g 
   D. takahashii  tggtgaatggcatgttgccacccaagttgcca-----------g 
     D. rhopaloa  tggtgaatggcatgttgccacccaagttgcca-----------g 
   D. ficusphila  tggtgaatggcatgttgccacccaagttgcca-----------g 
D. pseudoobscura  tggtgaatggcatgttgccacccaagttgccaactgtgcctcgg 
   D. persimilis  tggtgaatggcatgttgccacccaagttgccaactgtgcctcgg 
      D. miranda  tggtgaatggcatgttgccacccaagttgccaactgtgcctcgg 
      D. virilis  tggtgaatggcatgttgccacccaagttgccaactgtgtcttgg 
   D. mojavensis  tggtgaatggcatgttgccacccaagttgccaactgtgtcttgg 
 
 D. melanogaster  gcatc------aaacggtagc-tcttcttaattacaacaaccaa-------aaca-------acagc--- 
     D. simulans  gcatc------aaacggtagc-tcttcttaattacaacaaccaa-------aaca-------acagc--- 
    D. sechellia  gcatc------aaacggtagc-tcttcttaattacaacaaccaa-------aaca-------acagc--- 
       D. yakuba  gcatc------aaacggtagc-tcttcttaattacaacaaccaa-------aaca-------acagc--- 
       D. erecta  gcatc------aaacggtagc-tcctcttaattacaacaaccaa-------aaca-------acagc--- 
    D. biarmipes  gcatc------aaacggtagc-tcttcttaattacaacaaccaa-------aacaacc----acagc--- 
  D. bipectinata  agtcccctccaaaacggtagccccctcttaattacaataacaac-------aaca-------aaaac--- 
   D. eugracilis  gcatc------aaacggtagc-tgctcttaattacaacaaccaaaaacaacaaca-------acaac--- 
      D. elegans  gcatc------aaacggtagc-tctccttaattacaacaaccga-------agca-------gcaacaa- 
     D. kikkawai  gcatc------aaacggtagc-tcttcttaattacaacaacgac-------agca-------accacag- 
   D. takahashii  gcatc------aaacggtagc-tcttcttaattacaacaaccaa-------aaca-------acaac--- 
     D. rhopaloa  gcatc------aaacggtagc-tcttcttaattacaacaactaa-------aaca-------acagt--- 
   D. ficusphila  gcatc------aaacggtagc-tcttcttaattacaacaaccaa-------aaca-------acaac--- 
D. pseudoobscura  acatc------aaacggtagc-tcctcttaattacaacaacacc-------aacatccagaagcaacaag 
   D. persimilis  acatc------aaacggtagc-tcctcttaattacaacaacacc-------aacatccagaagcaacaag 
      D. miranda  acatc------aaacggtagc-tcctcttaattacaacaacacc-------aacatccagaagcaacaag 
   D. willistoni  ggagc------aaacggtagc-tgttcttaattacaacagcaac-------aaca-------ataacaac 
      D. virilis  gcgcc------aaacggtagc-cattcttaattacaacaacaac-------aaca-------acaac--- 














 D. melanogaster  aatcggaaacggaaatcgctaatg-aaa--aatttccatatttatggtaacgacaaag--agccgc-ttc 
     D. simulans  aatcggaaacggaaatcgctaatg-aaa--aatttccatatttatggtaacgacaaag--agccgc-ttc 
    D. sechellia  aatcggaaacggaaatcgctaatg-aaa--aatttccatatttatggtaacgacaaag--agccgc-ttc 
       D. yakuba  aatcggaaacggaaatcgctaatg-aaa--aatttccatatttatggta-------------------tc 
       D. erecta  aatcggaaacggaaatcgctaatg-aaa--aatttccatatttatggtaacgacaaag--agccgc-gtc 
    D. biarmipes  aatcggaaacggaaatcgctaatg-aaa--aatctccatatttatggtggcgataaag--agccac---- 
  D. bipectinata  aatcggaaacggaaatcactaatg-aaa--aatttccatatttatggtggcaataaag--agtc-----t 
   D. eugracilis  aatcggaaacggaaatcgctaatg-aaa--aatttccatatttatggtggcgataaag--agccac---- 
      D. elegans  aatcggaaacggaaatcgctaatg-aaa--aatttccatatttatggtggcgataaag--agccca---- 
     D. kikkawai  aatcggaaacggaaatcgctaatg-aaa--aatttccatatttatggtggcgataaag--cgatac-aac 
   D. takahashii  aatcggaaacggaaatcgctaatg-aaa--aatctccatatttatggcggcgataaag--agccac---- 
     D. rhopaloa  aatcggaaacggaaatcgctaatg-aaa--aatttccatatttatggcggcgataaag--agccc----- 
   D. ficusphila  aatcggaaacggaaatcgctaatg-aaa--aatttccatatttatggcggcgataaag--agccgcagcc 
D. pseudoobscura  aatcggaaacggaaatcgctaatg-aaa--aatttccatatttatgcagccgataaag--cgctac---- 
   D. persimilis  aatcggaaacggaaatcgctaatg-aaa--aatttccatatttatgcagccgataaag--cgctac---- 
      D. miranda  aatcggaaacggaaatcgctaatg-aaa--aatttccatatttatgcagccgataaag--cgctac---- 
   D. willistoni  aatcggaaacggaaatcgctaatgaaaa--aatttccatatttatgc--------atg--tgcc------ 
      D. virilis  aatcggaaacggatatcgctaatg-aaa--aatttccatatttatg-tggcgataaaagcagc-ac---- 
   D. mojavensis  aatcggaaacggatatcgctaatg-aaacgaatttccatatttatg-tgttaataaaaccagcaac----  
 
 D. melanogaster  tacgggctgcaattaattccaacgaa-attta--attag-aat 
     D. simulans  tacgggctgcaattaattccaacgaa-attta--attag-aat 
    D. sechellia  tacgggctgcaattaattccaacgaa-attta--attag-aat 
       D. yakuba  tacggactgcaattaattccaacgaa-attta--attag-aat 
       D. erecta  tacgggctgcaattaattccaaccaa-attta--attag-aat 
    D. biarmipes  cacgggctgcaattaattccaccgaa-attta--attag-aat 
  D. bipectinata  tatgtgttgcaattaattccaatgaa-attta--attag-aat 
   D. eugracilis  tacgggctgcaattaattccaacgaa-attta--attag-aat 
      D. elegans  tatgggctgcaattaattccaacaaa-attta--attag-aat 
     D. kikkawai  tacggactgcaattaattccaacgaa-attta--attag-aat 
   D. takahashii  tacgggctgcaattaattccaacgaa-attta--attag-aat 
     D. rhopaloa  tatgggctgcaattaattccaacgaa-attta--attag-aat 
   D. ficusphila  tatgggctgcaattaatcccaacgaa-attta--attag-aat 
D. pseudoobscura  tatgtgtcgcaattaatttcaacgaa-attta--attag-aat 
   D. persimilis  tatgtgtcgcaattaatttcaacgaa-attta--attag-aat 
      D. miranda  tatgtgtcgcaattaattttaacgaa-attta--attag-aat 
   D. willistoni  catag--cgcaattaatttcatcaaa-tttca--ttcagaaat 




 D. melanogaster  gcccgtgcccaatggccataattaattgct 
     D. simulans  gcccgtgcccaatggccataattaattgct 
    D. sechellia  gcccgtgcccaatggccataattaattgct 
       D. yakuba  gcccgtgcccaatggccataattaattgct 
       D. erecta  gcccgtgcccaatggccataattaattgct 
    D. biarmipes  gcccgtgcccaatggccataattaattgct 
  D. bipectinata  gtccaaacccgatggctataattaattgct 
   D. eugracilis  gcccgtgcccaatggccataattaattgct 
      D. elegans  gcccgtgcccaatggccataattaattgct 
     D. kikkawai  gtccgtgcccaatggctataattaattgct 
   D. takahashii  gcccgtgcccaatggccataattaattgct 
     D. rhopaloa  gcccgtgcccaatggccataattaattgct 
   D. ficusphila  gcccgtgcccaatggccataattaattgct 
D. pseudoobscura  gtccctgcccaatggccataattaatcgct 
   D. persimilis  gtccctgcccaatggccataattaatcgct 
      D. miranda  gtccctgcccaatggccataattaatcgct 
   D. willistoni  gttcatgcccattggctataattaattggt 














 D. melanogaster  ag--tcgtgctaaggtcaaacaaacagcc 
       D. yakuba  ag--tcgtgctaaggtcaaacacacagcc 
       D. erecta  ag--tcgtgctaaggtcaaacacacagcc 
    D. biarmipes  aa--ccgtgctaaggtcaaacacacagcc 
  D. bipectinata  aa--ccatgctaaggtcaaacacagagcc 
   D. eugracilis  aa--ccgtgctaaggtcaaacacacagcc 
      D. elegans  aa--tcatgctaaggtcaaacacacagcc 
     D. kikkawai  aa--gcatgctaaggtcaaacacagagcc 
   D. takahashii  aa--tcgtgctaaggtcaaacacacagcc 
     D. rhopaloa  aa--tcgtgctaaggtcaaacac--agcc 
   D. ficusphila  aa--tcgtgctaaggtcaaacacacagcc 
D. pseudoobscura  aa--ccatgctaaggtcaaacacacagcc 
   D. persimilis  aa--ccatgctaaggtcaaacacacagcc 
      D. miranda  aa--ccatgctaaggtcaaacacacagcc 
   D. willistoni  gatttcaggcaaaggtcaaacacgtgcta 
      D. virilis  gc--acatgctgaggtcaaacgcacagag 
   D. mojavensis  gc--acatgctgaggtcaagcacacacac !
 D. melanogaster  agccgtgacag-acttgtgggcaaacagaaacca 
    D. sechellia  agccgtgacag-acttgtgggcaaacagacacaa 
       D. yakuba  agccgtgacag-acttgtgggcaaacagacacca 
       D. erecta  ggccgtaacag-acttgtgggcaaacagacacca 
    D. biarmipes  agccgtggcag-acttgtgggtaaacagactcca 
  D. bipectinata  ggccgtgacag-acttgtgggtaaacagacacca 
   D. eugracilis  agccgtgacag-acttgtgggtaaacagacacca 
      D. elegans  agccgtgacag-acttgtgggtaaacagaaacca 
     D. kikkawai  ggccgtgacag-acttgtgggtaaacagacacca 
   D. takahashii  agccgtgacag-acttgtgggtaaacagaaacca 
     D. rhopaloa  agccgtgacag-acttgtgggtaaacagacacca 
   D. ficusphila  agccgtgactg-acttgtgggtaaacagaaacca 
D. pseudoobscura  ggccgtgacag-acttgtgggtaaacagaaacca 
   D. persimilis  ggccgtgacag-acttgtgggtaaacagaaacca 
      D. miranda  ggccgtgacag-acttgtgggtaaacagaaacca 
   D. willistoni  aaccgtgacaacaattgtgggtaaacagaaacca 
      D. virilis  -accatgacgt-tgttgcgggtaaataaaaacca 
   D. mojavensis  -accatgacca-tgttgtgggtaaatagaactca 
 
 D. melanogaster  ttc--acacaaccgcaaagcagttgaacaaacaatgat------cc------g 
     D. simulans  ttc--acacaaccgcaaagcagttgaacaaacaatgat------cc------a 
    D. sechellia  ttc--acacaaccgcaaagcagttgaacaaacaatgat------cc------g 
       D. yakuba  ttt--acacaaccgcaaggcagttgaacaaacaatgat------cc------g 
       D. erecta  ttt--acacaaccgcaaagcagttgaacaaaca-------------------- 
    D. biarmipes  ttc--acacaaccgcaaagcagttgaacaaacaatgat------ct------g 
  D. bipectinata  tcc--acacaaccgcaaaacagttgaacaaacaatgat------cc------g 
   D. eugracilis  ttc--acacaaccgcaaagcagttgaacaaacaatgat------ct------g 
      D. elegans  ttc--acacaaccgcaaagcagttgaacaaacaatgat------ct------g 
     D. kikkawai  ttt--acacaaccgcagaacagttgagcaaacaatgat------ccacaacag 
   D. takahashii  ttc--acacaaccgcaaagcagttgaacaaacaatgat------cc------g 
     D. rhopaloa  tcc--acacaaccgcaaagcagttgaacaaacaatgct------ct------g 
   D. ficusphila  ttc--acacaaccgcaaagcagttgaacaaacaatgct------cc------g 
D. pseudoobscura  ttt--acacaaccgcaaaacagttggacaaacaatgat------cc------g 
   D. persimilis  ttt--acacaaccgcaaaacagttggacaaacaatgat------cc------g 
      D. miranda  ttt--acacaaccgcaaaacagttggacaaacaatgat------cc------g 
   D. willistoni  ttt--acacaaccgcaaaacatttgtacaaacaatgat------cg------g 
      D. virilis  ttt--acacagccgcag------------aacaatgat----ctct------t 





















 D. melanogaster  c--accacca------------------------c---------------------ggcgttgataattg 
     D. simulans  ----ccacca------------------------c---------------------ggcgttgataattg 
    D. sechellia  ----ccacca------------------------c---------------------ggcgttgataattg 
       D. yakuba  ----ccgcca------------------------c---------------------ggcgttgataattg 
       D. erecta  ----ccgccg------------------------c---------------------ggcgttgataattg 
    D. biarmipes  ----ccgccc------------------------c---------------------ggcgttgataattg 
  D. bipectinata  ----ctactactcgcttttcattccatcgcatggc---------------------agcgttgataattg 
   D. eugracilis  ----ccgcca------------------------t---------------------ggcgttgataattg 
      D. elegans  ----ccacca------------------------c---------------------ggcgttgataattg 
     D. kikkawai  ttggccgcct------------------------c---------------------agcgttgataattg 
   D. takahashii  ----ccacca------------------------c---------------------ggcgttgataattg 
     D. rhopaloa  ----ccgctg------------------------c---------------------ggcgttgataattg 
   D. ficusphila  ----ccggct------------------------c---------------------ggcgttgataattg 
D. pseudoobscura  ----ctactc------------------------c-------------------cgggcgttgataattg 
   D. persimilis  ----ctactc------------------------c-------------------cgggcgttgataattg 
      D. miranda  ----ctactc------------------------c-------------------cgggcgttgataattg 
   D. willistoni  ----ttgcct------------------------c-----------ggcatctgtctctctggccaatgg 
   D. mojavensis  ---tctatcc------------------------agacgagagacaagcgtt----------aataatca 
      D. virilis  ====================================================================== 
 
 D. melanogaster  cgggtgg-----cc-gtgactgaggcgataact------------------------------------- 
     D. simulans  cgggtgg-----cc-gtgactgaggcgataact------------------------------------- 
    D. sechellia  cgggtgg-----cc-gtgactgaggcgataact------------------------------------- 
       D. yakuba  cgggtgg-----cc-gtgactgaggcgataact------------------------------------- 
       D. erecta  cgggtgg-----cc-gtgactgaggcgataact------------------------------------- 
    D. biarmipes  cgggtgg-----cc-gtcacgaaggcgataagc----gatg--gcaaat------------------gct 
  D. bipectinata  cgggtgg-----ccggtatcgaaggcgataact----gata--ccaaat------------------gcc 
   D. eugracilis  cgggtgg-----cc-gtaacggatctgataacctgatgatg--gcgaat------------------gta 
      D. elegans  cgggtgg-----cc-gtaacgaaggcgataacc----gatg--gcaaat------------------gct 
     D. kikkawai  cgggtgg--cgacc-ataacgaaggtgataact----ga-----------------------------ta 
   D. takahashii  cgggtgg-----cc-gtaactaaggcgataacc----gatg--gcgaag------------------gct 
     D. rhopaloa  cgggtgg-----cc-gtaacgaaggcgataacc----gatgctgcaaat------------------gcc 
   D. ficusphila  cgggtgg-----cc-gtaacgaaggcgataacc----gatg--gcacatcctgcacctccacctccacct 
D. pseudoobscura  cgggtgg-----cc-gtaactgaagtgataagt----gaca--gccatt------------------gcc 
   D. persimilis  cgggtgg-----cc-gtaactgaagtgataagt----gaca--gccatt------------------gcc 
      D. miranda  cgggtgg-----cc-gagactgaagtgataagt----gaca--gccagt------------------gcc 
   D. willistoni  cgggtgg-----cc-gtaactgaagtgataagt----gt----tctaat------------------gct 
   D. mojavensis  cgggtggtataccc-atatccaa-gtgccgaac----tctc--tcagat------------------ctt 
      D. virilis  ====================================================================== 
 
 D. melanogaster  a-aacatcttgt--gactatcatc----------------aatcgg--ggagcgca-------ccttgat 
     D. simulans  a-aacatcgtac--gactatcttc----------------aatcgg--gaagcgca-------ccttgat 
    D. sechellia  a-aacatcgtac--gactatcttc----------------aatcgg--cgagcgca-------ccttgat 
       D. yakuba  a-aacatcgtac--gattatcttc----------------cattgg--ggagcgca-------ccttgat 
       D. erecta  a-aactgcgcac--gattatcttc----------------catcag--ggaggatg-------gcttgat 
    D. biarmipes  ataacatcttac--gattatctgc----------------aatcag--ggagccca-------ccttgat 
  D. bipectinata  a-aatatcatac--gattatctgc----------------aatcagtccgagtgtgtgagttcccttgat 
   D. eugracilis  a-aacatcttac--gattatctgc----------------catcagt-ggggacca-------ccttgat 
      D. elegans  a-aacatcttac--gattatctgc----------------aatcag--cgggacca-------ccttgat 
     D. kikkawai  a-aacattgttcgagattacctac----------------aatcag--cgagccca-------ccttgat 
   D. takahashii  aaaacatcttac--gattatctgc----------------aatcag--agaacaca-------gcttgat 
     D. rhopaloa  a-aacatcttac--gattatctgc----------------aatcag--cgggccca-------ccttgat 
   D. ficusphila  a-aacatcttac--gattatctgc----------------catcag--cgagccca-------ccttgat 
D. pseudoobscura  a-aacattgtac--aattatctgcaacttccatca-----gatcggcctggttctc-------ccttgat 
   D. persimilis  a-aacattgtac--aattatctgcaacttccatca-----gatcggcctggttctc-------ccttgat 
      D. miranda  a-aacattgtac--aattatctgcaacttccatcagatcggatcggcctggttctc-------ccttgat 
   D. willistoni  a-aaaa--gttc--aatgaactgg-----taaaaa-----aatggg--aaagaata-------tttttat 














  D. melanogaster  aatgtaaacaaatgatatacggtcg------cagggc 
      D. simulans  aatgtaaacaaatgatatacggtcg------cagggc 
     D. sechellia  aatgtaaacaaatgatatacggtcg------cagggc 
        D. yakuba  aatgtaaacaaatgatatacggtcg------cagggg 
        D. erecta  aatgtaaacaaatgatatacggtcg------caggga 
     D. biarmipes  aatgtaaacaaatgatatacggtcg------cagggc 
   D. bipectinata  aatgtaaacaaatgatatacggtcggtggcccaggtc 
    D. eugracilis  aatgtaaacaaatgatatacggtcg------cagggc 
       D. elegans  aatgtaaacaaatgatatacggtca------cagggt 
      D. kikkawai  aatgtaaacaaatgatatacggtcg------cagggc 
    D. takahashii  aatgtaaacaaatgatatacggtcg------cagggc 
      D. rhopaloa  aatgtaaacaaatgatatacggtcg------cagggc 
    D. ficusphila  aatgtaaacaaatgatatacggtcg------cagggc 
 D. pseudoobscura  aatgtaaacaaatgatatacggtca------cagggc 
    D. persimilis  aatgtaaacaaatgatatacggtca------cagggc 
       D. miranda  aatgtaaacaaatgatatacggtca------cagggc 
    D. willistoni  aatgtaaacaaatgatatacggtca------cagagc 
       D. virilis  aatgtaaacaaatgatatacggtca------cagtcc 
    D. mojavensis  aatgtaaacaaatgatatacggtca------cagttc 
 
 D. melanogaster  cacttcacttcgcggcagtgtaaataaa--------------------gacgg-g-----tcat------ 
     D. simulans  cactccacttcgcggcagtgtaaataaa--------------------gacgg-g-----tcgt------ 
    D. sechellia  cactccacttcgcggcagtgtaaataaa--------------------gacgg-g-----tcgt------ 
       D. yakuba  cacttcacttcacggcagtgtaaataaa--------------------gacgg-g-----tcgt------ 
       D. erecta  cacttcacttcacggcagtgtaaataaa--------------------gacgg-g-----tcgt------ 
    D. biarmipes  tacttcacttcacggcagtgtaaataaa--------------------gacgg-g------ctt------ 
  D. bipectinata  tacttcacttcacgccagtgtaaataat--------------------gcctc-g----tttgt------ 
   D. eugracilis  cacttcacttcacggcagtgtaaataaa--------------------gacgg-c-----ttgttgactg 
      D. elegans  tacttcacttcacggcagtgtaaataaa--------------------gatgg-g-----gcga------ 
     D. kikkawai  cacttcacttcacggcaatgtaaataaa--------------------gtagg-g-----ttat------ 
   D. takahashii  cacttcacttcacggcagtgtaaataaa--------------------gacgg-g----gccgt------ 
     D. rhopaloa  cacttcacttcacggcagtgtaaataaa--------------------gatgg-g-----gcga------ 
   D. ficusphila  cacttcacttcacggcagtgtaaataaa--------------------gacgatg-----gtgt------ 
D. pseudoobscura  cacttgacttcacaccaatataaataca--------------------gccgt-a-----acgt------ 
   D. persimilis  cacttgacttcacaccaatataaataca--------------------gccgt-a-----gcgt------ 
      D. miranda  cacttgacttcacaccaatacaaataca--------------------gccgt-a-----gcgt------ 
   D. willistoni  ctcttcacttcacacc------aataaa--------------------ga----g-----tcgg------ 
      D. virilis  -acttcacttcacaccaataaaaatacaacaaaaataaactgaacacgggagt-g-----gtga------ 
  D. mojavensis  cacttcacttcacacccataaaaaacaaagagaaggcagctcgagtgggacgt-gtgtgtgtgg------ !
 D. melanogaster  tggggagtaacgaggca------tacctgcgggccgtaaataagcaa 
     D. simulans  tggggagtaacgaggca------taccttcgggccgtaaataagcaa 
    D. sechellia  tggggagtaac-aggca------taccttcgggccgtaaataagcaa 
       D. yakuba  tgcggagtaacgaggcatactcgtaccttcgggccgtaaataagcaa 
       D. erecta  tggggagtaacgaggca------taccttcgggccgtaaataagcaa 
    D. biarmipes  tggggagtaacgaggca------tacctccgggccgtaaataagcaa 
  D. bipectinata  ggggcagcaacgagaca------tacctttgagccgtaaataagcaa 
   D. eugracilis  tggggagtaacgaggca------taccttcgggccgtaaataagcaa 
      D. elegans  tggggagtaacgaggca------taccttcgggccgtaaataagcaa 
     D. kikkawai  tggggagtaacgaggca------taccttcgggccgtaaataagcaa 
   D. takahashii  tggggagtaacgaggca------taccttcgggccgtaaataagcaa 
     D. rhopaloa  tggggagtaacgaggca------taccttcgggccgtaaataagcaa 
   D. ficusphila  tggggagtaacgaggca------taccttcggaccgtaaataagcaa 
D. pseudoobscura  tggggg--aacgaa--a------taccttcaagccgtaaataagcaa 
   D. persimilis  tggggg--aacgaa--a------taccttcaagccgtaaataagcaa 
      D. miranda  tggggg--aacgaa--a------taccttcaagccgtaaataagcaa 
   D. willistoni  --------atcgaa--a------taccttcgagccgtaaataagcaa 
      D. virilis  --ggccacaccga---a------taccttaaagccgtaaataagcaa 















 D. melanogaster  gagaccacccaggtaacgatttgtgcagtcattccacgaattcccagc 
     D. simulans  gagaccacccaggtaacgatttgtgcagtcattccacgaattcccagc 
    D. sechellia  gagaccacccaggtaacgatttgtgcagtcattccacgaattcccagc 
       D. yakuba  gagaccacccaggtaacgatttgtgcagtcattccacgaattcccagc 
       D. erecta  gagaccacccaggtaacgatttgtgcagtcattccacgaattcccagc 
    D. biarmipes  gagaccacccaggtaacgatttgtgcagtcattccacgaattcccagc 
  D. bipectinata  gagaccacccaggtaacgatttgtgcagtcattccacgaattcccaac 
   D. eugracilis  gagaccacccaggtaacgatttgtgcagtcattccacgaattcccagc 
      D. elegans  gagaccacccaggtaacgatttgtgcagtcattccacgaattcccaga 
     D. kikkawai  gagaccacccaggtaacgatttgtgcagtcattccacgaattcccaac 
   D. takahashii  gagaccacccaggtaacgatttgtgcagtcattccacgaattcccagc 
     D. rhopaloa  gagaccacccaggtaacgatttgtgcagtcattccacgaattcccaga 
   D. ficusphila  gagaccacccaggtaacgatttgtgcagtcattccacgaattcccagc 
D. pseudoobscura  gggaccacccaggtaacgatttgtgcagtcattccacgaattctcgga 
   D. persimilis  gggaccacccaggtaacgatttgtgcagtcattccacgaattctcgga 
      D. miranda  gggaccacccaggtaacgatttgtgcagtcattccacgaattctcgga 
   D. willistoni  gag--cacaggtataacgataagagaagt------------------- 
      D. virilis  gagaccacccaggcgtcgatttgtgcagtcattccacgaattcttggc 
   D. mojavensis  gagaccacccaggcgacgatttgtgcagtcattccacgaattcttggc 
 
 D. melanogaster  cgaaattaatttgacagccaacgcaaaacgcatgcgtcgtcgacattcctcgcc---------------- 
     D. simulans  cgaaattaatttgacagccaacgcaaaacgcatgcgtcgtcgacattcctcgcc---------------- 
    D. sechellia  cgaaattaatttgacagccatcgcaaaacgcatgcgtcgtcgacattcctcgcc---------------- 
       D. yakuba  tgaaattaatttgacagccaacgcaaaacgcatgcgtcgtcggcattcctcgccagcactctaccccctt 
       D. erecta  tgaaattaatttgacagccaacgcaaaacgcatg---cgtcgacattcttcgcc---------------- 
    D. biarmipes  cgaaattaatttgacagccaacgcaaaacgcatgcttcgtcaacattcctcgcc---------------- 
  D. bipectinata  cgaaattaatttgacagccaacgcaaaacgcatgcgtcttcgacattcttcact---------------- 
   D. eugracilis  cgaaattaatttgacagccaacgcaaaacgcatgcgtcgtcaacattcttcgcc---------------- 
      D. elegans  cgaaattaatttgacagccaacgcaaaacgcatgcgtcgtcaacattcctcgcc---------------- 
     D. kikkawai  cgaaattaatttgacagccaacgcaaaacgcatgcgtcgtcaacattcctggcc---------------- 
   D. takahashii  cgaaattaatttgacagccaacgcaaaacgcatgcttcgtcaacattcctcgcc---------------- 
     D. rhopaloa  cgaaattaatttgacagccaacgcaaaacgcatgcgtcgtcaacattcctcgcc---------------- 
   D. ficusphila  cgaaattaatttgacagccaacgcaaaacgcatgcgtcgtcaacattcctcgcc---------------- 
D. pseudoobscura  cgaaattaatttgacagccaacgcaaaacgcatgcatcgtcaacattcttctgg---------------- 
   D. persimilis  cgaaattaatttgacagccaacgcaaaacgcatgcatcgtcaacattcttctgg---------------- 
      D. miranda  cgaaattaatttgacagccaacgcaaaacgcatgcatcgtcaacattcttctgg---------------- 
   D. willistoni  cgaaattaatttgacaaccaacgcaaaacgcatgcgtcgtcaacatttttcagc---------------- 
      D. virilis  cgaaattaatttgacaaccaacgcaaaacgcatgcgccttcaacattccacaac---------------- 
   D. mojavensis  cgaaattaatttgacaaccaacgcaaaacgcatgcgccgtcaacattccatgac---------------- 
 
 D. melanogaster  cgtggcggttgattacatgtacaaacgaaccgag 
     D. simulans  cgtggcggttgattacatgtacaaacgaaccgag 
    D. sechellia  cgtggcggttgattacatgtacaaacgaaccgag 
       D. yakuba  cgtggcggttgattacacgtataaacgaagcgag 
       D. erecta  cgtggcggttgattacacgtataaacgaacccag 
    D. biarmipes  cggggcggttgattacatgaacaaacgaaccgaa 
  D. bipectinata  cggggcggttgattacatgaacaaacgaaccgat 
   D. eugracilis  cggggcggttgattacatgaacaaacgaaccgaa 
      D. elegans  cggggcggttgattacatgaacaaacgaaccgaa 
     D. kikkawai  cggggcggttgattacatgaacaaacgaaccgat 
   D. takahashii  cggggcggttgattacatgaacaaacgaaccgaa 
     D. rhopaloa  cggggcggttgattacatgaacaaacgaaccgaa 
   D. ficusphila  cg-ggcggttgattacatgaacaaacgaaccgag 
D. pseudoobscura  cggggcggttgattacatgaacaaacgaaccgaa 
   D. persimilis  cggggcggttgattacatgaacaaacgaaccgaa 
      D. miranda  cggggcggttgattacatgaacaaacgaaccgaa 
   D. willistoni  ctgggcggttgattaca----------------- 
      D. virilis  ctcgacggttgattacatgaacaaacgaagcgaa 














 D. melanogaster  ggc--------ctacgtattaccggtggcaaatagtaattattacattaaatgcaccgcaa 
     D. simulans  ggc--------ctacgtattaccggtggcaaatagtaattattacattaaatgcaccgcaa 
    D. sechellia  ggc--------ctacgtattaccggtggcaaatagtaattattacattaaatgcaccgcaa 
       D. yakuba  ggc--------ctacgtattaccggtggcaaatagtaattattacattaaatgccccgcaa 
       D. erecta  ggc--------ctacgtattaccggtggcaaatagtaattattacattaaatgcaccgcaa 
    D. biarmipes  ggc--------ctacgtattaccggtggcaaatagtaattattacattaaatgcaccgcaa 
  D. bipectinata  ggc--------ctacgtattaccggtggcaaatagtaattattacattaaatgcaccgcaa 
   D. eugracilis  ggc--------ctacgtattaccggtggcaaatagtaattattacattaaatgcaccgcaa 
      D. elegans  ggc--------ctacgtattaccggtggcaaatagtaattattacattaaatgcaccgcaa 
     D. kikkawai  ggc--------ctacgtattaccggtggcaaatagtaattattacattaaatgcaccgcaa 
   D. takahashii  ggc--------ctacgtattaccggtggcaaatagtaattattacattaaatgcaccgcaa 
     D. rhopaloa  ggc--------ctacgtattaccggtggcaaatagtaattattacattaaatgcaccgcaa 
   D. ficusphila  ggc--------ctacgtattaccggtggcaaatagtaattattacattaaatgcaccgcaa 
D. pseudoobscura  ggc--------ctacgtattaccggtggcaaatagtaattattacattaaatgcaccgcaa 
   D. persimilis  ggc--------ctacgtattaccggtggcaaatagtaattattacattaaatgcaccgcaa 
      D. miranda  ggc--------ctacgtattaccggtggcaaatagtaattattacattaaatgcaccgcaa 
   D. willistoni  ggctggttcctctacgtattaccagtggcaaatagtaattattacattaaatacacccaaa 
      D. virilis  gcc--------acacgtattaccggtggcaaatagtaattattacattaaatgcaccgcaa 
   D. mojavensis  gcc--------acacgtattaccggtggcaaatagtaattattacattaaatgcaccgcaa 
 
 D. melanogaster  ccaaacttcaactc---cagccataaaagcaa 
     D. simulans  ccaaacttcaactc---cagccataaaagcaa 
    D. sechellia  ccaaacttcaactc---cagccataaaagcaa 
       D. yakuba  ctaaacttcaactc---cagccataaaagcaa 
       D. erecta  ccaaacttccactc---cagccataaaagcaa 
    D. biarmipes  ccgaacttcaactc---cagccatgaaagcaa 
  D. bipectinata  ctcaacttcaactc---cggccataaaaacaa 
   D. eugracilis  ccaaacttcaactc---cagccataaaagcaa 
      D. elegans  ccaaactccaactc---cagccataaaggcaa 
     D. kikkawai  caaaacttcaactc---cggccataaaaacaa 
   D. takahashii  ccaaacttcaactc---cagccataaaagcaa 
     D. rhopaloa  ccaaacataaactc---cagccataaaagcaa 
   D. ficusphila  ccaaacttcaactc---cagccataaaagcag 
D. pseudoobscura  ccaaacttcaactc---cagccataaaaacag 
   D. persimilis  ccaaacttcaactc---cagccataaaaacag 
      D. miranda  ccaaacttcaactc---cagccataaaaacag 
      D. virilis  caggcagctcgcttcagcagcaacaacaacaa 
   D. mojavensis  caggcagctcactt---cggccacagcaacat 
 
 D. melanogaster  gaaacggcaaatgaagctctcaaagcgaactgtgctt--cgctggtggtccatt 
     D. simulans  gaaacggcaaatgaagctctcaaagcgaactgtgctt--cgctggtggtccatt 
    D. sechellia  gaaacggcaaatgaagctctcaaagcgaactgtgctt--cgctggtggtccatt 
       D. yakuba  gaaacggcaaatgaagctctcaaagcgaactgtgctt--cgttggtggtccatt 
       D. erecta  gaaacggcaaatgaagctctcaaagcgaactgtgctt--cgttggtggtccatt 
    D. biarmipes  gaaacgacaaatgaagctctcaaagcgaactgcgctt--cgttggtggtccatt 
  D. bipectinata  gaaacggcaaatgaagctctcaaagcaaactccactt--cgttggtggtccagt 
   D. eugracilis  gaaacggcaaatgaagctctcaaagcgaactgtgctt--cgttggtggtccatt 
      D. elegans  gaaacggcaaatgaagctctcaaagcaaactgcgctt--cgttggtggtccatt 
     D. kikkawai  gaaacggcaaatgaagctctcaaagcaaactccgctt--cgttggtggtccagt 
   D. takahashii  gaaacggcaaatgaagctctcaaagcgaactgagctt--cgttggtggtccatt 
     D. rhopaloa  gaaacggcaaatgaagctctcaaagcaaactgcgctt--cgttggtggtccatt 
   D. ficusphila  gaaacggcaaatgaagctctcaaagcaaactgcgctt--cgttggtggtccatt 
D. pseudoobscura  gaaacggcaaatgaagctctcaaagcaaactcctctcaacgttggtggtccagt 
   D. persimilis  gaaacggcaaatgaagctctcaaagcaaactcctctcaacgttggtggtccagt 
      D. miranda  gaaacggcaaatgaagctctcaaagcaaactcctctcaacgttggtggtccagt 
   D. willistoni  gaaacggcaaatgaagctctcaa----------------cgttggtggtccagt 
      D. virilis  gaaacggcaaatgaagctctcaa--------ccgcca--cgttggtggtccaat 

















 D. melanogaster  ctgggga--------------gagcg------------------aaataaagctaaaatatgc 
     D. simulans  ctgggga--------------gagcg------------------aaataaagctaaaatatgc 
    D. sechellia  ctgggga--------------gagcg------------------aaataaagctaaaatatgc 
       D. yakuba  cttggga--------------gagcg------------------aaataaagctaaaatatgc 
       D. erecta  cttggga--------------gagcg------------------aaataaagctaaaatatgc 
    D. biarmipes  cttgggagatcgg--------gagag------------------gaataaagctgaaatatgc 
  D. bipectinata  ctgggga--------------gagcggctgatcgggagagcagtggataaagctaaaatatgc 
   D. eugracilis  cttgggagatcggg------agagcg------------------taataaagctaaaatatgc 
      D. elegans  cttgggagatcggg------agagcg------------------aaataaagctaaaatatgc 
     D. kikkawai  catcggagagcgga------agagat------------------ggataaagctaaaatatgc 
   D. takahashii  cttgggagatcgg--------gagag------------------gactaaagctaaaatatgc 
     D. rhopaloa  cttgggagatcggg------agagcg------------------gaataaagctaaaatatgc 
   D. ficusphila  ctcgggagatcggg------agagcg------------------gtataaagctaaaatatgc 
D. pseudoobscura  cttcagagagtaga--agagagagag--agagagagagagcaatggataaagctaaaatatgc 
   D. persimilis  cttcagagagtagaagagagagagag--agagagagagagcaatggataaagctaaaatatgc 
      D. miranda  cttcagagagtaga------agagag--agagagagagagcaatggataaagctaaaatatgc 
 
 D. melanogaster  atgttggag----------------------------------aaaaaatgccgcccatgtcgccaaaat 
     D. simulans  atgttggag---------------------------------aaaaaaatgccgcccatgtcgccaaaat 
    D. sechellia  atgttggag---------------------------------aaaaaaataccgcccatgtcgccaaaat 
       D. yakuba  atggtggag---------------------------------aaaaaaatgccgcccatgtcgccaaaaa 
       D. erecta  atgttggag---------------------------------aaaaaaatgccgcccatgtcgccaaaat 
    D. biarmipes  atgttggag----------------------------------aaaaaatgccgcccatgtcgccaaaat 
  D. bipectinata  acgttggagctgctggggcaacaacaacaacaacaacaacagaaaaaaaggccgcccatgtcgccaaaat 
   D. eugracilis  atgttggag---------------------------------aaaaaaatgccgcccatgtcgccaaaat 
      D. elegans  atgttggag------------------------------aagaaaaaaatgccgcccatgtcgccaaaat 
     D. kikkawai  aagttggag----------------------------------aaaaaatgccgcccatgtcgccaaaaa 
   D. takahashii  atgttggaa----------------------------------aaaaaatgccgcccatgtcgccaaaat 
     D. rhopaloa  atgttggag-------------------------------aagaaaaaatgccgcccatgtcgccaaaat 
   D. ficusphila  atgttggag---------------------------------aaaaaaatgccgcccatgtcgccaaaat 
D. pseudoobscura  aagctgaag-----------------------ctgctatggcaaaaaaatgccgcccatgtcgccaaaaa 
   D. persimilis  aagctgaag-----------------------ctgctatggcaaaaaaatgccgcccatgtcgccaaaaa 
      D. miranda  aagctgaag-----------------------ctgctatggcaaaaaaatgccgcccatgtcgctaaaaa 
 
 D. melanogaster  tttagcatc---ggaacatgcaaaaacagacatca-tcgcatggg--------------------gcagc 
     D. simulans  tttagcatc---ggaacatgcaaaaacagacatca-tcgcatggg--------------------gcagc 
    D. sechellia  tttagcatc---ggaacatgcaaaaacagacatca-tcgcatggg--------------------gcagc 
       D. yakuba  cttagcatc---ggaacatgcaaaaacagacatca-gcgcatggg--------------------gcagc 
       D. erecta  cttagcatc---ggaacatgcaaaaacagacatca-gcgcatggg--------------------ccagc 
    D. biarmipes  tttagcatcg--ggaacatgcaaaaacagacatca-tcgcatggg--------------------gcagc 
  D. bipectinata  tttagcatcg--ggaacatgcaaaaacagacatca-gcacatggggcaaaaacaataacaggaaagcaac 
   D. eugracilis  tttagcatcg--ggaacatgcaaaaacagacatca-tcgcatgag------------------caacaac 
      D. elegans  tttagcatcg--ggaacatgcaaaaacagacatca-gcgcatggg--------------------gcagc 
     D. kikkawai  tttagcatcg--agaacatgcaaaaacagacatca-------aag--------------------gcagc 
   D. takahashii  tttagcatcg--ggaacatgcaaaaacagacatca-tcgcatggg--------------------gcagc 
     D. rhopaloa  tttagtatcg--ggaacatgcaaaaacagacatca-gcgcatgga--------------------gcagc 
   D. ficusphila  tttagcatcg--ggaacatgcaaaaacaaacatca-gcgcattgg--------------------gctac 
D. pseudoobscura  ttttgtattgaaataacatgcaaaaacagacatca-gc----gag--------------------gcag- 
   D. persimilis  ttttgtattgaaataacatgcaaaaacagacatca-gc----gag--------------------gcag- 
      D. miranda  ttttgtattgaaataacatgcaaaaacagacatca-gc----gag--------------------gcag- 
   D. willistoni  tttagcatta--aaaacatgcaa----------------------------------------------- 
      D. virilis  tttagtatta--aaaacatgcaaaaacagacatcaagcccatgtg--------------------gcagc 






















 D. melanogaster  --------------ta------------------------ggg-----------gaccacccacatcgct 
     D. simulans  --------------tg------------------------ggg-----------gaccacccacatcgct 
    D. sechellia  --------------tg------------------------ggg-----------gaccacccacatcgct 
       D. yakuba  --------------t-------------------------ggg-----------gaccacccacaacgct 
       D. erecta  --------------tg------------------------ggg-----------gaccacccacaacgct 
    D. biarmipes  --------------tg------------------------ggg----------cgaccacccacaacgct 
  D. bipectinata  --------------tggagagggagggaggtagaaggaacgga-----------gaccacccacaacgct 
   D. eugracilis  gtgggggtacggtatg------------------------gcg-----------gaccacccactacgct 
      D. elegans  --------------aggagagagccggcgagggt------tgg-----------gaccacccacaacgct 
     D. kikkawai  --------------ta------------------------gtg-----------gaccacccacaacgct 
   D. takahashii  --------------tg------------------------gggtggcgtggcgcgaccacccacaacgct 
     D. rhopaloa  --------------aggagaggggcgaggggag-------gag-----------gaccacccacaacgct 
   D. ficusphila  --------------tg------------------------ggg----------cgaccacccacaacgct 
D. pseudoobscura  --------------ct------------------------aag------gctacgaccacccacaacgcc 
   D. persimilis  --------------ct------------------------aag------gctgcgaccacccacaacgcc 
      D. miranda  --------------ct------------------------aag------gctacgaccacccacaacgcc 
   D. willistoni  --------------tacgaaaccc----------------gag-----------gaccacccacaatgcc 
      D. virilis  --------------ct------------------------ggg-----------gaccacccacaatgcc 
   D. mojavensis  --------------cc------------------------ggg-----------gaccacccacaatgcc 
 
 D. melanogaster  acatcgcttggcggtttcagtttaatgaaggcaga-- 
     D. simulans  acatcgcttggcggtttcagtttaatgaaggcaga-- 
    D. sechellia  acatcgcttggcggtttcagtttaatgaaggcaga-- 
       D. yakuba  acaacgcttggcggtttcagtttaatgaaggcagc-- 
       D. erecta  acaacgcttggcggtttcagtttaatgaaggcagc-- 
    D. biarmipes  acaacgctcggcggtttcggtttaatgaaggcagc-- 
  D. bipectinata  acaacgcttggcggtttcagtttaatgaaggcagc-- 
   D. eugracilis  actacgcttcgcgttttcagtttaatgaaggcagc-- 
      D. elegans  acaacgctcgacggtttcagtttgatgaaggcagc-- 
     D. kikkawai  acaacgcttggcggtttcagtttaatggaagcagc-- 
   D. takahashii  acaacgctcggcggtttcagtttaatgaaggcagc-- 
     D. rhopaloa  acaacgctcgacggtttcagtttaatgaaggcagc-- 
   D. ficusphila  acaacgctcggcggtttcagtttaatgaaggcagc-- 
D. pseudoobscura  acaacgccggtcg--ttgagtttaatgaaggcaacaa 
   D. persimilis  acaacgccggtcg--ttgagtttaatgaaggcagcaa 
      D. miranda  acaacgccggtcg--ttgagtttaatgaaggcaac-- 
   D. willistoni  acaatgccggccg--ttgagtttaatgaaggcaac-- 
      D. virilis  acaatgccggcag--ccgcttttaatgaa-gcaac-- 
   D. mojavensis  acaatgccggcag--ccgcttttaatgaa-gcaac-- 
 
  D. melanogaster  --------tttttgggtggtccacac----tgcagcg--aaaa-------taa----actacagtggcaa 
      D. simulans  --------tttttgggtggtccacac----tgcaacg--aaaa-------taa----accacagtggcaa 
     D. sechellia  --------tttttgggtggtccacac----tgcaacg--aaaa-------taa----accacagtagcaa 
        D. yakuba  --------tttttgggtggtccacac----tgcaacg--aaaa-------taa----accacagtggcaa 
        D. erecta  --------tttttgggtggtccccac----tgcagcg--aaaa-------taa----accacagtggcaa 
     D. biarmipes  ccgaaagcactttgggtggtctttgc----gaaaata--aaaa-------taatggcacgcgaataacaa 
   D. bipectinata  --------tttttgggtggtccccgg----tgccatg--aaaa-------taa----accgccgcag--a 
    D. eugracilis  --------tttttgggtggtccacac----tgcaatg--aaaa-------taa----accaccgtggaaa 
       D. elegans  --------attttgggtggtccacac----tgcaatg--gaaa-------taa----accaccgtggcaa 
      D. kikkawai  --------tttttgggtggtccacac----tgcagtgaaaaaa-------taa----agcaccgcagcaa 
    D. takahashii  --------tttttgggtggtccacac----tgcaata--aaaa-------taa----accaccgtggcaa 
      D. rhopaloa  --------tttttgggtggtccacac----tgcaatg--aaaaaagaaagaaa----accaccgtggcaa 
    D. ficusphila  --------tttttgggtggtccatccacactgcaat---aaaa-------taa----accaccgtggcag 
 D. pseudoobscura  --------tttttgggtggtc--tgc----tacaaca--acaa-------tca----------------- 
    D. persimilis  ---------ttttgggtggtc--tgc----tacaaca--acaa-------tca----------------- 
       D. miranda  --------tttttgggtggtc--tgc----tacaaca--acaa-------tca----------------- 
    D. willistoni  --------tatttgggtggtcc-----------------acca-------cca----------------- 
       D. virilis  --------tatttgggtggtc---gc----tgcaata--aaaa-------taa--------caacaacat 
    D. mojavensis  --------tatttgggtggtc---gc----tgcaata--aaaa-------taa--------cagcaacaa 
 














  D. melanogaster  caac---------aaaccagc-agc----ca-aggcacttt---gggtggtccatgcaaaa--------- 
      D. simulans  caac---------aaaccagc-agc----cg-aagcacttt---gggtggtccgtgcaaaa--------- 
     D. sechellia  caac---------aaactagc-agc----ca-aagcacttt---gggtggtccgtgcaaaa--------- 
        D. yakuba  caac---------aaaccagc-agc----ca-aagcacttt---gggtggtccgtgcaaaa--------- 
        D. erecta  caac---------aaaccagc-agc----ca-aagcacttt---gggtgggccgtgcaaaa--------- 
     D. biarmipes  caat-------agaaattagcgagctccgca-gtgaatgttggaggggagttagctcgata--------- 
   D. bipectinata  aaag---------gaaacaga-aac-------ggccgtttt---gggtggtctttgaaaat--------- 
    D. eugracilis  caacaactacaaaaaaacagc-agc----cagaagcacttt---gggtggtct-tgcgaat--------- 
       D. elegans  catcaacaaca--aaaacagc-agc----caaaagcacttt---gggtggtctcggcaaaa--------- 
      D. kikkawai  caacaatagca--aaagcggc-agc-----a-aaatacttc---g----------ccaaaaaccaaaatc 
    D. takahashii  caac----acaaaaaagcagc-agc----cgaaagcacttt---gggtggtctttgcgaaa--------- 
      D. rhopaloa  catcaacaaca--aaaacagc-agc----caaaagcacttt---gggtggtctcgccaaaa--------- 
    D. ficusphila  caaaaaaa-----aaaacagc-agc----ca-aatctcttt---aggtggtctcggcgaaa--------- 
 D. pseudoobscura  -------------aaa------agc----ct-------ttt---gggtggtcgtggcaaca--------- 
    D. persimilis  -------------aaa------agc----ct-------ttt---gggtggtcgtggcaaca--------- 
       D. miranda  -------------aaa------agc----ct-------ttt---gggtggtcgtggcaaca--------- 
    D. willistoni  -------------------gc-aac----ct-----cgctt---gggtggtc----caaac--------- 
       D. virilis  gaata--------acgccagc-ggg----cg-cag--tcgt---gtgtggtcttagctaaa--------- 





 D. melanogaster  gaaccc--aatggcccaca------taactcc 
     D. simulans  gaaccc--aatggcccaca------taactcc 
    D. sechellia  gaaccc--aatggcccaca------taactcc 
       D. yakuba  gagccc--aatggcccaca------taactcc 
       D. erecta  gaaccc--aatggcccaca------taactcc 
    D. biarmipes  gagccc--aatggcccaca------taactcc 
  D. bipectinata  gaaccc--aatggcccacatacacgtaacacc 
   D. eugracilis  gaaacc--aatggcccaca------taactcc 
      D. elegans  gacacc--aatggcccaca------taactcc 
     D. kikkawai  gagccccgaatggcccacatata--taactcc 
   D. takahashii  gaaccc--aatggcccaca------taactcc 
     D. rhopaloa  gatccc--agtggcccaca------taactcc 
   D. ficusphila  gagccc--aatggcccaca------taactcc 
D. pseudoobscura  ataccc--aatggcccaca------taacacc 
      D. miranda  ataccc--aatggcccaca------taacacc 
   D. willistoni  taaacc--tttgccccaca------taacacc 
      D. virilis  ggagtc--agtgccccaaa------tagcacc 
 
 D. melanogaster  acaac--------------------------gg------------cccgac------------------a 
     D. simulans  acaac--------------------------gg------------cccgac------------------- 
    D. sechellia  acaac--------------------------gg------------cccgac------------------- 
       D. yakuba  acaac--------------------------gg------------ctcgac------------------- 
       D. erecta  acaac--------------------------ag------------cccgac------------------- 
    D. biarmipes  acaac--------------------------gg------------c-cgac------------------- 
  D. bipectinata  acgac--------------------------ga--------agaccccgaa------------------- 
   D. eugracilis  acaac--------------------------gg------------gccgacacatagggagagagagaga 
      D. elegans  acaac--------------------------gg------------cccaag------------------- 
     D. kikkawai  -------------------------------ga---------------gac------------------- 
   D. takahashii  acaac--------------------------gg------------cccgac------------------- 
     D. rhopaloa  acaac--------------------------gg------------cccgag------------------- 
   D. ficusphila  acaac--------------------------gg------------cccgaa------------------- 
D. pseudoobscura  acagc--------------------------aa--------------caac------------------- 
      D. miranda  acagc--------------------------aa--------------caac------------------- 

















 D. melanogaster  gagagagagag---------------------agaa-----------------gaa 
     D. simulans  ---agagagag---------------------agaa-----------------gaa 
    D. sechellia  ---agagagag---------------------agaa-----------------gaa 
       D. yakuba  ---agcgagag---------------------agaa-----------------gaa 
       D. erecta  ---a--gagag---------------------agaa-----------------gaa 
    D. biarmipes  ---agagagag---------------------agaa-----------------g-a 
  D. bipectinata  --gagaaagag---------------------agaa-----------------gaa 
   D. eugracilis  gagagagagagacagagagagagggagagagaagaa-----------------gaa 
      D. elegans  ---agagagagaca------------------agaa-----------------gaa 
     D. kikkawai  ---a-----ag---------------------agga-----------------gaa 
   D. takahashii  ---agagagag---------------------agaa-----------------gaa 
     D. rhopaloa  ---agagagag---------------------agaa-----------------g-a 
   D. ficusphila  gaaagagagag---------------------agaa-----------------gaa 
D. pseudoobscura  ---a-aaagag---------------------agaa-----------------gaa 
      D. miranda  ---a-aaagag---------------------agaa-----------------gaa 
   D. willistoni  ---agaaaaaa---------------------agaa-----------------aaa 
 
 D. melanogaster  cagtgacagagag------cgaatacc 
     D. simulans  cagtgacagagag------cgaatacc 
    D. sechellia  cagtgacagagag------cgaatacc 
       D. yakuba  cagtgacagagag------cgaatacc 
       D. erecta  cagtgacagagag------cgaatacc 
    D. biarmipes  cagtgacagagag------cgaatacc 
   D. eugracilis  cagtgacagagag------cgaatacc 
      D. elegans  cagtgacagagag------cgaatacc 
     D. kikkawai  cagtgacagagag------cgaatacc 
   D. takahashii  cagtgacagagag------cgaatacc 
     D. rhopaloa  cagtgacagagag------cgaatacc 
   D. ficusphila  cggtgacagagag------cgaatacc 
D. pseudoobscura  gagtggaagagagggggcccgaatacc 
      D. miranda  gagtggaagagagggggcccgaatacc !!!!D. melanogaster  ctagtcacgttttcggggcgccataaatt 
     D. simulans  ctagtcacgttttgggggcgccataaatt 
    D. sechellia  ctagtcacgttttgggggcgccataaatt 
       D. yakuba  ctagtcacgttttgggggcgccatatatt 
       D. erecta  ctagtcacgttttgggggcgccataaatt 
    D. biarmipes  ctagtcacgtttc-ggggcgccataaatt 
  D. bipectinata  ctagtcacgttttgggggcgccataaatt 
   D. eugracilis  ctagtcacgttttgggggcgccataaatt 
      D. elegans  ctagtcacgttttgggggcgccataaatt 
     D. kikkawai  ctagtcacgttttgggggcgccataaatt 
   D. takahashii  ctagtcacgttttgggggcgccataaatt 
     D. rhopaloa  ctagtcacgtttcgggggcgccgtaaatt 
   D. ficusphila  ctagtcacgttttgggggcgccataaatt 
D. pseudoobscura  ctagtcacgttttgggggcgccataaatc 
      D. miranda  ctagtcacgttttgggggcgccataaatc 
   D. willistoni  ctagtcacgttttgggggcgccataaatt 
      D. virilis  ctggtcacgttttaggggcgccataaatt 
   D. mojavensis  ccagtcacgtttaaggggcgccataaatt 
 
 D. melanogaster  ct--acaagttttatggcacacg-c 
     D. simulans  ct--acaagttttatggcacacg-c 
    D. sechellia  ct--acaagttttatggcacacg-c 
       D. yakuba  ct--acaagttttatggcacacg-c 
       D. erecta  ct--acaagttttatggcacacg-c 
    D. biarmipes  ct--acaagttttatggcacacg-c 
  D. bipectinata  ct--acaagttttatggcacacg-c 
   D. eugracilis  ct--acaagttttatggcacacg-c 
      D. elegans  ct--acaagttttatggcacacg-t 
     D. kikkawai  ct--acaagttttatggcacacg-t 
   D. takahashii  ct--acaagttttatggcacacg-c 
     D. rhopaloa  ct--acaagttttatggcacacg-c 
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   D. ficusphila  ct--acaagttttatggcacacg-c 
D. pseudoobscura  ct--acaagttttatggcacacg-t 
      D. miranda  ct--acaagttttatggcacacg-t 
   D. willistoni  ctacacaggttttatggcacacgtc 
      D. virilis  ct--acacgtttaatggcacaca-t 




 D. melanogaster  tcgtctgggtggtctgccatataga---------- 
     D. simulans  tcgtctgggtggtctgccatattga---------- 
    D. sechellia  tcgtctgggtggtctgccatattga---------- 
       D. yakuba  tcgtctgggtggtctgccatattga---------- 
       D. erecta  tcgtctgggtggtctgccatattga---------- 
    D. biarmipes  gtgtctgggtggtctgccatattga---------- 
  D. bipectinata  gcctctgggtggtctgccatattga---------- 
   D. eugracilis  atatctgggtggtctgccatattga---------- 
      D. elegans  ggatct-ggtggtctgtcatattga---------- 
   D. takahashii  gtgtctgggtggtctgccatattga---------- 
     D. rhopaloa  ggatctgggtggtctgccatattga---------- 
   D. ficusphila  ---tctgggtggtctgccatattga---------- 
D. pseudoobscura  gcctttgggtggtctgccatattga---------- 
      D. miranda  gcctttgggtggtctgccatattga---------- 
      D. virilis  tcggctgggtggtccgtcacgtcgc---------- 
   D. mojavensis  ttcactgggtggtccggcacgttgctgcttattga 
 
 D. melanogaster  cggcataactgggtgcgctcatatt------taatggcc 
     D. simulans  cggcataactgggtgcgctcatatt------ttatggcc 
    D. sechellia  cggcataactgggtgcgctcatatt------ttatggcc 
       D. yakuba  cggcataactgggtgcgctcatatt------ttatggcc 
       D. erecta  cggcacaactgggtgcgctcatatt------ttatggcc 
    D. biarmipes  cggcacaactgggtgcgctcatact------ttatggcc 
  D. bipectinata  cggcataactgggtgcgctcatatt------ttatggcc 
   D. eugracilis  cggcataactgggtgcgctcatatt------ttatggcc 
      D. elegans  cggcataactgggtgcgctcgtatt------ttatggcc 
     D. kikkawai  cggcataactgggtgcgctcatattttatggttatggcc 
   D. takahashii  cggcataactgggtgcgctcatatt------ttatggcc 
     D. rhopaloa  cggcataactgggtgcgctcatgtt------ttatggcc 
   D. ficusphila  cggcataactgggtgcgctcatatt------ttatggac 
D. pseudoobscura  cggcataactgggtgcgctcatatt------ttatggct 
      D. miranda  cggcataactgggtgcgctcatatt------ttatggct 
 
 D. melanogaster  agc-ggt--------------ccgtgtaattaagtagtcagg-cgctgtggggggcc 
     D. simulans  agc-ggt--------------ccgtgtaattaagtagtcagt-cgctgtggggggcc 
    D. sechellia  agc-ggt--------------ccgtgtaattaagtagtcagg-cgctgtgtggggcc 
       D. yakuba  agc-ggt--------------ccgtgtaattaagtagtcagg-cgctgtggggggcc 
       D. erecta  agc-ggt--------------ccgtgtaattaagtagtcggg-cgctctggggggcc 
    D. biarmipes  agc-ggg--------------ccgagtaattaagtagtcaag-cgctgtggggggcc 
  D. bipectinata  atc-ggg--------------tcgtgtaattaagtagtcatt-ctctgtggggggtt 
   D. eugracilis  agc-ggt--------------ccgtgtaattaagtagtcaag-cgctgtggggggcc 
      D. elegans  agc-ggc--------------ccgtgtaattaagtagtcaag-cgctgtggggggcc 
     D. kikkawai  agc-gga--------------ccgtgtaattaagtagtcagatctctgtggggggta 
   D. takahashii  agc-ggg--------------ccgtgtaattaagtagtcaag-cgctgtgggggggc 
     D. rhopaloa  ----ggc--------------ccgtgtaattaagtagtcaag-cgctgtggggggcc 
   D. ficusphila  agc-ggt--------------ccgtgtaattaagtagtcaac-caccgtggggggcc 
D. pseudoobscura  atcgggg--------------ccgtgtaattaagtagtcaag-ctctgtgggggggc 
      D. miranda  atcgggg--------------ccgtgtaattaagtagtcaag-ctctgtgggggggc 
      D. virilis  ---------------------ccgtgtaattaagtagtcaaa-gcccgtggggggtg 
   D. mojavensis  gtc-gactatttataatgcttcggtgtaattaagtagtcaaa-gcccgtgaggcatt 
 
 D. melanogaster  gtcgga-tcttttgattgattgatgcgtg 
     D. simulans  gtcgga-tcttttgattgattgatgcgcg 
    D. sechellia  gtcgga-tcttttgattgattgatgcgtg 
       D. yakuba  gtc-gg-tcttttgattgattgatgcgtg 
       D. erecta  gtcggg-tcttttgattgattgatgcgtg 
    D. biarmipes  gtcgga-tcttttgattgattgatgcgtg 
  D. bipectinata  gtcgga-ta-tatgattgattgatgggga 
   D. eugracilis  gtcgga-tcttttgattgattgatgcgtg 
      D. elegans  gtcgga-ccttttgattgattgatgcgtg 
     D. kikkawai  gtcgga-tc-tttgattgattgatgcgtg 
   D. takahashii  gtcgga-tcttttgattgattgatgcgtg 
     D. rhopaloa  gtcgga-tcttttgattgattgatgcgtg 
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Figure 2.16 Sequence conservation of selected TF binding motifs in enhancers of 
patched 
Sequence alignments were obtained from the UCSC Genome Browser, dm6 build.  
Selected conserved Tango/Spineless (Tgo/Ss) motifs are in gray; Distaless (Dll) in light 
blue; Engrailed (En) in green;  Pannier (Pnr/dGATAe) in purple; Scalloped (Sd) in blue; 
Cubitus interruptus (Ci) in red; Odd-Skipped (Odd) in dark red; Forkhead (Fkh) in dark 
yellow; Sloppy-paired (Slp) in blue-green; Pleiohomeotic (Pho) in pink, GAGA Factor 
(GAF/Trl) in yellow.  Blocks of sequence separated by line breaks are not necessarily 
contiguous.  
  
   D. ficusphila  gtcggg-tcttttgattgattgatgcgtg 
D. pseudoobscura  gtcggt-tcttttgattgattgacggctg 
      D. miranda  gtcggt-tcttttgattgattgacggctg 
      D. virilis  cacgaa-ctctttgattgattagtgcgtt 
   D. mojavensis  cacgaacctttttgattgattagagtgtt 
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Figure 2.17 Drosophila and vertebrate patched orthologs share a similar cis-regulatory 
architecture and gene regulatory strategy 
(A) X-gal-stained E10.5 mouse embryos carrying novel Ptch1 enhancers as transient-
transgenic lacZ reporters (Figure 2.22) are shown above a map of the mouse Ptch1 
region. Known Ptch1 enhancers (Lopez-Rios et al., 2014; Vokes et al., 2007) are shown 
as cartoons. Red boxes along the gene locus schematic represent GLI1 occupancy in 
neural progenitors near Ptch1 (as identified by ChIP-seq; (Peterson et al., 2012). (B) 
ChIP-seq of GLI2 and GLI3 near Ptch1. Red arrowheads highlight tissue-specific GLI 
 90 
binding. (C) ChIP-seq shows H3K27me3 is enriched at the proximal promoter but 
reduced upon pathway stimulation, consistent with relief of Polycomb-mediated 
repression. (D) Summary of the ptc response to Hh in the Drosophila embryonic 
ectoderm. Multiple Hh-responsive enhancers combine Ci/GLI sites (red bands) and 
tissue-specific inputs (colored bands), generating overlapping subsets of the embryonic 
ptc response which are integrated and amplified by the promoter-proximal region, 
resulting in a complete segment-polarity stripe pattern (top). The promoter-proximal 
region also generates the basal signal-independent ptc expression (bottom, purple). (E) 
Summary of the Hh response of ptc in the wing disc. A large battery of tissue-specific 
GLI-responsive enhancers, driving wing stripes of different widths, intensities, and 
dorso-ventral extents, interact with a Polycomb/Trithorax-bound promoter-proximal 
region to provide a complete wing stripe pattern (top). The PRE-containing promoter-
proximal region also produces signal-independent ptc expression in the anterior 
(bottom, purple). Identification of flanking CTCF insulator sites for both fly and mouse 
patched were determined using ChIP-seq and ChIP-CHIP analyses available from the 





Figure 2.18 Topological boundaries and chromatin insulators at mouse PTCH1 and fly 
patched 
(A) Map of the immediate vicinity of mouse Ptch1, displayed in the UCSC Genome 
Browser (genome.ucsc.edu), showing the topological domains and boundary regions in 
mouse ES cells and cortex, as determined by Hi-C chromatin interactions (Dixon et al., 
2012), and ChIP-seq binding data for the chromatin insulator/boundary factor CTCF in 
embryonic mouse brain(Wang et al., 2012).  Red box indicates a cluster of CTCF peaks 
in the Fancc gene, downstream of Ptch1. (B) Larger-scale view (~5.5 Mb) of a 
chromosomal region including Ptch1.  Red box shows a boundary region far upstream 
of Ptch1.  The topological domain containing Ptch1 extends from Fancc over 2 Mb to 
the 5’ of Ptch1 (to the right in this view). (C) Summary of modENCODE Drosophila 
genomic data (Celniker et al., 2009) in the vicinity of the ptc locus (~90 kb), showing 
binding of CTCF and other insulators and boundary-associated factors.  As in the 
mouse, the nearest 3’ CTCF boundary to fly ptc is nearby (between the 3’ end of ptc 
and the promoter of the adjacent gene Ascl), while the nearest 5’ boundary is further 
away (~18 kb upstream, at the CG8635 gene promoter).  All characterized ptc 




Figure 2.19 PCR primers used to amplify Drosophila genomic sequences 
The promoter analysis primers A_F and B_F contain a 5’ tag of CACCctcgag – CACC is 
used to facilitate TOPO cloning (Life Technologies; see Methods) for ease of 
sequencing, and a XhoI site (ctcgag) for cloning purposes. The A_R primer contains a 
















































5’ tag of GTAaccggt. The GTA serves as a buffer for ease of restriction digest and an 
AgeI restriction site (accggt) for cloning purposes. The B_R primer contains a 5’ tag of 
GTActcgag. The GTA serves as a buffer for ease of restriction digest and a XhoI 
restriction site (ctcgag) for bidirectional cloning purposes. All other primers were 
designed for TOPO cloning of enhancer sequences: Each enhancer’s forward primer 
contains a 5’ tag of CACCCCGCGG. CACC again was used to facilitate TOPO cloning 
while CCGCGG is a SacII restriction site for screening purposes. Each Reverse primer 
contains a 5’ tag of GTACCGCGG, the GTA again serves as a buffer for ease of 




Figure 2.20 EMSA oligonucleotides used in GBS competition binding assays 
The top strand of each double stranded oligonucleotide is shown. The GBS being tested 

































Figure 2.21 Mouse Ptch1 enhancer coordinates 
Sequence coordinates, corresponding to the mm9 build of the Mus musculus genome, 
are provided for all enhancers tested as lacZ reporters in E10.5 mouse embryos in 
Figure 6A. Enhancers are named for their position relative to the Ptch1 promoter. 
References are provided for previously published enhancers. 
 
 
-456kb chr13:64122052-64122757 this study
-438kb chr13:64104376-64104670 this study
-415kb chr13:64081569-64081954 this study
-154kb chr13:63820845-63821332 this study
-8.1kb chr13:63674651-63674885 this study
-3.7kb chr13:63670185-63671020 this study
-0.95kb chr13:63667602-63667781 Vokes et al., 2007
+2.6kb chr13:63664151-63664519 this study
+11kb chr13:63655468-63657042 Visel et al., 2007
+45kb chr13:63621577-63634154
Lopez-Rios et al., 
2014
SourceCoordinates (mm9)Enhancer location (relative to Ptch1 promoter)
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Chapter 3  
 
Non-GLI Transcription Factors Regulating patched 
 
3.1 Abstract 
The constitutive response of ptc to Hh signaling is regulated by an array of 
context specific enhancers controlled by the GLI family of TFs in both flies and mice. It 
is important to remember that no gene or enhancer is regulated by a single TF, which 
implies that there is still much to learn about other factors acting on the enhancers 
already discussed. Multiple tissue-specific TFs contribute to the regulation of these 
enhancers in different developmental and adult contexts, for an example of a very well 
characterized enhancer requiring multiple inputs, see (Swanson et al., 2010). Since only 
a handful of Hh-responsive enhancers have been identified (Ramos and Barolo, 2013), 
there has not been a major, comprehensive effort to identify the TFs that regulate Hh-
responsive enhancers, aside from GLI. After identifying more than 30 context specific, 
GLI-responsive enhancers (Chapter 2), I have begun to identify and characterize tissue-
specific inputs that also regulate ptc. In this chapter, I have assessed several novel 
transcriptional inputs predicted to contribute to ptc regulation. 
3.2 Introduction 
Although many components of the Hh signaling pathway were originally identified 
in flies (Ingham and McMahon, 2001; Ingham et al., 1991; Nüsslein-Volhard and 
Wieschaus, 1980), most of what we know about additional tissue specific transcription 
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factors controlling Hh target genes have been identified in mice (Hoffmann et al., 2014; 
Oosterveen et al., 2012; Peterson et al., 2012; Ribes et al., 2010). Here, I have 
compiled most of what is known about these additional non-GLI inputs identified by 
other groups and complete new experiments to address novel tissue specific TFs 
required for Hh-responsive enhancer function in flies.  
One of the first and best characterized transcription factors to be identified as a 
context-specific input into Hh target gene enhancers is SOX2, a key determinant of 
neural progenitor identity (Peterson et al., 2012; Pevny and Placzek, 2005). The 
experiments leading to this discovery were carried out by tagging murine GLI1 with a 
FLAG epitope at the C-terminus (Vokes et al., 2007) and using ChIP-seq in 
differentiated neural progenitors to identify regions of the genome occupied by GLI. 
Computational analysis of these GLI-bound regions demonstrated that the most 
significantly enriched binding site was that of GLI, as expected. Interestingly, there were 
many other motifs identified that were shared and overrepresented among the newly 
identified GLI-binding regions. Of these, one of the top non-GLI predicted factors was 
SOX2. Peterson and colleagues then performed SOX2 ChIP-seq in the same cells to 
further test their hypothesis that SOX2 also regulates GLI-responsive enhancers and 
showed that SOX2 was bound to about 12% of the regions also occupied by GLI. 
Furthermore, these binding regions aligned with active enhancer marks like H3K27Ac 
upon SHH stimulation, suggesting that these regions were most likely active enhancers 
bound by both GLI and SOX2. A subset of these co-bound enhancers were tested as 
transient transgenic reporters with all predicted SOX2 binding sites mutated (similar to 
how I mutated the GBS in Chapter 2). Each enhancer relied on SOX2 binding sites for 
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activity in this assay, further demonstrating that SOX2 activates Hh-responsive 
enhancers. 
While SOX2 is one of the best characterized non-GLI inputs into Hh regulated 
enhancers, the ChIP-seq analysis of GLI1 targets by Peterson et al. also predicted other 
context specific inputs based on sequence alone. The top candidates included FOXA2, 
PBX, EVX, and RFX, although they have not yet been confirmed with transgenic 
reporters. FOXA2 was of particular interest because independent work published 
concurrently also identified FOXA2 as a potential co-regulator of SHH target enhancers 
(Metzakopian et al., 2012). These experiments set out to identify all targets of FOXA2 in 
the neural tube and one of their main findings was that many of the FOXA2 ChIP-seq 
peaks overlapped known GLI-bound peaks, several of which had already been tested 
as SHH regulated enhancers in reporter assays. These included enhancers of the 
Ptch1, GLI1, Nkx2.9, and HHip genes (Agren et al., 2004; Dai et al., 1999; Hallikas et 
al., 2006; Peterson et al., 2012; Santagati et al., 2003; Sasaki et al., 1997; Vokes et al., 
2007).  While this group made a convincing argument for the co-regulation of these 
enhancers by FOXA2 and GLI, they did not actually make transgenic animals following 
up on the role of FOXA2 in these contexts. Therefore, while there is much evidence 
implying that FOXA2 is a co-regulator, it has not been directly confirmed.  
In addition to these datasets, Oosterveen et al., completed another study that 
identified GLI regulated enhancers for SHH targets in the neural tube (Oosterveen et al., 
2012). Their analysis examined sequence conservation and the presence of GLI binding 
sites and then tested predicted enhancers as minimal lacZ reporter constructs in the 
chicken neural tube. Using this experimental set up, they identified enhancers for the 
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Nkx2.2, Nkx2.9, Olig2, Nkx6.1, Nkx6.2, Dbx2, Dbx1, and Pax6 genes. They also 
observed that many of these enhancers correlated to regions occupied by SOX proteins 
by ChIP analysis in neural tissue, where these enhancers are active. SOX proteins are 
a class of bHLH transcriptional activators known to regulate neural tube development, 
so it was plausible that SOX regulated these enhancers (Bergsland et al., 2011). To 
confirm this, binding sites for SOXB1 were mutagenized resulting in a loss of activation 
in the neural tube. This result was repeated in murine cell lines using luciferase assays 
to measure transcriptional activity as well. Together, this group identified several SHH 
responsive enhancers in the neural tube that depend on GLI binding sites of various 
affinities (see Chapters 1 and 2 for a more thorough discussion about the importance of 
low affinity binding sites) and also identified SOXB1 as a non-GLI input that is essential 
for mediating the SHH response in the neural tube. 
Limited progress has been made in identifying co-regulators of SHH responsive 
enhancers outside of the neural progenitor cell types discussed so far. However, in the 
heart, another tissue that requires SHH signaling for normal development, at least one 
additional factor called TBX5, a T-box transcription factor, has been identified 
(Goddeeris et al., 2008; Hoffmann et al., 2009). While studying the role of TBX5 in heart 
development, Xie and colleagues demonstrated via in situ hybridization that both TBX5 
and GLI1 transcription factors are expressed in the same tissue at the same time. 
Inhibiting expression of either factor with a dominant negative or a genetic deletion led 
to impaired development (Xie et al., 2012). With these data, Hoffman and colleagues 
set out to identify the mechanism underlying how these two factors might work together 
and went on to identify a single region of overlap between GLI and TBX5 ChIP-seq in 
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heart tissue, suggesting the presence of an enhancer occupied by both TFs in this 
context. Transient transgenic lacZ reporter mice carrying either an enhancer with wild 
type sequence or with mutated GLI or TBX5 binding sites demonstrated a requirement 
for both GLI and TBX5 to activate expression in the developing heart, suggesting that 
TBX5 is another tissue-specific input into SHH responsive enhancers. 
While a handful of context-specific inputs have been shown to regulate SHH 
responsive enhancers, the list is still short, partly because of the lack validated GLI 
dependent enhancers. While there are many GLI bound regions identified by ChIP-seq, 
the overwhelming majority have not been tested for functionality, and at this time are 
still predicted enhancers. Because I now have identified and characterized more than 
30 tissue specific enhancers of Drosophila ptc, I have the unique opportunity to identify 
other inputs into these regions, and therefore, into ptc. I began this analysis by combing 
through the sequences of the enhancers identified in Chapter 2 (see Figure 2.3 for 
complete list) using several criteria (Figure 3.1). Initially, I looked for large blocks of well-
conserved sequences among related species of Drosophila. This was carried out in two 
ways: First, I used the UCSC genome browser to identify conservation within 
Drosophilids. Second, I used a freely available online comparative genomics tool called 
EvoprinterHD (https://evoprinter.ninds.nih.gov/evoprintprogramHD/drosophila.html) that 
aligns multiple genomes simultaneously to search for highly conserved orthologous 
sequences that might be of regulatory importance (Yavatkar et al., 2008) (Figure 3.1).  
After identifying conserved blocks of sequence within each enhancer, I searched for 
predicted transcription factor binding sites within these shorter blocks using several 
different computer programs. These included algorithms that searched entire databases 
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worth of TFBS positional weight matrices and predicted binding sites, such as CisBP 
(Weirauch et al., 2014), WeederWeb (Pavesi et al., 2004), Fly Factor Survey 
(http://mccb.umassmed.edu/ffs/DownloadData.php), or the JASPAR transcription factor 
binding database (Mathelier et al., 2016), http://jaspar.genereg.net/). While these 
programs use different algorithms, they all examine a particular sequence and identify 
predicted binding motifs that were generated from previously completed bacterial 1-
hybrid screens, yeast 1 hybrid screens, and any additional published literature or 
datasets including ChIP-seq motif prediction. These programs predicted several binding 
sites for different TFs. I then examined any available expression data for that TF either 
by conducting a literature search or by using the Berkeley Drosophila Genome Project 
(Stapleton et al., 2002) http://www.fruitfly.org/index.html ), which provides in situ 
expression data in an array of differently staged embryos for many Drosophila genes. 
These expression data were critical in making an assessment of whether or not to 
proceed. Even if there was a perfect binding site for a transcription factor using any of 
the prediction methods discussed above, if that TF is not expressed in that tissue, it 
cannot be regulating expression. Furthermore, I examined ChIP-seq datasets for the 
predicted transcription factors that had been published previously to see if any binding 
occurred in the enhancer of interest. With this information, I then used PCR 
mutagenesis to ablate these predicted binding and then made transgenic animals to 
visualize any change in expression in that tissue.  
Although this work is still in progress, I have identified multiple novel TF-inputs 
into these enhancers. First, I describe Pannier, a Drosophila GATA TF, which provides 
activation in a subset of ptc positive cells (Herranz and Morata, 2001). I also have 
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strong evidence that 1EH requires GAGA input (first discussed in Chapter 2). 
Interestingly, there are at least two enhancers that were predicted to require additional 
transcriptional inputs from the repressors Sloppy Paired 1 (Slp1) and Odd-Skipped 
(Odd) using these criteria, but neither had a large effect on expression in our assay. I 
will discuss alternative explanations for the tissue specific responses of these 
enhancers as well. Finally, I have demonstrated a requirement for RFX (Regulatory 
Factor X) as an additional input into a previously characterized mouse Ptch1 enhancer 
and suggest a role for RFX in flies as well (Vokes et al., 2007). Importantly, there are 
RFX transcription factors in Drosophila that mainly regulate ciliogenesis in sensory 
neuron differentiation (Dubruille, 2002) and recently Hh signaling has been shown to be 
active in Drosophila cilia, although a direct mechanism of target gene activation has not 
yet been identified (Kuzhandaivel et al., 2014). The reporter data I present here 
suggests a novel link between mouse and fly patched regulation and expands our 
knowledge of how Hh target enhancers combine multiple inputs to respond to signaling 
in a variety of different contexts.  
3.3 Results 
3.3.1 GATA: a novel regulator of Drosophila ptc   
The ptc enhancers identified in Chapter 2 did not recapitulate a complete 
response to Hh signaling. Many of these enhancers were highly cell type specific, not 
only restricted to a developmental stage like the embryonic ectoderm, but spacially 
restricted within that particular tissue. PN, for example, was active only at the dorsal 
most cells of the embryo and this expression was not mediated by the predicted GBS in 
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this enhancer (Figure 3.2A-C). I reasoned that this highly restricted patterning might be 
the result of non-GLI tissue specific inputs that regulate expression in a subset of cells.  
I then used the methods described in the introduction (Figure 3.1) to identify a set 
of highly conserved Pannier transcription factor binding sites near the 5’ end of 
enhancer PN (Figure 3.2D-E). Pannier (Pnr or dGATAe), a Drosophila GATA zinc finger 
transcription factor, is known to be a critical regulator of embryonic development 
(Calleja et al., 2000). It is critical for the embryonic process called dorsal closure, which 
is one of the last major morphogenetic changes during embryogenesis and is 
responsible for closing the cellular hole left over after germ band retraction (Herranz and 
Morata, 2001; Jacinto et al., 2002). Since these newly identified dGATAe binding sites 
in this enhancer are conserved (Figure 3.2D) and the expression of this TF matches the 
expression patterns generated by the PN enhancer (Figure 3.2B,F), I used PCR 
mutagenesis to ablate these two predicted dGATAe binding sites found in this 
enhancer. Mutation of these sites greatly reduced activation, indicating that these 
dGATAe binding sites contribute to enhancer activity (Figure 3.2G-H) and suggesting 
that dGATAe regulates this enhancer in the dorsal embryonic ectoderm while also 
highlighting a potential role for Hh signaling in the process of dorsal closure.  
3.3.2 The case for GAGA factor input into ptc enhancers 
In addition to enhancer PN, I also noticed that the expression pattern of 1EH also 
did not appropriately recapitulate the ptc response; rather than producing a more 
restricted pattern, 1EH produced too broad of an expression pattern (Figure 3.3). I 
wanted to determine whether a cluster of GBS at the 3’ end of the enhancer was 
primarily responsible for the activity of 1EH. To test this, I generated a minimal 
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enhancer construct, 1GH, consisting of this cluster of conserved sites (Figure 3.3A). 
Interestingly, although 1GH contains most of the well-conserved GBS (Chapter 2), it 
was not sufficient to respond to Hh signaling (Figure 3.3B,C) even using the 
endogenous ptc promoter, BA. I then hypothesized that 1EH required information from 
its 5’ end, specifically within 1EF. By looking at sequence conservation, I found several 
blocks of well conserved sequence, and within those blocks, noticed several GAGAG 
repeats, which are characteristic binding sites for GAGA Factor, or GAF (Oh et al., 
2013; Schaaf et al., 2013; van Steensel et al., 2003; Figure 3.3A, green lines). 
Furthermore, these GAF binding sites are located over a region of DNA predicted to be 
highly accessible by DNAse-hypersensitivity at the same stage of embryonic 
development as when this enhancer is active (Figure 3.3A, blue track). The initial 
experiment of generating the 1GH transgenic reporter fragment was a fortuitous choice: 
by isolating the cluster of GLI binding sites in 1GH, I had also excluded the predicted 
GAF binding sites in 1EF. Examining the same results with this new information, the 
drastic reduction in activation and patterning might be explained by the loss of those 
GAF binding sites (Figure 3.3B,C). Using the native ptcBA promoter in this experiment 
was not sufficient to rescue activation even though the BA region contains GAF binding 
sites, sits on a region of accessible chromatin, and has predicted GAF occupation in 
embryos (Figure 3.3A, 2.12).  
3.3.3 Regulatory Factor X: another link between flies and mice 
In addition to examining the fly enhancers identified in Chapter 2, I also 
examined the sequences of several mouse enhancers using the same basic strategy 
outlined in Figure 3.1. This resulted in the identification of a highly conserved binding 
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site for a TF called Regulatory Factor X (RFX). The RFX binding motif had 
independently been shown to be over-represented in a previous GLI1 ChIP-seq dataset, 
suggesting that it might be a significant player in regulating Hh target genes (Peterson 
et al., 2012). We identified a high quality RFX binding site in a previously characterized 
mouse Ptch1 enhancer, called Peak2 (Vokes et al., 2007). This small, 180bp promoter 
proximal Ptch1 enhancer is active in the murine neural tube, a well-characterized site of 
SHH signaling. Much of the sequence in this enhancer is well conserved, often to 
zebrafish, suggesting functional relevance. The RFX binding site we found sits in one of 
these well-conserved regions (Figure 3.5A-C). While there are no available ChIP-seq 
data in mice for RFX, there has been ChIP-seq analysis in human cells looking at the 
binding of RFX5, one of 8 members of the family the RFX family of transcription factors 
(Choksi et al., 2014). Interestingly, there is a strong peak of RFX5 binding to Peak2 in 
these cells, suggesting that this might be a functional binding site (ENCODE Project 
Consortium, 2012). With this information, I generated a luciferase construct containing a 
wild type Peak2 enhancer and compared it to a version with its RFX binding site 
mutated. In NIH3T3 cells, wild type Peak2 responds to SHH signaling via GLI1 
induction, but this response is weakened when the RFX binding site is mutagenized, 
demonstrating this binding site is required for maximum levels of activation upon SHH 
pathway stimulation (Figure 3.4D).  
Because Peak2 was active in murine cells as well as the neural tube, I wanted to 
see if this enhancer could also respond to Hh signaling in Drosophila. Therefore, I 
examined Peak2 as a GFP reporter in transgenic flies. I found that Peak2-GFP was 
active in pupal and larval salivary glands (Figure 3.5E-E’’) and depended on its RFX 
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binding site for achieving maximum levels of activation in this context (Figure 3.5 F-F’’). 
The minimal promoter alone weakly activated GFP in these contexts, but was weaker 
than the Peak2 RFXWT construct (Figure 3.5 G-G’’ compared to 3E-E”). Peak2 failed to 
respond in any other context examined, including known sites of Hh signaling like 
imaginal discs, which is not totally unexpected, since there is no RFX protein normally 
expressed in these contexts (data not shown). There is, however, RFX expressed in 
salivary glands during late embryogenesis (Hammonds et al., 2013; Tomancak et al., 
2002; Tomancak et al., 2007). Together, these data suggest that Peak2 requires RFX 
input to respond to Hh signaling and hints at a strong evolutionarily conserved 
mechanism for Hh activation, fitting the evolutionary themes discussed in Chapter 2.  
3.3.4 Predicted TFs that weakly regulate or do not contribute to ptc expression in 
the embryonic ectoderm 
It is also important to note that not all predicted tissue specific inputs contributed 
to ptc expression. For instance, enhancer LK produced a highly restricted expression 
pattern in the embryonic ectoderm in posterior cells while enhancer VT was active in the 
anterior region of each segment (Figure 2.5E,F). After analyzing the sequences of these 
enhancers, I found conserved binding sites for at least one transcriptional repressor in 
each enhancer. First, I found a Slp1 binding site in enhancer LK (Figure 3.5A-C). Slp1 is 
a transcriptional repressor, and is active specifically in the anterior cells proximal to the 
Engrailed positive, Hh secreting cells (Gebelein et al., 2004; Figure 3.5D). Importantly, 
these are cells in which ptc is expressed, but LK fails to respond. I hypothesized that LK 
was being repressed in the anterior by Slp1. Upon mutation of this Slp1 binding site, I 
saw a weak de-repression in these cells (Figure 3.5E-F, arrows point out derepression), 
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suggesting that Slp1 might be partially repressing ptc in these cells directly through 
enhancer LK.  
I next examined the conserved regions of enhancer VT, where I found an Odd-
Skipped (Odd) binding site using Fly Factor Survey that was well-conserved in other 
Drosophilid genomes (Figure 3.6B,C). Odd is a transcriptional repressor that is 
expressed specifically in the posterior of Hh positive cells in the embryonic ectoderm 
(Mulinari and Häcker, 2009, Figure 3.6D). When I mutated this predicted binding site in 
the context of VT, however, I did not see de-repression in the posterior, as expected. 
The GFP expression pattern was largely unchanged compared to wild type expression 
(Figure 3.6E,F), indicating that even though the sequence contained a predicted binding 
site for Odd, it is not functional in this context. This experiment does not rule of the 
possibility of Odd regulating expression of ptc through other binding sites in this, or any 
other enhancer in the locus, as there might be other (potentially lower affinity) binding 
sites missed in the analysis.  
3.4 Discussion 
In this chapter, I have characterized several novel TFs that contribute to the 
tissue specific response of patched to Hh signaling. While GLI binding site affinity 
informs the tissue specific response of these enhancers, GLI is not the sole contributor 
to enhancer function. Here I present evidence for novel additional inputs that contribute 
to patterning created by Hh signaling in different tissues and developmental contexts. 
It is interesting to note that enhancer PN is the only embryonic ectoderm 
enhancer identified in Chapter 2 that was not affected by removing its GBS (Figure 
3.2B,C). This could potentially be accounted for by two, non-exclusive explanations. 
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First, there could be even lower affinity GBS within this enhancer that were not 
examined in this analysis. When I mapped the low affinity GBS onto the ptc enhancers, 
I chose a cutoff of the top 200 sites (Gurdziel et al., 2015; Hallikas et al., 2006; 
Lorberbaum et al., 2016). Lower affinity GBS might be key to regulating expression in 
dorsal cells. Second, enhancer PN might work together with other enhancers in the 
locus to generate the full response of ptc to Hh. Testing this would require a locus wide 
manipulation using targeted genomic engineering like CRIPSR/Cas9, rather than the 
reporter experiments mostly used in this dissertation. We are actively working on both of 
these explanations to better understand how Hh targets are regulated (see Chapter 5 
for more details of these ongoing experiments). 
I then demonstrated that enhancer PN requires input from dGATAe in the dorsal 
most cells of the embryonic ectoderm (Figure 3.2), suggesting a novel role for dGATAe 
in the regulation of Hh target genes. These data hint at a direct mechanism by which Hh 
signaling might be playing a role in dorsal closure, which is significant because many of 
the components of Hh signaling are expressed and functional in the cells that undergo 
dorsal closure where dGATAe is most active (Yavari et al., 2010; Figure 3.2F). The 
process of dorsal closure in flies is essentially two epithelial sheets of cells that are 
“sewn” or “zipped” together to close an open region of the embryo (Martin and 
Parkhurst, 2004). The process of epithelial tissues coming together is important in 
development, since failure of successful fusion of tissues in mammalian development 
often leads to defects such as spina bifida and cleft lip/palate (Millard and Martin, 2008). 
These defects are also two common defects associated with defective SHH signaling as 
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well (Cobourne et al., 2009; Teglund and Toftgård, 2010). Enhancer PN’s requirement 
of dGATAe might lend additional insight to the role of Hh signaling in epithelial fusion. 
The potential regulation of ptc by GAF has already been extensively discussed in 
Chapter 2, but mostly in the context of the ptc promoter. It is not uncommon for 
Trithorax group proteins (TrxG) to mediate epigenetic regulation of the locus from non-
promoter regions (Bowman et al., 2014; Brown and Kassis, 2013; Kassis and Brown, 
2013; Schaaf et al., 2013). Here I introduce another piece of evidence suggesting that 
GAF regulates ptc in this way. In the case of 1EH, it seems that GAF activates its target, 
since when you remove most of the well-conserved GAF binding sites from the 
enhancer, expression is attenuated (Figure 3.3B,C). Further studies that target those 
GAF sites directly would provide valuable information about how GAF regulates 1EH. In 
the above experiment, I did not mutagenize target sites, rather, I removed a large region 
of the enhancer that could have additional binding sites for other activating transcription 
factors besides GAF. Thus we cannot be certain that all of the activation seen in 1EH vs 
1GH mediated by the GAF binding sites. 
It is also interesting that the GAF input into the promoter region, BA, was not able 
to provide enough activation to 1GH to generate a more complete Hh response (Figure 
3.3A,C), even though I have already demonstrated that region B contains significant 
activation potential in the embryo (Figure 2.11C). This could be explained by either of 
two explanations. First, like discussed earlier, there might be additional activating 
factors binding to this enhancer in the 1EF region. By removing this entire sequence, I 
might have lost additional factors required to respond. Second, this enhancer is found in 
the intron of ptc, therefore when it presumably is looped to the promoter in its native 
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genomic context to activate ptc expression, the orientation of its GAF sites are at a 
different position than when examined in the context of the reporter tested here. This is 
also in agreement with previous data because the other embryonic enhancer that 
showed increased activation when examined with the BA promoter (LK, Figure 2.11) is 
located upstream of the promoter, so it may not change 5’ to 3’ orientation when it 
interacts with the promoter. We could test this by completing a 3C (chromatin 
conformation capture), experiment to identify how these enhancers are physically 
interacting with the promoter to give us a clue about how orientation of enhancers might 
affect expression (Dekker et al., 2002). 
The identification of RFX input into the mouse Ptch1 enhancer highlights an 
exciting new input into Hh signaling. It is known that SHH signaling in mammals often 
requires cilia to function properly (Carpenter et al., 2015; Choksi et al., 2014) and a 
large number of developmental defects associated with cilia dysfunction, known as 
ciliopathies, have already been described (Hildebrandt et al., 2011). Hence, the RFX 
input into Ptch1 regulation described here provides at least one potentially direct 
trancriptional link between cilia and SHH target gene regulation. Furthermore, many 
RFX transcription factors are required for ciliogenesis (Ashique et al., 2009; Dubruille, 
2002; Swoboda et al., 2000), so a link between patched regulation and RFX implicates 
either a role for SHH signaling in building and maintaining cilia, or a role for RFX in 
regulating expression of genes that are processed in cilia.  
Another exciting result is the transcriptional activity of Peak2 in the salivary 
glands of Drosophila. Because this is a mouse enhancer that is able to respond to Hh 
signaling in the context of a fly, it is consistent with our previous claim that there is a 
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deeply conserved cis-regulatory strategy regulating ptc during development. 
Additionally, Peak2 only responds in a very restricted region of the fly, but not in the 
regions of the fly best characterized by Hh signaling, like the imaginal discs focused on 
in Chapter 2. This is not that surprising because RFX is not expressed in that context, 
probably because these are non-ciliated tissues. In fact, flies only use cilia in a few 
settings, most notably in sensory neuron differentiation where a new role for Hh 
signaling has recently been described (Kuzhandaivel et al., 2014), and where RFX has 
been shown to be active as well (Cachero et al., 2011). If Hh is required in the sensory 
neurons, then ptc should respond since it is a broadly responsive target gene (Chapter 
2). Following this logic, then, it is likely that one of the enhancers characterized in 
Chapter 2 responds in sensory neurons. Since we have a large number of enhancers to 
examine, we may be able to find one that responds to Hh in this region and then search 
the sequence for potential RFX binding sites.  
Peak2 requires its RFX binding site in the context of the salivary gland, raising 
the possibility that this tissue might be ciliated in flies. While this has never been 
demonstrated, it has been shown that mammalian salivary glands require cilia or normal 
development and function (Bernfield et al., 1972). Future work would be required to 
demonstrate if Drosophila salivary glands are ciliated, which could be done by using 
known markers of cilia, like Arl13B, for example (Joiner et al., 2015; Vieillard et al., 
2015). We could then attempt to identify the fly patched enhancer(s) that respond in the 
salivary glands and then see how RFX might contribute to this expression. An RFX 
ChIP-seq experiment would also be very helpful to identify when and where this ciliary 
 113 
factor binds DNA, although isolating sensory neuron in flies might be challenging since 
they are found in such a heterogeneous cell population in the embryo.  
Not all of our predicted transcription factors regulated patched enhancers exactly 
as we expected. Our predicted Slp1 and Odd inputs into LK and VT, respectively, did 
not contribute much patterning information to ptc expression in our transgenic readout. 
These data could mean that, although both binding sites are highly similar in sequence 
to the motifs for Odd and Slp1, there might be more, lower affinity binding sites for these 
TFs within these enhancers, similar to how Ci requires low affinity sites in the embryo. 
These particular positional weight matrices (PWMs) were generated by yeast one hybrid 
screens. So, while these TFs are able to recognize this consensus, the PWM allows for 
some nucleotide variation (Figure 3.5C,H) and I may have incorrectly predicted these 
binding sites. To account for this, I could more carefully search the sequences of these 
enhancers for lower affinity sites and also test the predicted binding sites using gel shift 
assays, or EMSAs to validate binding events. Furthermore, I could also use ChIP-qPCR 
to identify if either Odd or Slp1 recognizes these enhancers in their native cellular 
context.  
The partial derepression seen upon removal of the Slp1 binding site in enhancer 
LK does suggest Slp1 might play a role in ptc regulation (Figure 3.6). However, the 
response was weak when compared to nearly all of the binding site mutations 
completed with GLI binding sites in Chapter 2, and with dGATAe (Figure 3.2). This 
weak de-repression might still be functionally relevant, but much more work is needed 
to confirm the potential Slp1 contribution. In addition to the ChIP-qPCR already 
discussed, I would also like to more carefully analyze this sequence to search for lower 
 114 
affinity Slp1 binding sites, since I only looked for the highest affinity sites in this set of 
experiments. It is also important to note that when the Slp1 protein is deleted in a 
genetic knockout, ptc is not able to respond to Hh signaling, although, it was additionally 
shown that Hh itself is not produced at its normal levels either, so Slp1 may not be 
regulating ptc directly (Cadigan et al., 1994).  
Another interpretation of my concerning enhancers VT and LK is that neither 
Slp1 nor Odd are regulate these enhancers. This highlights the possibility that enhancer 
VT is required for activation in the anterior, while LK is required for activation in the 
posterior and they work together in their native context to generate a full response to Hh 
signaling. This mechanism could be tested by examining expression of patched in the 
context of the endogenous locus, and manipulating each enhancer individually, using 
CRISPR/Cas9. Alternatively, if I made a transgene containing both VT and LK as a 
single enhancer driving GFP, they might generate a more full response to Hh signaling. 
One of the pitfalls of this is that this experiment violates the endogenous spacing of 
these enhancers, which might prevent the proper recognition of TFs with their cognate 
binding sites in the DNA.  
While there is much work to be done to highlight the function of these elements, I 
have identified a novel set of tissue specific transcription factors including dGATAe, 
GAGA factor (GAF), and RFX that contribute to patched regulation and have laid out a 
successful framework with which we can predict context specific transcription factors 
that might be regulating known enhancers (summarized in Figure 3.1).  
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3.5 Materials and Methods 
 
DNA sequence alignments  
Sequences and multi-species alignments were obtained from the UCSC Genome 
Browser (www.genome.ucsc.edu ) or evoPrinterHD 
(https://evoprinter.ninds.nih.gov/evoprintprogramHD/evphd.html). 
 
DNA cloning and mutagenesis 
Wild-type ptc enhancers were amplified by PCR (Roche Expand High Fidelity PCR 
System) from BAC DNA (CH322-170A-12 or CH322-188E13). PCR primers are 
provided in Table 3.1. Enhancer constructs were sub-cloned into the pENTR/D-TOPO 
plasmid (Life Technologies) by TOPO cloning. Enhancers tested with the hspmin 
promoter, taken from the D. melanogaster Hsp70 gene, were subsequently cloned into 
the pHPdesteGFP transgenesis vector via LR Cloning (Life Technologies). Enhancers 
tested with the endogenous ptc promoter were cloned by traditional methods into the 
pStinger transgenesis vector (Barolo et al., 2000). Targeted GBS mutations were 
created by overlap-extension PCR (Swanson et al., 2010b). All enhancers and 
promoters were screened by restriction digest and sequencing. Peak2 mouse enhancer 
sequence was taken from the mm9 genome build and was ordered as a GeneBlock 
fragment to facilitate cloning (Table 3.2; details about ordering these fragments can be 




P-element transformation was performed as previously described (Swanson et al., 
2010a) in the w1118 strain. Site-directed transformation by embryo injection was 
performed as described by (Bischof et al., 2007), with reporter transgenes integrated 
into a ΦC31 landing site at genomic position 86Fb.  
 
Immunohistochemistry and confocal microscopy 
Primary antibodies used included rabbit anti-EGFP (Invitrogen 1:100), mouse anti-
Engrailed (Developmental Studies Hybridoma Bank 4D9, 1:50). In Drosophila embryos, 
EGFP antibodies were used to visualize reporter expression; in salivary glands from 
both pupa and larvae, native GFP fluorescence was imaged directly. Antibodies 
obtained from the Developmental Studies Hybridoma Bank were developed under the 
auspices of the National Institute of Child Health and Human Development and 
maintained by the Department of Biological Sciences, The University of Iowa (Iowa City, 
IA). AlexaFluor488, AlexaFluor555, and AlexaFluo568 conjugates with secondary 
antibodies from Invitrogen were used at 1:2000 dilutions. DAPI was included in the 
Prolong Gold antifade mountant (Life technologies). Confocal images were captured on 
an Olympus FluoView 500 Laser Scanning Confocal Microscope mounted on an 
Olympus IX-71 inverted microscope, and on a Nikon A1 confocal miscroscope. Samples 
to be directly compared were fixed, prepared, and imaged under identical confocal 
microscopy conditions and settings.  
   
Cell culture assay  
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NIH/3T3 cells were cultured at 37°C, 5% CO2, 95% humidity in Dulbecco’s modified 
eagle medium (DMEM; Gibco, cat. #11965-092) containing 10% bovine calf serum 
(ATCC; cat. #30-2030) and penicillin/streptomycin/glutamine (Gibco, cat. #10378-016). 
Luciferase assays were performed by plating 2.5 x 104 cells/well in 24 well plates. The 
next day, cells were co-transfected using Lipofectamine 2000 with the DNA constructs 
indicated in each experiment in addition to ptc∆136-GL3 (Chen et al., 1999; Nybakken 
et al., 2005) and pSV-Beta-galactosidase (Promega) constructs to report Hh pathway 
activation and normalize transfections, respectively. GLI1 cDNA was added where 
relevant to activate the Hh pathway. Cells were changed to low-serum media (DMEM 
supplemented with 0.5% bovine calf serum and penicillin/streptomycin/glutamine) 48 
hours after transfection and cultured at 37°C in 5%CO2 for an additional 48 hours. Cells 
were harvested and luciferase and beta-galactosidase activities were measured using 
Luciferase Assay System (Promega, cat. # E1501) and BetaFluor -gal assay kit 
(Novagen, cat. #70979-3). Multiple assays were performed and each treatment group 
was assayed in triplicate. Two-tailed t tests for two samples with unequal variances 
were used to compare samples.  
 
Encode Project Consortium 
Peak2 was analyzed with information from ENCODE (ENCODE Project Consortium, 
2012) with Data Coordination Center (DCC) and GEO accession numbers of the 
datasets,DCC accession: ENCSR037HRJ; GEO accession: GSE30567. 
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Figure 3.1 Predicting non-GLI transcriptional regulators of patched 
After a predicted ptc enhancer had been identified in Chapter 2, the sequence was 
examined for regions that were well conserved using the UCSC genome browser (black 
bars underneath enhancer). These conserved regions were then examined with binding 
site prediction software. High-ranking binding sites were followed up by examining the 
tissue specific expression pattern of that TF using either an in situ database or by 
searching through published literature. If the expression pattern of this TF matched the 
expression pattern of the enhancer-reporter construct, the predicted binding sites were 
mutated using overlap extension PCR and examined in transgenic animals (bottom 
right). If the expression pattern of the predicted TF did not match the enhancer 




Figure 3.2 dGATAe contributes to ptc expression via enhancer PN 
(A) Enhancer PN, in red, is shown in relation to ptc. (B) Wild type PN drives GFP 
expression. (C) PN lacking best predicted GLI binding sites as a GFP reporter. (D) 
Conservation of predicted dGATAe binding sites in enhancer PN. (E) Fly Factor Survey 
motif associated with dGATAe. (F) In situ showing expression of dGATAe in 
appropriately staged embryo (from the Berkeley Drosophila Genome Project). (G) Wild 
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type PN drives GFP expression, dorsal view. (H) PN lacking best predicted dGATAe 




Figure 3.3 GAF contributes to ptc expression via enhancer 1EH 
(A) Enhancers 1EH and 1GH are found in the first intron of ptc. DNAse hypersensitivity 
is shown as the blue track underneath the gene diagram (taken from UCSC genome 
browser, dm3, red bar over the blue peak in 1F indicates statistical significance). Green 
lines in the enhancers and locus indicate predicted GAGAG binding sites based upon 





Figure 3.4 RFX regulates Ptch1 in mice and might contribute to ptc regulation in 
Drosophila salivary glands  
 125 
(A) The Peak2 enhancer is depicted upstream of mouse Ptch1. Conservation of 
sequence is shown as a blue track underneath the gene diagram, all taken from the 
UCSC genome browser. (B) Positional weight matrix of RFX, from Fly Factor Survey. 
(C) Conservation of RFX binding site in Peak2 from mouse to fish. (D) GLI1-
responsiveness of Peak2 enhancer in NIH/3T3 cells (wild type on left, Peak2-
RFXbinding site KO on right). (E-G”) fly transgenic GFP reporter constructs examine in 




Figure 3.5 Slp1 provides minimal contribution to repression of enhancer LK  
(A) Enhancer LK, in orange, is shown in relation to ptc. (B) Conservation of predicted 
Slp1 binding sites in enhancer LK. (C) Fly factor Survey motif associated with Slp1. (D) 
Expression of Slp1 in embryos (adapted from Gebelein et al., 2004). (E) Wild type LK 
drives GFP expression (GFP is green, En is Red). Bottom is GFP channel alone. (F) LK 
lacking best predicted Slp1 binding site as a GFP reporter (GFP is green, En is Red). 
Bottom is GFP channel alone. Arrows highlight de-repression in the anterior. 
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Figure 3.6 Odd does not contribute to VT repression through predicted binding site 
(A) Enhancer VT, in green, is shown in relation to ptc. (B) Conservation of predicted 
Odd binding site in enhancer VT. (C) Fly Factor Survey motif associated with Odd. (D) 
Expression of Odd in embryos (adapted from Mulinari and Häcker, 2009). (E) Wild type 
VT drives GFP expression mainly in anterior. (F) VT lacking best predicted Odd binding 




Table 3.1 Primers used to generate enhancer-reporter constructs to detect tissue 
specific inputs into ptc enhancers  
All primers are written from 5’ to 3’ orientation. F refers to forward primer, R refers to 
reverse primer. Additional binding site to facilitate cloning are depicted in colors. 
  































Predicted RFX Binding Site
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Chapter 4  
 
Computational Prediction of Hedgehog Responsive Enhancers 
 
4.1 Abstract 
The Hedgehog (Hh) signaling pathway directs a multitude of cellular responses 
during embryogenesis and adult tissue homeostasis. Stimulation of the pathway results 
in activation of Hh target genes by the transcription factor Ci/GLI, which binds to specific 
motifs in genomic enhancers. In Drosophila, only a few enhancers (patched, 
decapentaplegic, wingless, stripe, knot, hairy, orthodenticle) have been shown by in 
vivo functional assays to depend on direct Ci/GLI regulation. All but one (orthodenticle) 
contain more than one Ci/GLI site, prompting us to directly test whether homotypic 
clustering of Ci/GLI binding sites is sufficient to define a Hh-regulated enhancer. We 
therefore developed a computational algorithm to identify Ci/GLI clusters that are 
enriched over random expectation, within a given region of the genome. Candidate 
genomic regions containing Ci/GLI clusters were functionally tested in chicken neural 
tube electroporation assays and in transgenic flies. Of the 22 Ci/GLI clusters tested, 
seven novel enhancers (and the previously known patched enhancer) were identified as 
Hh-responsive and Ci/GLI-dependent in one or both of these assays, including: 
Cuticular protein 100A (Cpr100A); invected (inv), which encodes an engrailed-related 
transcription factor expressed at the anterior/posterior wing disc boundary; roadkill (rdx), 
the fly homolog of vertebrate Spop; the segment polarity gene gooseberry (gsb); and 
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two previously untested regions of the Hh receptor-encoding patched (ptc) gene. We 
conclude that homotypic Ci/GLI clustering is not sufficient information to ensure Hh-
responsiveness; however, it can provide a clue for enhancer recognition within putative 
Hedgehog target gene loci.  
4.2 Introduction 
The Hedgehog (Hh) signaling pathway plays multiple roles in embryonic organ 
development and adult tissue homeostasis across animal phyla (Briscoe and Thérond, 
2013; Jiang and Hui, 2008; McMahon et al., 2003). Hh signaling directs specific cell fate 
choices, controls tissue patterning and governs cell proliferation. Several human 
developmental diseases are caused by altered Hh signaling, including spina bifida, 
exencephaly (Murdoch and Copp, 2010), holoprosencephaly (Schachter and Krauss, 
2008), cleft lip/palate (Lipinski et al., 2010), and a host of malformations in vertebral, 
anal, cardiac, tracheal, esophageal, renal, and limb tissues (together known as 
VACTERL Association;(Ngan et al., 2013)). Aberrant Hh signaling is also responsible 
for several cancers, including basal cell carcinoma, medulloblastoma and 
rhabdomyosarcoma (Teglund and Toftgård, 2010). Recently, cancers of the pancreas, 
colon, ovary, stomach and lung have also been associated with increased Hh signaling 
(Barakat et al., 2010; Teglund and Toftgård, 2010), prompting initiation of clinical trials 
with Hh antagonists for some of these conditions (de Sauvage, 2007; Scales and de 
Sauvage, 2009; Sekulic et al., 2012; Tang et al., 2012). 
The Hh-regulated GLI family transcription factors (including Cubitus interruptus 
(Ci) in the fly and GLI1-3 in mammals) are highly conserved across metazoans, as is 
the sequence of the preferred consensus Ci/GLI binding site (Hallikas et al., 2006; 
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Winklmayr et al., 2010). Despite the functional importance and high conservation of the 
Hh pathway, surprisingly little is known about its target genes in any organism. These 
target genes and their associated enhancers, which are responsible for the genomic 
response to Hh in development and disease, have significant potential therapeutic and 
diagnostic value. 
One method for identifying putative enhancers is chromatin immunoprecipitation 
(ChIP) (Biehs et al., 2010; Lee et al., 2010; Vokes et al., 2007; Vokes et al., 2008), 
though such data are subject to the spatiotemporal limitations of the analyzed cells or 
tissues and can be diluted by a high number of false positive binding sites. While many 
potential murine Hedgehog-responsive enhancers have been pinpointed in this manner, 
relatively few have been functionally verified by mutagenesis of transcription factor 
binding sites (Lee et al., 2010; Peterson et al., 2012; Vokes et al., 2007; Vokes et al., 
2008). In Drosophila, an alternative approach, DamID which fuses a DNA interacting 
protein to DNA adenine methyltransferase leading to methylation near binding locations, 
identified 52 potential Ci/GLI target enhancers, though none of these were functionally 
verified by mutagenesis of Ci/GLI sites (Biehs et al., 2010). To date, only seven 
Drosophila enhancers have been shown by mutational analysis to be Ci/GLI-dependent 
(Alexandre et al., 1996; Blanco et al., 2009; Hersh and Carroll, 2005; Müller and Basler, 
2000; Ohlen et al., 1997; Piepenburg et al., 2000; Ramos and Barolo, 2013), which 
limits our understanding of the basic rules that govern their activity and context 
specificity. 
Analysis of the known Drosophila Hh enhancers reveals that three (regulating 
ptc, wg, and knot) contain clusters of three or more Ci/GLI binding sites, while the 
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remaining enhancers (of the dpp, stripe and hairy genes) contain two sites (Alexandre 
et al., 1996; Blanco et al., 2009; Hersh and Carroll, 2005; Müller and Basler, 2000; 
Ohlen et al., 1997; Piepenburg et al., 2000; Ramos and Barolo, 2013). These examples, 
and findings in other systems (Berman et al., 2002; Gotea et al., 2010; Lifanov et al., 
2003; Markstein et al., 2002; Rebeiz et al., 2002) suggest that homotypic clustering 
might be a relevant indicator of Hh enhancer activity in the fly. To test this, we 
computationally identified regions of the fly genome in which the density of Ci/GLI 
binding sites is enriched relative to chance expectation. We then tested the ability of 
these regions to: 1) drive Hh-dependent activity in the developing chicken neural tube, 
and 2) direct tissue-specific gene expression in a Drosophila transgenic reporter model. 
Importantly, the functional significance of the Ci/GLI binding motifs was also tested by 
mutation of these sites within each active enhancer. Of the 17 top clusters, four (23%) 
drove reporter expression in a known Hh domain and/or in a Ci/GLI-dependent fashion 
in one or both assays. Thus, while some Hh-regulated enhancers indeed contain 
homotypic clusters of Ci/GLI motifs, not all such clusters function as enhancers in vivo. 
We also asked whether Ci/GLI site clustering could be used to predict the 
location of enhancers in genes that are known or putative targets of Hh signaling. Using 
the strategy outlined in Figure 4.1, we identified five such Ci/GLI site clusters, four of 
which were subsequently validated as Hh enhancers by functional assays (80%). Thus, 
altogether, our analysis of clustered Ci/GLI sites identified eight Hh enhancers, including 
seven novel enhancers and one previously identified ptc enhancer. These findings 
double the number of functionally verified Hh enhancers. 
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4.3 Results 
4.3.1 Computational identification of clustered Ci/GLI sites across the Drosophila 
genome 
To test if clustering of Ci/GLI sites could be used to predict Hh enhancers, we 
developed a computational strategy to identify all regions of the genome that contain 
clusters of 3-10 Ci/GLI sites that are enriched above chance expectation. Since the 
Ci/GLI binding sequence is highly GC rich, these sites are more likely to occur by 
chance in GC rich regions of the genome. Thus, to achieve an unbiased assessment of 
clustering likelihood, it was important to utilize a background model with a GC 
landscape similar to that of the native genome.  Three different background models 
were examined (see Materials and Methods for details). The three models were 
compared by mapping all predicted Ci/GLI sites (MSS ≥0.75) and examining the GC 
content of the genomic sequence surrounding each predicted Ci/GLI site (Figure 4.2). 
Importantly, the randomized (Model 1) and shuffled 3-mer (Model 2) strategies 
significantly change (i.e., homogenize) the GC context around Ci/GLI sites, while the 
Flip GC/AT model (Model 3), by its nature, faithfully replicates the GC context of Ci/GLI 
sites in the real genome; thus, this model was selected for use. 
An accurate assessment of the relative density of Ci/GLI clusters found in the 
native genome also requires that the background genomes contain a similar 
composition (number and type) of Ci sites as the native genome. After generating 
background genomes using the Flip GC/AT method, we noticed that the total number of 
predicted Ci/GLI binding sites on each chromosome was consistently reduced 
compared to the native Dm genome (Figure 4.3A). Left uncorrected, this deficit in total 
sites would lead to an artificial enrichment of clusters of Ci/GLI sites in the Dm genome 
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when compared to the background model. To correct for this discrepancy, we re-built 
background chromosomes (see detail in Materials and Methods) so that they contained 
the same number of each type of Ci/GLI binding site (based on matrix similarity score) 
found in the Dm genome (Figure 4.3B). Relative enrichment of Ci/GLI clusters in each 
genomic region was then assessed across the native genome by direct comparison to 
the 100 rebuilt background chromosomes (Figure 4.3C). 
4.3.2 Ci/GLI cluster analysis in Drosophila melanogaster 
Clusters of 3-10 Ci/GLI sites (with a maximum end-to-end distance of1000 bp) 
were identified in the native Dm and Dp genomes. Background modeling and 
background correction was performed separately for Dm and Dp. For each putative 
cluster, a cluster coefficient (CC) was defined as the number of Ci/GLI sites in a given 
genomic region divided by the average number of Ci/GLI sites in the same genomic 
location in 100 control genomes (schematically illustrated in Figure 4.3C). Only clusters 
with a CC of greater than or equal to 4 and at least one Ci/GLI site with a MSS of 0.81 
or greater were chosen for subsequent analysis. These filters (1kb length; CC ≥ 4; one 
site ≥ MSS of 0.81) were designed to increase the likelihood that functional enhancers 
would be identified. As an additional stringency filter, we required that Ci/GLI site 
clusters be present in orthologous regions of both Dp and Dm genomes (see Materials 
and Methods for details). Table 4.1 lists all selected Dm clusters with a CC greater than 
or equal to 4 (ranked by order of Ci/GLI site density and average MSS). We sorted 
these results by average MSS (high to low), to strengthen the likelihood that all of the 
Ci/GLI sites located within any putative cluster were capable of binding Ci/GLI, and 
observed that sites in a known Hh-regulated enhancer of the ptc gene (Alexandre et al., 
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1996) had the maximum average MSS of 1 (Table 4.1). In addition to this known 
enhancer region, we selected the next 16 putative Hh enhancer regions for functional 
validation (Table 4.2). 
4.3.3 Functional verification of Ci/GLI-driven enhancers in a chicken neural tube 
assay 
We first screened for possible enhancer function of the 16 novel genomic regions 
(Table 4.2) in the developing chicken neural tube, one of the best-studied sites of Hh 
signaling (Dessaud et al., 2008). In this assay, Hamburger-Hamilton stage 11 embryos 
are electroporated with DNA reporter constructs in which the putative enhancer is 
cloned upstream of a minimal promoter driving EGFP expression (see Materials and 
Methods). This assay has been previously used to validate enhancers for multiple 
signaling pathways (Lang et al., 2010; Lei et al., 2006; Oosterveen et al., 2012; 
Peterson et al., 2012; Timmer et al., 2001; Uchikawa et al., 2003; Vadasz et al., 2013; 
Wang et al., 2011).  Endogenous Sonic Hedgehog (SHH) produced by the notochord 
and floorplate drives expression of Hh-dependent enhancers in the ventral half of the 
neural tube (Dessaud et al., 2008). Additionally, to further increase the sensitivity of our 
assay, we co-electroporated a constitutively active form of Smoothened (SmoM2) (Xie 
et al., 1998), which activates Hh signaling throughout the neural tube. Successful 
activation of Hh signaling by SmoM2 is readily detectable as an expansion of the 
expression domain of the known Hh target gene, NKX6.1(Oosterveen et al., 2012; 
Peterson et al., 2012), on the electroporated side of the neural tube. An RFP-expressing 
plasmid (pCIT) was co-electroporated to confirm the success of the electroporation. For 
those enhancers that demonstrated apparent Hh activation (expression of the 
enhancer-containing construct, but not the enhancer-less construct, in the presence of 
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SmoM2), Ci/GLI-dependent activity was further confirmed by mutagenesis of the Ci/GLI 
binding sites. 
Of the 16 computationally predicted enhancers tested in this way, four drove Hh-
enhancer dependent expression in the chicken neural tube assay (Figure 4.4). An 
intronic sequence of the invected (inv) gene harbors two of these active regions, each 
containing a cluster of four Ci/GLI sites with MSS ≥0.81. Both regions drive expression 
in the presence of co-electroporated SmoM2 and mutagenesis of the Ci/GLI binding 
sites abrogates this response in both cases (Figure 4.4B,C). 
Two additional predicted enhancers, located near the genes Cpr100A and 
Plc21C, also showed expression in the chicken neural tube assay (Figure 4.4D,E). 
However, mutation of the Ci/GLI sites abrogated EGFP expression only in the putative 
Cpr100A enhancer (Figure 4.4D), but not in the Plc21C enhancer (Figure 4.4E). Thus, 
only the former behaved as a direct Hh target; the Plc21C enhancer is responsive to Hh 
pathway activation, but this activity does not depend upon the Ci/GLI binding sites. 
Thus, altogether, in addition to the top scoring, previously validated proximal ptc 
enhancer, three of the 16 novel predicted enhancers were validated by the chicken in 
ovo electroporation assay, for an overall success rate of 4/17 or 23%.  
We next tested whether additional information would further improve prediction of 
Hh enhancers. We searched the list of clusters in Table 4.1 for regions annotated to 
genes that are known or likely Hh targets or that participate in Hh-regulated 
developmental events, and chose regions linked to roadkill (rdx), retinal homeobox (Rx), 
gooseberry (gsb) (Kent, 2006; Li and Noll, 1993; Ohlen et al., 1997), and two additional 
regions of the patched gene (ptc-2.8 and ptc+5.3) for testing. Of these five cluster regions, 
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only rdx tested positive in the chicken neural tube assay (Figure 4.4F), reflecting a 
similar 20% success rate. 
To learn more about the sensitivity of the chicken neural tube assay, we also 
tested 18 clusters with Ci/GLI sites of low MSS (0.75-0.8). These may represent 
clusters of sites of low affinity Ci/GLI binding. The regions tested included the known 
enhancers regulating the wingless (wg) and decapentaplegic (dpp) loci (Table 4.3). 
However, none of these showed activity in the chicken neural tube. 
Having identified two closely associated novel regions of the inv gene that both 
act as Hh enhancers in the chicken electroporation assay (Figure 4.4B,C), we next 
utilized this assay to further examine these regions. While both enhancers respond to 
SmoM2 co-electroporation, only one (inv+18.6), drives EGFP expression in response to 
endogenous levels of Hh signaling (i.e. in the absence of SmoM2 co-electroporation) 
(Figure 4.5).   
Notably, though it is not in the top 16 predictions, Table 4.1 lists a third cluster in 
this region of the inv locus, lying between the two active regions tested above. Thus, we 
also tested a fragment spanning all three of these predicted inv Ci/GLI clusters, 
containing a total of 12 Ci/GLI binding sites (invlong) (Figure 4.6A). This larger construct 
is activated both by endogenous SHH in the ventral neural tube and by co-
electroporation of SmoM2 (Figure 4.6B). Furthermore, a construct (invlong-CiKO) 
containing mutations in 10 of the 12 Ci/GLI binding sites identified computationally (only 
the two Ci/GLI sites with lowest MSS were left intact) fails to activate EGFP expression, 
even when co-expressed with SmoM2 (Figure 4.6C), confirming the Hh-dependent 
activity of this large complex enhancer. Further selective mutagenesis of Ci/GLI sites 
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within the larger fragment demonstrates that, in the absence of the inv+16.8 and inv+18.6 
Ci/GLI clusters, the central cluster of Ci/GLI binding sites is unable to drive enhancer 
activity in the chicken neural tube (Construct D, Figure 4.6C).  
4.3.4 Functional verification of Ci-driven enhancers in transgenic Drosophila 
To further verify enhancer function in Drosophila, we generated transgenic 
reporter flies in which EGFP was driven by predicted enhancers and examined gene 
expression in two of the best-studied Hh-responsive contexts: the stage 9-13 embryo 
(when Hh signaling is active during development of a variety of tissues) and the 
anterior/posterior boundary of the larval wing imaginal disc (Alexandre et al., 1996; 
Ohlen and Hooper, 1997; Ramos and Barolo, 2013). The top computational hit, 
upstream of the ptc gene (Table 4.2, Figure 4.7A) has three consensus Ci/GLI binding 
sites and was previously shown to harbor enhancer activity (Alexandre et al., 1996). 
This conserved cluster was examined as a minimal fragment, (ptc-0.6), which was able to 
respond to Hh signaling in the wing (Figure 4.7A). When the three consensus Ci/GLI 
binding sites were mutated, enhancer activity was abrogated (Figure 4.7B), confirming 
that enhancer activity directly depends upon function of the Ci/GLI binding motifs. This 
region was also found to have enhancer activity in a recent unbiased search for 
imaginal disc enhancers (Jory et al., 2012). 
We next examined the other novel 16 top computationally predicted enhancers in 
Drosophila and found that three regions exhibited enhancer activity in the fly assay. 
Although inv+16.8 and inv+18.6 were both active in the chicken neural tube assay when co-
electroporated with SmoM2 (Figure 4.7B,C), only inv+18.6 responded in the wing imaginal 
disc (Figure 4.7 E,G). This inv+18.6 enhancer was also the only enhancer to demonstrate 
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positive activity in the chicken ventral neural tube in the absence of SmoM2, in 
response to endogenous Hh expression (Figure 4.5). When the four predicted Ci/GLI 
binding sites with higher MSS were mutated in inv+18.6, this enhancer was no longer able 
to respond to Hh signaling in the wing imaginal disc (Figure 4.7F), demonstrating its Hh-
dependent activity. A larger construct (invlong), encompassing the four Ci/GLI sites in 
inv+16.8, the four in inv+18.6, and the intervening cluster of four predicted sites that was 
tested in the chicken assay in Figure 4.6A, was also able to drive expression in Hh-
responsive cells of the wing imaginal discs of transgenic flies (Figure 4.7C). The in vivo 
activity of this genomic fragment depended on the predicted Ci/GLI sites (Figure 4.7D), 
confirming it as a direct Ci/GLI target enhancer. 
In addition to confirming direct Hh-responsiveness of the ptc and inv enhancers, 
we also examined the other predicted enhancers in Table 4.2 in transgenic fly assays. 
Both hth and Plc21C showed enhancer activity in the transgenic fly assay, but neither 
was Hh-dependent (Figure 4.8). Hth exhibited a segmented expression pattern in the fly 
embryo, which remained unaltered after mutagenesis of the Ci/GLI binding sites (Figure 
4.8A,B).  Plc21C was expressed in the fly gut and expression persisted after mutation of 
the Ci/GLI binding sites (Figure 4.8C,D), consistent with the results in the chicken neural 
tube assay (Figure 4.4E). 
Examination of the five additional Ci/GLI clusters selected from known or 
suspected Hh target genes yielded four potential Hh-responsive enhancers: rdx, ptc-2.8, 
ptc+5.3 and gsb. A Ci/GLI cluster in the intron of roadkill (rdx) was active at the A/P 
boundary of the wing imaginal disc in Hh-responsive cells (Figure 4.7H). Mutating the 
predicted Ci/GLI sites within this cluster abrogated its activity (Figure 4.7I). rdx had 
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previously been shown to be genetically downstream of Hh signaling (Kent, 2006), but 
the enhancer that mediates this response had not been identified. The rdx enhancer 
identified here also responds to Hh in the chicken neural tube assay (Figure 4.4F). 
Within the ptc locus, two other Ci/GLI binding site clusters are computationally 
predicted in addition to the previously identified promoter-proximal enhancer that topped 
the list. The first of these, ptc-2.8, is found 2.8 kb upstream of ptc, and contains 5 
predicted Ci/GLI binding sites. When examined in the wing imaginal disc, ptc-2.8 
responds with a stripe of expression largely overlapping Ptc positive cells (Figure 4.7J). 
Upon mutation of the predicted Ci/GLI binding sites in this novel enhancer, its ability to 
respond to Hh is greatly reduced (Figure 4.7K). A second cluster of Ci/GLI sites in the 
first intron of ptc (ptc+5.3) is also predicted. This putative enhancer contains 7 predicted 
Ci/GLI binding sites, one of which matches the optimal consensus site recognized by 
Ci/GLI. In flies containing this transgene, ptc-like reporter gene expression is seen in the 
embryo (Figure 4.7L), but not the wing disc (data not shown). Two stripes of enhancer 
expression are detected, proximal to cells secreting Hh ligand, marked by En, in all 
segments of the embryonic ectoderm. After mutation of the predicted Ci/GLI binding 
sites contained within this enhancer, the segmentally repeated stripes are lost (Figure 
4.7M).  
Finally, a region with several clusters of Ci/GLI binding sites was identified 
downstream of the gooseberry (gsb) coding region. Gooseberry, a segment polarity 
gene, is part of the Hh-Wnt segmentation network, but no direct Ci/GLI target enhancer 
has been identified (Li and Noll, 1993). One of the known enhancers of gsb, which does 
not appear to be regulated by Ci/GLI, is 5' of the gene (Bouchard et al., 2000). The 3' 
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enhancer identified by our analysis contains five predicted Ci/GLI binding sites and is 
active in segmental stripes in the embryonic ectoderm of transgenic Drosophila, 
posterior to each stripe of Hh-secreting cells at stage 11 (Figure 4.7N). Upon mutation 
of the Ci/GLI binding sites, activity is attenuated, suggesting that the gsb enhancer 
requires direct Ci/GLI input in order to respond to Hh signaling in the embryo (Figure 
4.7O). 
Overall, the fly assay functionally verified six Hh-dependent enhancers out of 22 
tested, for a success rate of 27%. The genomic locations of these enhancers, relative to 
the gene locus, are presented in Figure 4.9. One additional enhancer, cpr100A, was 
demonstrated to be Hh-dependent in the chicken, but had no activity in the fly assay; 
thus, it must be considered a potential regulatory element. This result suggested that 
cpr100A might have been a false-negative in the fly assay, and prompted us to examine 
it, along with all of the other predicted enhancers, in a third site of Hh signaling, the 
adult testis. Although the testis depends on Hh signaling, none of the predicted 
enhancers were active in this tissue.  It is possible, however, that the cpr100A cluster 
(or any other predicted enhancer that is negative in the chicken and/or fly assays) may 
be active in another tissue that was not examined (Michel et al., 2012). Altogether, both 
assays established 7/22 (31.8%) of tested Ci/GLI clusters as Hh enhancers, six of which 
are novel (the potential cpr100A element is not included in this count). 
4.4 Discussion 
Homotypic clustering of transcription factor binding sites has been observed in 
multiple settings and has been successfully used to identify potential enhancers 
(Berman et al., 2004; Gotea et al., 2010; Lifanov et al., 2003; Markstein et al., 2002; 
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Suryamohan and Halfon, 2015). Since all but one of the known Drosophila Hh-driven 
enhancers contain two or more Ci/GLI sites, we assessed the extent to which clustering 
of Ci/GLI sites can be used to predict the location of Hh-dependent enhancers, a 
question that has not previously been directly tested. To do this, we utilized a 
background correction method that preserves local nucleotide topography to allow us to 
identified genomic regions that appear to have unusually dense Ci/GLI binding site 
representation and tested the extent to which these regions can function as Hh-
dependent enhancers. 
To establish background genomes for comparison of GLI density, we used a 
strategy that randomly flips each base to its complimentary partner. This approach 
maintains the GC/AT landscape of the native Drosophila chromosomes. Overall, only 
43% of the D. melanogaster contains G or C bases while the consensus Ci/GLI binding 
site itself is 67% GC rich (Hallikas et al., 2006; Keightley et al., 2009). Distribution of GC 
content has been strongly correlated with gene density and other genomic features and 
the importance of maintaining the original properties of the native sequence when 
generating a background comparison has been discussed previously (Fitch, 1983). 
Other background generation methods that preserve dinucleotide frequencies also exist 
(Coward, 1999; Fitch, 1983). Additional comparisons would be needed to determine 
which background strategy best strengthens enhancer detection. 
The success rate of functional enhancer identification based on the approach 
used here was 23%, suggesting that clustering of Ci/GLI sites alone is not sufficient to 
effectively predict Hh-regulated enhancers. However, this success rate increased to 
80% when examining Ci/GLI clusters associated with known or suspected Hh target 
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genes. Together, these data indicate that Ci/GLI clustering is not, by itself, an effective 
means to predict Hh-regulated enhancers. While some Hh enhancers can be identified 
by virtue of Ci/GLI homotypic clustering, not all homotypic clusters function as 
enhancers. Since one of the previously identified Hh enhancers (in orthodenticle) only 
has one Ci/GLI site (Ramos and Barolo, 2013), it is also clear that the presence of 
clustered Ci/GLI sites is not a requirement for functional Hh enhancers. However, in the 
context of additional information, clustering can be used as one criterion to predict 
enhancers within a suspected Hh target gene locus. Future studies will be necessary to 
determine whether the presence of multiple Ci/GLI sites are more effective predictors of 
Hh-regulated enhancers associated with putative Hh target genes, or whether a single 
Ci/GLI site is equally likely to drive Hh-dependent target gene expression.   
Given that Ci/GLI binding site clustering alone is not sufficient to identify Hh-
regulated enhancers, this raises the question: what is an effective method to identify 
Hh-regulated enhancers? One possibility is to pair Ci/GLI binding sites with sites for 
other transcriptional co-activators or co-repressors. De novo motif analysis has been 
performed previously as part of ChIP-chip analysis of GLI repressor binding in the 
developing limb (Vokes et al., 2008). More recent studies suggest that GLI proteins 
cooperate with SOXB1 proteins to drive Hh-regulated gene expression during spinal 
cord development (Oosterveen et al., 2012; Peterson et al., 2012). However, specific 
co-factor identification may yield only tissue-specific Hh-regulated enhancers. Thus, 
other approaches include: 1) examining Ci/GLI binding site association with active or 
repressive chromatin modifications, which has been recently used to investigate Hh-
regulated enhancers in the developing neural tube (Nishi et al., 2015), and 2) 
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investigating Ci/GLI binding site location near sites of open chromatin using techniques 
such as DNAse I hypersensitivity and FAIRE (Giresi et al., 2007; McKay and Lieb, 
2013). It is likely that a combination of these methods will be required to effectively 
identify a more complete set of Hh-regulated enhancers on a genome wide basis 
One intriguing finding from this work is the identification of multiple discrepancies 
between the chicken neural tube and transgenic fly assays (Table 4.2). These data 
emphasize the importance of testing putative enhancers in diverse assay systems to 
provide several different contexts in which an enhancer can show activity. The chicken 
neural tube assay is a quick and inexpensive strategy that, in a large-scale study, could 
improve throughput. It has been successfully used previously to identify Hh-regulated 
mouse enhancers (Oosterveen et al., 2012; Peterson et al., 2012), and is used here to 
validate Hh-regulated fly enhancers. However, because some enhancers may require 
additional species-specific information that is not present in the chicken neural tube, 
false negative calls are a limitation of this assay. Further, the requirement for context-
specific information may also restrict the utility of this assay in the identification of 
general Hh-regulated enhancers (Vokes et al., 2007). Along these lines, analysis of 18 
clusters containing Ci/GLI sites of lower predicted affinity, including the known Hh 
enhancers in the wg and dpp loci (Müller and Basler, 2000; Ohlen and Hooper, 1997), 
showed no activity in the chicken neural tube (Table 4.3). Thus, this assay may only 
detect Hh enhancers with high affinity Ci/GLI binding sites, thereby missing some true 
positives (Ramos and Barolo, 2013). Nevertheless, the assay can be useful to dissect 
enhancer activity in the context of a complex developing tissue (Figure 4.5). 
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The computational study presented here can be compared with a recent analysis 
of potential Ci/GLI-driven enhancers in Drosophila, by Biehs et al., who fused CiACT 
(activator) and CiREP (repressor) proteins with DNA adenine methyltransferase (Dam) 
domains to define chromatin regions in stage 10-11 embryos that are occupied by 
Ci/GLI in vivo (Biehs et al., 2010). That study listed 1743 sites bound by Dam-Ci fusion 
proteins; of these, 55 sites (3%, listed in Table 4.4) were represented in clusters that 
were selected by our computational analysis. This limited overlap is likely due to two 
factors. First, since the computational study was limited to analysis of larger clusters, 
enhancers that are driven by one or two Ci/GLI sites were not selected, by design. 
Second, because the DamID study was performed in 2-6 hour embryos, Ci/GLI binding 
events were likely limited to chromatin regions that were accessible at that 
developmental stage.  Of the seven previously known Hh/GLI-regulated enhancers, the 
DamID approach identified Ci/GLI binding to two (ptc and wg), while the computational 
strategy described here detected three (ptc, wg and knot). The other four previously 
known enhancers (stripe, hairy, dpp and orthodenticle) were not detected 
computationally because those enhancers have only two Ci/GLI sites (our filters 
selected clusters of 3-10). Of the new enhancers functionally confirmed in our study, 
none were found to harbor protected regions in the DamID assay. Biehs et al. used 
expression assays to identify 147 genes whose expression appeared to correlate with 
Hh signaling activity. They then asked, of these 147 genes, how many had protected 
regions within or adjacent to the transcription unit? Protected regions were identified as 
DamAct or DamRep protection and consisted of a total 2108 protected regions. They 
identified 52 genomic regions that were DamID-protected and showed expression 
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changes when Hh signaling was modulated. Thus, 35% of the genes that appear to be 
targets (as assessed by their expression modulation) showed some DamID protection, 
but only 2.5% of the total DamID protected regions were found to be probable Hh 
targets (Biehs et al., 2010). Four of these 52—but none of the validated enhancers—
can be found in the list of 55 sites common to the two studies. 
An important aspect of the present study is that the direct Hh dependency of all 
enhancers was verified by Ci/GLI binding site mutagenesis. While expression assays 
such as those used by Biehs et al. clearly demonstrate a Hh response, they do not 
establish whether this response is direct or indirect and do not confirm that the response 
is mediated through the Ci/GLI binding sites in the candidate enhancers. Indeed, of the 
top 17 clusters detected computationally, we found four direct targets and two additional 
enhancers that showed apparent expression in ptc-expressing cells, but this expression 
persisted after mutation of the Ci/GLI sites (Figure 4.8) suggesting that other factors 
might be responsible for this enhancer activity. This raises a cautionary note about 
assigning potential Hh, or any signaling cascade, responsiveness in the absence of 
functional verification (Halfon et al., 2011). 
Using homotypic Ci/GLI site clustering as a criterion together with functional 
analyses, we have doubled the number of previously verified Drosophila Ci/GLI-
dependent enhancers, including multiple distinct enhancers that regulate a single Hh-
responsive gene (i.e., ptc, inv, and gsb). Further testing of other candidate clusters 
identified in this study might further enlarge the pool of known Hh-responsive enhancers 
that are active in diverse tissues and organs, providing a robust substrate for the future 
dissection of the rules that underlie context-specific enhancer function. 
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4.5 Materials and Methods 
 
Computing resources 
Except where otherwise indicated, all computational steps were performed using 
custom Perl scripts, which are available for download at https://github.com/um-
gurdziel/GurdzielUdagerLorberbaum2015. Overlap between coordinates in bed file 
format were performed using the UCSC Table Browser. 
  
Definition of putative Ci/GLI binding sites 
A mono-nucleotide distribution matrix for Ci binding sites, derived from in vitro 
competitive DNA binding assays with recombinant Ci protein and labeled 
oligonucleotides, was obtained via the Genomatix Software Suite (www.genomatix.de; 
Genomatix, Germany) (Hallikas et al., 2006). The consensus index vector for such a 
matrix reflects the degree of nucleotide preference at each position; values range from 
0, indicating equal preference for any of the four nucleotides, to 100, indicating strict 
preference for a single nucleotide (Quandt et al., 1995). The matrix similarity score 
(MSS) for a given site is calculated as the ratio of its matrix-vector product to that of the 
consensus site, as described previously (Quandt et al., 1995), and MSS values range 
from 0 to 1 (where 1 equals an exact match to the consensus site). The first nine of the 
eleven positions in the Ci matrix have consensus index vector values greater than 70, 
suggesting that they contain a high degree of specific information about potential Ci 
binding. Thus, these matrix positions were used to define a set of 211 9-mers (422 in 
sense and antisense directions) that pass a minimum level (0.75) of overall matrix 
similarity (i.e. with a MSS ≥ 0.75) to the optimal consensus Ci site (GACCACCCA) 
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(Table 4.5) (Hallikas et al., 2006; Quandt et al., 1995) and also contain concordant (C 
and C or G and G) nucleotides in the 4th and 6th position, which are critical for Ci binding 
(Winklmayr et al., 2010). 
  
Identification and annotation of predicted Ci binding sites in genomic sequence 
Genomic sequence files (chromFa) for D. melanogaster (Dm) and D. pseudoobscura 
(Dp) were downloaded from UCSC Genome browser (genome.ucsc.edu) build dm3 
(Celniker et al., 2002; Fujita et al., 2011; Richards et al., 2005). The genomic 
coordinates of predicted Ci/GLI binding sites were identified for chr2R, chr2L, chr3R, 
chr3L, chr4, and chrX (build dm3); and chr2, chr3, chr4 and chrX (build dp3). Each 
putative Ci/GLI binding site was annotated for nearest gene/transcript, distance to 
nearest gene/transcript, and associated gene/transcript feature transcript using refFlat 
files obtained from UCSC Genome Bioinformatics. Ci/GLI clusters were defined as 
regions containing at least three and at most ten putative Ci/GLI binding sites within a 
maximum distance of 1000 base pairs (bp) (measured from the outside ends of the 
flanking sites (Fujita et al., 2011; McQuilton et al., 2012). Predicted sites were also 
annotated with respect to the nearest CTCF boundary region (Holohan et al., 2007). 
Cluster regions that contained predicted Ci binding sites that mapped to exons or repeat 
regions were excluded. Repeat regions often have regulatory function (Sawaya et al., 
2013; Taher et al., 2015). However, testing the regulatory activity of Ci binding motifs in 
repetitive sequences, and the effect of their clustering in these regions, was beyond the 




To identify regions of the genome that exhibit a higher density of Ci/GLI sites than would 
be expected by chance, we compared the actual distribution of Ci/GLI sites to a 
randomized background model. Three different modes of background modeling were 
examined. For Model 1 (Random), all bases in the genome were randomized, as was 
done in a previous analysis of clustered binding sites for Suppressor of Hairless (Rebeiz 
et al., 2002). For Model 2 (Shuffle 3mer), the genome was parsed into contiguous 3-
mers and these were then shuffled to create the background. In Model 3 (Flip GC/AT), 
each base was randomly flipped between itself and its complementary base pair (e.g., 
G will randomly become G or C; A will become A or T; C will become C or G; T will 
become T or A). On the basis of the data shown in Results, only the Flip GC/AT model 
generates background genomes that most closely represent the GC content 
surrounding Ci/GLI sites in the native genome. Since GC rich Ci/GLI sites will occur by 
chance more often in GC rich than AT rich regions, use of a randomization model that 
homogenizes the AT/GC landscape would artificially reduce the density of expected 
Ci/GLI sites in GC rich areas and increase this density in AT rich regions. Therefore, 
using the Flip GC/AT strategy, background models were generated separately for the 
Dm and Dp genomes for comparison to each native genome. 
  
Generation of artificial genomic sequence and random genomic distributions of 
binding sites 
On a chromosome-by-chromosome basis, 1000 sets of background genomic 
sequences were generated using the Flip GC/AT method. However, base flipping 
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resulted in fewer Ci/GLI sites in the randomized chromosomes, relative to the native Dm 
or Dp genome. To correct for this, putative Ci/GLI binding sites were identified in each 
of the 1000 background genomic sequences and the genomic coordinates of each site 
was recorded. Site motifs, tagged with their location coordinates, were pooled into a 
master list of possible site positions. This master list was used to re-create 100 
background chromosomes for each chromosome, such that each background 
chromosome contained the same composition of Ci/GLI sites (overall number and motif) 
as the native Dm or Dp chromosome (see Results). 
  
Assessment of relative Ci/GLI binding site clustering 
Ci/GLI site clusters were defined as regions containing at least three and at most ten 
putative Ci/GLI sites within a maximum distance of 1000 base pairs (bp; measured from 
the outside ends of the flanking sites). The genomic coordinates of each cluster were 
cataloged, and clusters were subsequently filtered for the presence of at least one 
predicted binding site with a MSS ≥0.81. This was done to decrease the number of 
clusters comprised entirely of low scoring sites, substantial portions of which are 
predicted to be non-functional. Clusters that contained exon or repeat elements were 
excluded. Clusters for which the Ci/GLI binding sites themselves accounted for more 
than 25% of the end-to-end cluster length were also excluded, since the majority of 
such clusters were composed of repetitive sequence. For each cluster, the number of 
binding sites expected to be present by chance for that specific genomic region was 
determined from 100 control reconstructed genomes as described in Results. A 
clustering coefficient (CC) was defined as the number of Ci/GLI sites observed in a 
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given interval of the native genome (at a given location) divided by the average number 
of Ci/GLI sites in the same region of the background genome (at the same location). To 
enrich for clusters likely to represent enhancers, we selected a CC cutoff of four which 
captured all of the previously known clustered Hh enhancers. Importantly, the CC score 
was used as a filter, and not as a ranking tool. 
  
Orthologous enrichment of Ci clusters 
Clusters were identified and annotated in the Dp genome exactly as described above 
for Dm. Background modeling for the Dp genome was done by Flip GC/AT; 1000 
randomized genomes were generated and corrected as outlined above for number and 
affinity class to make 100 randomized, corrected Dp genomes for comparison to the 
native Dp genome. Clusters identified in the Dp genome were selected according to the 
same criteria as for the Dm genome (cluster size ≤ 1000; 3-10 Ci/GLI sites; CC ≥ 4; at 
least one site with MSS ≥ 0.81). The coordinates for enriched clusters of Ci/GLI binding 
sites (CC ≥ 4) were determined for Dm and Dp and compared using the LiftOver tool 
available from UCSC Genome Bioinformatics (Fujita et al., 2011). All clusters that were 
present in orthologous positions of the Dm and Dp genomes (i.e., with an overlap of one 
or more bases, irrespective of sequence identity) were selected for further analysis. 
  
Cloning of putative enhancer regions for testing 
Putative enhancer regions in the Dm genome were visualized in the UCSC Genome 
Browser, and using the Conservation track (12 Flies, Mosquito, Honeybee, Beetle Multiz 
Alignments & phastCons Scores), the ends of an individual enhancer element were 
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extended to include contiguous highly conserved sequence (Blanchette et al., 2004). 
Putative enhancers were amplified from w1118 genomic DNA using template-specific 
PCR primers (Table 4.6). A CACC extension was added to the end of one primer to 
facilitate directional cloning. PCR fragments were cloned into the pENTR/D-TOPO 
vector using the standard kit (Invitrogen) and then shuttled into either Ganesh-G2 
(Swanson et al., 2008) or HP-desteGFP (Boy et al., 2010) vectors using the Gateway® 
cloning system (Invitrogen). Ci binding site mutations (C4A) were introduced by overlap 
extension PCR, as previously described (Swanson et al., 2010a). QuikChange 
mutagenesis (Stratagene) was also used to mutate some Ci binding sites. pCIT was 
generated by replacing eGFP in pCIG (Megason and McMahon, 2002) with 
TdTOMATO, which was cloned into the location between the third PmlI site and the NotI 
site in pCIG. SmoM2-pCIT was generated by cloning rat SmoM2 into the XhoI and ClaI 
sites of pCIT. 
  
Drosophila transgenesis 
Transformation was achieved by injection of w1118 or ZH-attP-86Fb embryos, essentially 
as described previously (Bischof et al., 2007; Rubin and Spradling, 1982). A current 
protocol is available at:  http://sitemaker.umich.edu/barolo/injection. For w1118 
transgenesis, at least three independent lines were examined; one or more lines were 
examined for ZH-attP-86Fb transgenesis. 
  
Drosophila tissue analysis 
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Since Hh is active in a variety of tissue contexts in the embryo (brain, gut, muscle, 
segmental stripes etc.), we utilized embryos at stages 9-13 to gain an unbiased view of 
all of these contexts. Additionally, we specifically examined the wing imaginal disc since 
this is a well-known and well-characterized expression domain for Hh signaling. Of the 
22 genes selected for analysis (Table 4.2), 17 are expressed in the embryo or imaginal 
disc (Hammonds et al., 2013; Tomancak et al., 2002; Tomancak et al., 2007). There are 
no data on two (CG5475, CG4704) and three others (beat-IV, BDGP, HGTX) are not 
reported to be expressed in these sites, but these have been incompletely studied. For 
imaginal disc analysis, 3rd instar wandering larvae were collected from vials, and discs 
were dissected fresh and fixed in 4% paraformaldehyde. For embryo analysis, embryos 
were collected in 6-hour batches at 25°C, dechorionated in 100% bleach, fixed in 4% 
paraformaldehyde, and devitellinized by shaking in methanol and heptane. 
  
Chicken in ovo electroporations 
Chicken neural tube electroporations were performed essentially as described 
previously (Tenzen et al., 2006). Briefly, 500 ng/ml of reporter vector and 500 ng/ml of 
either pCIT or SmoM2-pCIT was dissolved in PBS with 50 ng/ml of Fast Green and 
injected into the neural tubes of Hamburger-Hamilton stage 10–12 chicken embryos. 
Approximately 48 hours following electroporation embryos were recovered and fixed in 
4% paraformaldehyde for subsequent immunofluorescent analysis. Fertile eggs were 
obtained from the Michigan State University Poultry Farm. 
  
Immunofluorescence and microscopy 
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Drosophila embryos and imaginal discs were blocked with 10% BSA in phosphate-
buffered saline (PBS) with 0.1% Triton X-100. The following primary antibodies were 
used overnight at 4°C:  rabbit anti-GFP IgG antibody (1:200; Life Technologies 
A11122), mouse anti-Ptc (1:50, DSHB; APA1) and mouse anti-En (1:50, DSHB; 4D9). 
Samples were then incubated in the following secondary antibodies for 2 hours at room 
temperatures, Alexa Fluor 488-conjugated goat anti-rabbit IgG antibody (1:2,000; Life 
Technologies A11008) and/or Alexa Fluor 468-conjugated goat anti-mouse IgG 
antibody (1:2,000; Life Technologies A11004). Embryos and imaginal discs were 
mounted on glass slides using ProLong Gold with DAPI and imaged on an Olympus BX-
51 upright microscope, Nikon A1 confocal with Ti-E microscope or Olympus FluoView 
500 Laser Scanning Confocal Microscope. For direct comparisons, wild type and mutant 
constructs were processed in parallel including being imaged on the same day, using 
the same exposure settings. 
  
Immunofluorescent analyses of chicken neural tubes were performed essentially as 
described previously (Jeong and McMahon, 2005). The antibodies used were as 
follows: 1:20 Mouse IgG1 anti-NKX6.1 (DSHB; F55A10). DAPI (Life Technologies) was 
used at a dilution of 1:30,000. All secondary antibodies (Alexa Fluor; Life Technologies) 
were used at a dilution of 1:500. Primary antibodies were incubated overnight at 4°C, 
followed by incubation with secondary antibodies for one hour at room temperature. 
Images were collected with a Leica SP5X confocal microscope. 
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Figure 4.1 Pipeline for detection and validation of Hh-responsive enhancers 
Ci/GLI cluster identification and background genome generation were performed as 
outlined in Figure 4.3.  The cluster (CC) for a given genomic region was calculated as 
the total number of sites observed in the Dm or Dp genome (observed) divided by the 
average number of sites per background genome for that species (expected). Clusters 
of Ci/GLI sites with a (CC) ≥ 4 were further filtered as follows: Clusters were required to 
contain at least one Ci/GLI site of ≥0.81 MSS; Dm Clusters were required to overlap in 
position (but not sequence) with a cluster in Dp; Clusters in exon or repeat regions were 
excluded.  The entire table of selected clusters, sorted by chromosomal location, is 
provided in Table 4.4. The list of clusters was then ranked by average MSS of the 
predicted Ci/GLI sites and the top 17 were examined functionally (these included 16 
novel hits and one known enhancer, ptc-0.6).  The Hh-responsive enhancer activity of 
genomic regions containing selected clusters was functionally evaluated by means of a 
transgenic fly assay as well as by chicken neural tube electroporation. For genomic 
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regions that showed apparent Hh responsiveness, Ci/GLI sites were mutated and re-




Figure 4.2 Assessment of GC content surrounding Ci/GLI sites in the Drosophila 
melanogaster genome 
Proportion of sequence that is GC in the 50 bp surrounding predicted Ci/GLI sites on 
each Dm chromosome is displayed in the left panel. Chromosomes are color-coded: 2L 
(red); 2R (light blue); 3L (blue); 3R (green); 4 (yellow), and X (purple). Notably, all 
Drosophila chromosomes have similar distributions of GC content surrounding the 
predicted existing Ci sites, except for Chromosome 4, which is considerably more AT 
rich in regions surrounding predicted Ci sites (yellow line). Three different models (Flip 
GC/AT, Shuffle 3-mer and Random, see Materials and Methods for details) were used 
to create three background sequences for each chromosome and the GC content in 50 
bp surrounding each Ci/GLI site was compared among the models. Black is used for the 
randomized model since all chromosomes collapse on the same distribution. Error bars 
show standard error of the mean for the 100 chromosomes in each model. Only the Flip 




Figure 4.3 Construction of background genomes and determination of cluster 
enrichment 
(A) The actual number of predicted Ci/GLI sites (≥0.75 MSS) determined in each Dm 
chromosome is shown by the green lines. The Flip GC/AT method was used to create 
1000 background sequences and the number of predicted Ci/GLI sites was tallied for 
each sequence. Box plots show that randomized chromosomes contain substantially 
fewer predicted Ci/GLI sites.  Brackets represent the range in total number of Ci/GLI 
sites across the background sequences for each chromosome. (B) To correct for the 
depleted number of predicted Ci/GLI sites and create background chromosomes that 
would closely mirror the native Dm genome, the location (coordinates) and type 
(sequence) of all predicted Ci/GLI sites in each of the 1000 background sequences 
were recorded and pooled. Background genomes were then constructed by randomly 
selecting coordinates from the pools so that the composition (number and site type) 
matched that of the corresponding Dm chromosome. (C) Enrichment of clusters of 3-10 
Ci/GLI sites relative to the background chromosomes was then determined. The 
example shows analysis of enrichment for clusters of 3 Ci/GLI sites (blue boxes). The 
Dm chromosome (black line) is compared with 100 background chromosomes (grey 
lines); the diagram shows only three of the 100 background chromosomes. In a moving 
window, each group of three Ci/GLI sites was delineated in the Dm chromosome (one 
such cluster is outlined in orange) and the average number of Ci/GLI sites was 
determined within that same genomic space in each of the 100 background 
chromosomes. The cluster outlined by the orange box is considered enriched if the 
average number of sites in the Dm chromosome is ≥4 fold more than the average 
number of Ci/GLI sites per background chromosome.  
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Figure 4.4 Validation of predicted Hh-responsive enhancers in the chicken neural tube 
Transverse sections of Hamburger-Hamilton stage 21-22 chicken embryos are shown. 
DAPI (grayscale, far left column) depicts nuclei. tdTOMATO (red, middle left column) 
marks cells electroporated with pCIT or SmoM2. GFP (green, middle right column) 
reports enhancer activation. Anti-NKX6.1 antibody staining (magenta, far right column) 
denotes Hh-responsive cells. (A) Chicken embryos co-electroporated with an 
enhancerless pGanesh construct (containing only an Hsp70 minimal promoter) and 
either pCIT or a constitutively active SmoM2. An arrowhead (middle right column; 
bottom row) depicts a few GFP positive cells in pGanesh electroporated embryos. Note 
the ectopic NKX6.1 expression (far right column) indicative of overactive Hh signaling in 
electroporated cells (white arrow). (B-E) Candidate Hh-responsive inv+16.8 (B top row), 
inv+18.6 (C top row), cpr100A (D top row), and plc21C (E top row) constructs all exhibit 
GFP expression in cells in which Hh is activated by co-electroporation of SmoM2.  
However, chicken embryos co-electroporated with SmoM2 in combination with a Ci/GLI-
binding deficient mutant (CiKO) of each candidate (bottom rows) show a complete 
absence of GFP expression in the case of inv+16.8-CiKO (B) and inv+18.6-CiKO (C), 
despite ectopic NKX6.1 expression in both conditions (far right column). cpr100A-CiKO 
(D) has a greatly diminished expression pattern with only a few GFP positive cells 
(white arrowhead) remaining (middle right column; bottom row). plc21C-CiKO (E) does 
not show loss of GFP expression, indicating that it is not a direct Hh target, since its 
response to Hh signaling is not Ci/GLI dependent. rdx (F top row) GFP expression 
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corresponds to Hh expressing cells and shows no expression once Ci/GLI sites are 





Figure 4.5 Endogenous expression of inv+16.8 and inv+18.6 in the chicken neural tube 
Transverse sections of Hamburger-Hamilton stage 21-22 chicken embryos are shown. 
DAPI (grayscale, far left column) depicts nuclei. tdTOMATO (red, middle left column) 
marks cells electroporated with pCIT. GFP (green, middle right column) reports 
enhancer activation. Anti-NKX6.1 antibody staining (magenta, far right column) denotes 
Hh-responsive cells. (A) Chicken embryos electroporated with inv+16.8 show no GFP 
expression in the chicken neural tube. (B) Chicken embryos electroporated with 




Figure 4.6 Expression of a complex inv enhancer in the chicken neural tube and 
Drosophila wing imaginal disc 
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(A) Genomic landscape of the inv locus depicting the invlong, inv+16.8 and inv+18.6 
constructs. Ci/GLI binding sites are shown as red/orange bars; the intensity of red 
coloration indicates the MSS. Sequence conservation is indicated by the track at bottom 
of the panel. (B) Transverse sections of Hamburger-Hamilton stage 21-22 chicken 
embryos are shown as in Fig. 5. DAPI (gray, far left column) depicts nuclei. tdTOMATO 
(red, middle left column) marks cells electroporated with pCIT or SmoM2. GFP (green, 
middle right column) reports enhancer activation. Anti-NKX6.1 antibody staining 
(magenta, far right column) marks Hh-responsive cells. The invlong (top row) enhancer 
demonstrates GFP expression in the ventral neural tube (white arrowhead).  The 
expression of invlong is strengthened and broadened with co-electroporation of SmoM2 
(middle row). Mutagenesis of Ci/GLI binding sites demonstrates that enhancer activity is 
Ci/GLI dependent (bottom row).  (C) Tabulation of activity in the chicken neural tube of 
invlong constructs containing different Ci/GLI site compositions.  Green boxes indicate 
wild type Ci/GLI sequences; purple boxes indicate mutated Ci/GLI sites. Constructs that 
have functional Ci/GLI sites that correspond to inv+18.6 (construct A) or inv+16.8 
(construct B and C) exhibit GFP expression in the neural tube.  However, the central 





Figure 4.7 Novel enhancers directly respond to Hh signaling in the wing imaginal disc 
and embryo 
(A-K) β-galactosidase or GFP marks the expression of enhancers in the pouch of the 
wing imaginal disc. A diagram of the fragments tested and location and MSS for all 
Ci/GLI sites is shown for each candidate (yellow rectangles). Each wild type enhancer 
responds to Hh signaling along the anterior-posterior compartment boundary of the wing 
disc, with the exception of inv+16.8(G). Active enhancers lose Hh responsiveness in the 
wing imaginal disc when predicted Ci/GLI binding sites are mutated, as shown in the 
right of each panel. (L-O) GFP marks the expression of the noted enhancers in the 
embryo. En expression (red) marks cells producing Hh ligand. When the predicted 
Ci/GLI binding sites in these enhancers are mutated (M-O), activity in Hh-responsive 




Figure 4.8 Expression of hth and plc21C regions in the fly are not Ci/GLI-dependent 
Both hth and Plc21C drive GFP expression in the fly embryo.  Hth exhibits expression in 
the brain as well as a punctate segmental pattern parallel but outside of En expression 
(shown in red) which marks cells that produce and secrete Hh ligand (A,B). plc21C 
expresses throughout the gut (C).  Expression for both constructs is not Hh dependent 




Figure 4.9 Mapping six Hh regulated enhancers in four genetic loci 
(A-D) Genomic landscape of the ptc, inv, rdx and gsb loci with fragments tested marked 
by green bars. All predicted Ci/GLI binding sites are highlighted (red/orange tick marks, 
annotated according to MSS, as noted at top of Figure). The sequence conservation 
track (gray bars) marks conservation among the 12 sequenced Drosophila species, 
whereas the dark and light blue bars represent clusters of predicted Ci/GLI binding sites 
















































chr2L AACCACCCC 224157 224165 0.771 kis NM_078717X Intron 12 224157 224425 268 0.769 0.915 0.8122 CG13693,,kis,AACCACCCC,AGCCACCCC,AGCCACCCC,agcCAXCCC ,AGCCAXCCC,TCCCCTCCC,ATCCGXCTG,ATCCGXCTG,XXXXXXTGC ,GTCAAXCAG,GACAAXCAG,GTCATXCAA 0 18 4 8.85
chr2L CACCCCCCA 224160 224168 0.799 kis NM_078717X Intron 12 224157 224425 268 0.769 0.915 0.8122 CG13693,,kis,CACCCCCCXXXXXXXXXXXXXXXXXXXXXXXXXXXA,CACCCCCC XXXXXXXXXXXXXXXXA,CACCCCCC XXXXXXXXXXXXXXXXA,CA CCCCC XXXXXXXXXXXXXXXA,CA CCCCC XXXXXXXXXXXXXXXXA,CCTCCCCC TCCCCCTACTTGGCCAG,CG CTG TXXXXXXXXXXXXXXXXXXXXXXXXXXXX, G CTGCT XXXXXXXXXXXXXXXX, TGCCT XXXXXXXXXXXXXX,AAXCAGCA XXXXXXXXXXXXXXXXXX,AAXCAGTAXXXXXXXXXXXXXXXXXXXXXXXXXXXX,AT CAACGGCTGCTTGAATTTTATATTTTATATTTG2 18 4 8.85
chr2L TGGGTGGGC 224175 224183 0.915 kis NM_078717X Intron 12 224157 224425 268 0.769 0.915 0.8122 CG13693,,kis,TGGGTGXXXXGGC,T GGTGXXXXGGC,T GGTGXXXXGGC,T GGTGXXXXGGC,T GGTGXXXXGGC,T GGTGXXXXGGC,TCGGTGXXXXGGC,T GGTGXXXXGGC,T GGTGXXXXGGC,T GGTGXXXXGGC,T GGTGGGCAGGC,TG TGXXXXGGC 8 18 4 8.85
chr2L CACCACCCG 224363 224371 0.769 kis NM_078717X Intron 12 224157 224425 268 0.769 0.915 0.8122 CG13693,,kis,CXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXACCACCCG,A XXXXXXXXXXXXXXXXACCACCCG,AXXXXXXXXXXXX XXXXXXXXXXXXXXXXACCACCCG,AA AA ACCAAG XXXXXXXXXXXXXXXXXXXXACCAAAACCACCCG,AXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX CC AA ACCCG,CAGAG CCAAG C G AA AAACCAAAACCTTAAACCAAAACCACCCG,G XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXC GCAGAAACCACCCG,G XXXXXXXXXXXXXXXXC G G A CA CG,A XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXAG AA AACCACCCG,c agcagcagcagcagcagcagcagcagcagcaacaacaACCACCCG,XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXCAAC AC G, XXXXXXXXXXXXX AATAACCACCCG0 18 4 8.85
chr2L GTCCACCAA 224417 224425 0.807 kis NM_078717X Intron 12 224157 224425 268 0.769 0.915 0.8122 CG13693,,kis,GTCCACXXXXXXXCAA,GTCCACXXXXXXXCAA,GTCCACXXXXXXXCAA,GTCCACXXXXXXXCAA,GTCCACXXXXXXXCAA,GTCCACXXXXXXXCAA,GTCCACXXXXXXXCAA,GTCCACXXXXXXXCAA,GTCCACXXXXXXXCAA,G CCGCXXXXXXXCAA,GTCCGCXXXXXXXTGC,AGCAGCAGCATGGCAA8 18 4 8.85
chr2L AGGGTGGTA 307304 307312 0.771 Plc21C NM_057504+ Intron 1 307304 307667 363 0.766 0.814 0.7822 Plc21C,,CG11911,,CG33992,,CG31921,,CG33127,,CG11912,,CG31920,AGGGT GTA,, ,AGGGTGGTA, A GAGGAG, GGGAGGAG,, ,GGGGAGGTG, GGGAGGTG, GGAATACG, GGTGCGTG, GTTGGGTG, GGTTCGTG 1 21 10 5.54
chr2L CACCACCAA 307523 307531 0.778 Plc21C NM_057504+ Intron 1 307304 307667 363 0.766 0.814 0.7822 Plc21C,,CG11911,,CG33992,,CG31921,,CG33127,,CG11912,,CG31920,CACCACCAA,, ,XXXXXXXAA ,XXXXXXXAA ,XXXXXXXAA ,XXXXXXXTG ,TTXXXXXGG ,TTXXXXXGG ,XXXXXXXAT ,XXXXXXXAG ,XXXXXXXAG ,, 0 21 10 5.54
chr2L GCCCACTCA 307549 307557 0.814 Plc21C NM_057504+ Intron 1 307304 307667 363 0.766 0.814 0.7822 Plc21C,,CG11911,,CG33992,,CG31921,,CG33127,,CG11912,,CG31920,GCCCACTCA,, ,GC CACTCA,GCCCACTCA,GCCCACTCA,GCCCACTCA,GCCCACTCA,GCCCACTCA,GGCAACCXX,GACAGCXXX ,GACTGTXXX ,GACAGCXXX 6 21 10 5.54
chr2L GAGCACCCT 307659 307667 0.766 Plc21C NM_057504+ Intron 1 307304 307667 363 0.766 0.814 0.7822 Plc21C,,CG11911,,CG33992,,CG31921,,CG33127,,CG11912,,CG31920,GAGCACCCT,, ,AAGCGCCCT,CGACCCCCC,AATCCCCCT,AGTCCTCCT,AACCACCCA,TACCACCCA,CATCATCAT,, ,ACGCACACG,GTGCCCCAC 0 21 10 5.54
chr2L CACCACCCA 308379 308387 0.881 Plc21C NM_057504+ Intron 1 308379 308837 458 0.807 1 0.8922 Plc21C,,CG11911,,CG33992,,CG31921,,CG33127,,CG11912,,CG31920,CACCACCXCA,CAC ACCXCA,CA CACCXCA,CACCACCXCA,CACCACCXCA,CACCACCXCA,CACCAACGCA,CACCAACGCA,, ,XXXXXXAXAA ,, ,, 5 21 10 4.695
chr2L CACCACCCA 308406 308414 0.881 Plc21C NM_057504+ Intron 1 308379 308837 458 0.807 1 0.8922 Plc21C,,CG11911,,CG33992,,CG31921,,CG33127,,CG11912,,CG31920,CACCACCCA,CAC ACCCA,CA CACCCA,CACCACCCC,CACCACCCA,XACCACCCA,, ,, ,, ,, ,, ,, 3 21 10 4.695
chr2L TGGGTGGTC 308766 308774 1 Plc21C NM_057504+ Intron 1 308379 308837 458 0.807 1 0.8922 Plc21C,,CG11911,,CG33992,,CG31921,,CG33127,,CG11912,,CG31920,TGXXXXXXXXXXXXXXGGTXGGTC,T XXXX XXXXXXXXXGGTXGGTC,T XXXX XXXXXXXXXGGTXCATC,TXXXXXX XXXXXXXXXXTXCGAC,T XX XXXXXXXXXXXXXTXGGGC,T XX XXXXXXXXXXXTTTXCCAC,TGXX XXXXXXXXXXXAGTACCAC,TGXXXXXXXXXXXXXXAGTGCCAC,, ,TGGAGGGGGGGTTAAAGGTXTAGA,, ,, 1 21 10 4.695
chr2L GTCCACCTA 308829 308837 0.807 Plc21C NM_057504+ Intron 1 308379 308837 458 0.807 1 0.8922 Plc21C,,CG11911,,CG33992,,CG31921,,CG33127,,CG11912,,CG31920,GTCCAXCCTXA,GTC AXCCTXA,GT CAXCCTXA,GTCCAXCCCXA,GTCCAXGCTXA,GTCCAXTCCGA, TCCAXCGGXA,GTCCAXCGGXA,, ,GTCCGTTTTXG,, ,GTCCGXTTTXG 2 21 10 4.695
chr2L ACCCACCCA 343915 343923 0.797 Plc21C NM_057504+ Intron 13 343561 344047 486 0.78 0.812 0.7935 Plc21C,,CG11911,,CG33992,,CG31921,,CG33127,,CG11912,,CG31920,AXXXXXXXXXCXXXXXXXXXXXXCCACCCA,A CAAT XXXX CACCXXA CACCCA,A XXXXXXX XX XX C ACCCA,AXXXXXXXX CXXXXCCA CXXACCACCCA,aXXXXXXXX cXXXXccacCXXACCACCCC,aa aaccaacXXXXcaaccaaACCACACA, XXXXXXCXXXX ACXXCCGACCAC, XXXXXXXX XXXXCCACCXXCCGACCAC,AXXXXXXXX CXXXXATATTXXACCACCAC,aXXXXXXXX caccatcaacXXaccaccaa, XXXXXXXXXCAACAACAACXXACCACCAA,AXXXXXXXXXCACAACCAACXXACCACCAA0 21 10 8.639
Table 4.1 Predicted clusters of Ci/GLI binding sites in the Drosophila melanogaster genome 
(using the dm3 build of the genome browser).  
This is a snapshot of the full table available at 
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0145225#sec021 as S4 
Table.  Columns A-Q are labeled accordingly in row 1. Columns R through AC represent 
sequence for each Drosophila species that corresponds to the multiple sequence alignment 
(9-mer at the position of the Ci/GLI site in Dm). Number of species that show 100% 
conservation is shown in column AD. The number of sites assigned to each locus is listed in 
column AE (boundaries between loci are considered as half of the distance between two 
neighboring loci). Column AF indicates the number of sites in the locus with MSS≥0.81 
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Table 4.2 Summary of top predicted Hh-responsive enhancers in Drosophila 
melanogaster  
The chicken neural tube (CNT) and transgenic fly (TF) assays together identified eight 
predicted regions as Hh-responsive.  Both assays showed positive Hh activity for 
inv+18.6 and rdx as well as the previously identified ptc enhancer region.  Five 
additional regions were positive in only one assay: CNT: Cpr100A and inv+16.8; TF: 
gsb and two ptc additional genomic regions (ptc+5.3 and ptc-2.8).  All enhancer regions 
were verified by mutagenesis to be Ci/GLI binding site dependent.  
  
Annotated 














ptc-0.6 chr2R:4536264-4536572 3 1 + +
inv+16.8 chr2R:7378801-7380000 4 0.941 + -
Sox100B chr3R:26894840-26896225 3 0.92 - -
inv+18.6 chr2R:7380576-7381900 4 0.903 + +
beat-IV chr3R:19385801-19387033 5 0.899 - -
CG6475 chr3R:17227902-17229095 4 0.898 - -
CG34139 chr3R:16067525-16068300 3 0.893 - -
Plc21C chr2L:308225-309200 4 0.892 - -
CG4704 chr3R:18671231-18671930 3 0.891 - -
Bi chrX:4316001-4317440 4 0.886 - -
HGTX chr3L:14583895-14584670 4 0.886 - -
Cpr100A chr3R:26692110-26692580 3 0.886 + -
Ets21C chr2L:550010-551035 4 0.885 - -
CG12541 chrX:6927600-6928375 5 0.884 - -
Sp1 chrX:9613671-9614922 4 0.881 - -
Hth chr3R:6433650-6434996 5 0.879 - -
Ko chr3L:21072420-21073658 3 0.879 - -
ptc+5.3 chr2R:4542467-4545417 7 0.875 - +
ptc-2.8 chr2R:4531601-4534319 5 0.847 - +
Rx chr2R:16820211-16822050 5 0.845 - -
Rdx chr3R:9815295-9817061 3 0.838 + +
Gsb chr2R:20952400-20953750 7 0.834 - +
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Table 4.4 Overlap between clusters predicted in this study and DamID protected sites 
DamID%locations%from%Biehs%et%al.%%(Build%dm3)
Chromosome Start End Cluster%Start Cluster%End Symbol Gene
chr2L 1455284 1456528 1455873 1456140 snRNA:U3:22A NR_001600
chr2L 1927769 1928140 1927228 1928142 CG7337 NM_001103581
chr2L 7538466 7543325 7538294 7539165 Rapgap1 NM_001103644
chr2L 9111843 9113084 9111745 9112729 Or30a NM_078796
chr2L 15937296 15944819 15937185 15937383 beatAIb NM_078855
chr2L 17431677 17434112 17433182 17433529 CG5043 NM_135994
chr2R 2655624 2656580 2656051 2656477 Epac NM_001103732
chr2R 6418206 6419765 6418353 6418759 lola* NM_080027
chr2R 6462021 6462381 6461408 6462025 psq NM_165790
chr2R 11004693 11007129 11004180 11005090 chn NM_206119
chr2R 11336766 11337435 11336714 11337271 CG34365 NM_001103852
chr2R 12283866 12284542 12284061 12284394 CG33960 NM_001038863
chr2R 12412600 12412659 12412235 12412734 SemaA2a NM_166178
chr2R 12414984 12419228 12416993 12417312 SemaA2a NM_166178
chr2R 12498703 12500537 12498903 12499084 CG5065 NM_137299
chr2R 12658866 12659557 12659107 12659386 uncA104 NM_166192
chr2R 12677166 12679045 12676636 12677619 CG5522 NM_166193
chr2R 13045282 13055248 13051217 13051370 CG10953 NM_137355
chr2R 13073470 13078925 13073362 13073564 CG10950 NM_137356
chr2R 13166767 13167736 13166630 13167109 mbl NM_176211
chr2R 13391488 13396940 13394739 13395102 CG4844 NM_001032265
chr2R 15209157 15212514 15211205 15211546 Rgk1 NM_137567
chr2R 15681071 15682013 15680992 15681678 Obp56g NM_137603
chr2R 15742583 15743824 15743081 15743609 Obp56i NM_166376
chr2R 18226254 18226613 18226458 18226970 CG11206 NM_001103944
chr2R 18259854 18261720 18260459 18261287 Rtf1 NM_137821
chr2R 18431154 18433651 18432448 18432907 px* NM_001103947
chr2R 20272172 20272571 20272357 20273224 mAcRA60C NM_079120
chr3L 8052940 8054760 8052894 8053443 bip1 NM_139912
chr3L 11862617 11864769 11864451 11864952 CG5906 NM_140261
chr3L 12458113 12459080 12457913 12458121 eyg NM_079318
chr3L 13940701 13941699 13941029 13941736 CG32137 NM_168564
chr3L 17339408 17344264 17341139 17341588 Mip NM_140714
chr3L 20692805 20697982 20692956 20693766 kni* NM_079463
chr3R 2329935 2332092 2329972 2330257 CG15186 NM_169145
chr3R 3976809 3982873 3978441 3978655 grn NM_001144554
chr3R 4101609 4106766 4102638 4102804 ato* NM_169213
chr3R 4401007 4404074 4403133 4403663 CenpAC NM_169228
chr3R 5682908 5683267 5682873 5683534 Teh1 NM_141702
chr3R 9669658 9672691 9670696 9671137 CG31495 NM_169559
chr3R 17217597 17220086 17219899 17220257 CG6475 NM_001104389
chr3R 17227813 17229687 17227902 17228674 CG6475 NM_001104389
chr3R 20530764 20536210 20530430 20531229 slo NM_001170241
chr3R 20549088 20550942 20549943 20550067 tok NM_170168
chr3R 21180551 21181210 21180942 21181629 Fur1 NM_170654
chrX 3720410 3720469 3719976 3720491 ec NM_130722
chrX 4249010 4249973 4249936 4250271 norpA NM_001169190
chrX 4256130 4258561 4256588 4257103 norpA NM_080330
chrX 4537017 4537076 4537020 4537166 CG3062 NM_131949
chrX 5540520 5540876 5539974 5540628 CG42492 NM_001169205
chrX 6202614 6205080 6202296 6202630 CG3823 NM_132085
chrX 6297612 6298259 6296956 6297618 CG33669 NM_001031872
chrX 7309802 7314072 7309556 7310205 CG34337 NM_001103431
chrX 7400950 7404588 7400758 7401576 CG32719 NM_167128
chrX 15536311 15537530 15537132 15537533 CG8117 NM_132821
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Asterisks indicate four sites that map to one of the 52 probable Ci target genes 




Table 4.5 Predicted 9-mer GLI binding sites with a minimum level (≥0.75) Ci matrix 
similarity score  
Full Table can be found at 
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0145225#sec021 as 




























Table 4.6 PCR primers used to amplify genomic DNA from the D. melanogaster 
genome (build dm3) 
 
Annotation Forward+primer Reverse+primer Genomic+coordinates+(dm3)
ptc$%0.6 CACCGGCGCGCCATGCATGCGCAGCCTGCCAC GTACCGCGGTTTCTATTGTTATTCGCATG chr2R:4536264/4536572
inv$+16.8 CACCTGATATCTTAGGTTAGTAGTAT AATCTAATTTTGCCCTGATATT chr2R:7378801/7380000
Sox100B CACCTAAGCTCGGGATATTTTGCC AGCTTAGAGGTCCTGCATAG chr3R:26894840/26896225
inv$+18.6 CACCTATGTTATAAAATTTGTAATAT TTTGGTTATACTGTCTAACAAA chr2R:7380576/7381900
beat%IV CACCGTTTTTTTGCATTTCACC AAACTACACGGCTGCCCTG chr3R:19385801/19387033
CG6475 CACCGACCACACAACAGACGC TACTTGAGCACCCGATTGG chr3R:17227902/17229095
CG34139 CACCCTTTCGTTTTATGTTAACG TTGTTTTTTTTCTTTTCGCTGTGCG chr3R:16067525/16068300
Plc21C CACCTCGTTATGATGTGCCTTAAAAG AAAATATTAACGCGAAATAGG chr2L:308225/309200
CG4704 CACCGTCATATTAGGCTATTTC CATTTTATTAGCCGAATGC chr3R:18671231/18671930
bi CACCGAGAGGGAGCGAGTGAGTAAG TGAGGCAATCGATAAAATTAGC chrX:4316001/4317440
HGTX CACCTGCAGCCGCTTAATAATTCC AGTGCCGTGCTTAACCCG chr3L:14583895/14584670
Cpr100A CACCATAATGCCAAAAGTTCTCTG TGTCTTTTTGATTTTTCCAGTG chr3R:26692110/26692580
Ets21C CACCGTTTGTACCCTGTAAAGGG ACTTAAACGGAGCCACATTTTTCTC chr2L:550010/551035
CG12541 CACCCAGCAAGAAGCATACCAAAG ACTATTAGCTACATTTTCTTCC chrX:6927600/6928375
Sp1 CACCTTCGCCGTGTGTATGTATTAGC TATCAACGGAAATTCATTAC chrX:9613671/9614922
hth CACCTAAAGCCGAAAGCCTAAAATAG TTTGCTTGTATTTTCCGAAC chr3R:6433650/6434996
ko CACCAGGAGACAGGTGGTATGGTC ATTCACAGTGTAATTTTACAGC chr3L:21072420/21073658
ptc$+5.3+A3 CACCGGCGCGCCGAAGTGCTTAACAAGTTAAC GTACCGCGGCACGACAACCAATGAGATCG chr2R:4542467/4545417
ptc$%2.8 CACCGGCGCGCCTACGTACTCTTATTACTCCACTC GTACCGCGGGCTATTGCATTTGTCATTGGC chr2R:4531601/4534319
Rx CACCACTCCTTCCCCGACTTAC GTTTAAACCGAAAAACGTTTAATTTAATCTGG chr2R:16820211/16822050
rdx CACCTTTAGCCAGGTGTGGATTGTG CCAGCGAAAGCAAACAGAGTAC chr3R:9815295/9817061
gsb CACCGCGAGTCAAACTCATTCCGTG AAGTGTACGGTGAATTC chr2R:20952400/20953750
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Chapter 5  
 
Genomic Engineering of the Hedgehog Signaling Pathway  
  
5.1 Abstract 
Thus far I have examined how the Hedgehog signaling pathway regulates gene 
expression using mainly GFP reporter assays. These experiments provide an in vivo 
transcriptional readout of Hh target gene enhancers in several developmental contexts, 
but two caveats still apply. First, I have not demonstrated tissue-specific Ci occupancy 
in vivo at any of the Drosophila enhancers identified in chapters 2-4. Instead, I have 
used EMSA analysis to demonstrate that Ci recognizes a particular binding site in vitro, 
but this neglects other co-activators, repressors, or other TFs that might affect Ci 
binding to these sites in vivo. Second, I have not demonstrated the functional 
contribution of these enhancers to the development of the animal. The GFP expression 
suggests functional significance, but I have not directly demonstrated it. In order to 
address these questions, I have employed the powerful CRISPR/Cas9 approach to 
quickly and efficiently target genomic sequences in vivo, allowing me to more effectively 
examine enhancer function. 
5.2 Introduction 
Direct manipulation of the genome is the new gold standard for assessing the 
function of genes and cis-regulatory elements. Historically, researchers have 
manipulated the genome in many ways—for instance, by using chemical mutagens to 
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disrupt functionally relevant genes. This is how hh, ptc, odd-skipped and many other 
critical patterning genes were identified by Christiane Nusslein Volhard and Eric 
Weishchaus in a series of Nobel Prize-winning forward genetic screens (Nüsslein-
Volhard & Wieschaus 1980; Adams & Sekelsky 2002). In flies, “jumping genes” called 
transposons have long been used as an alternative method for creating mutations 
(Spradling et al. 1999). Though these genomic manipulation strategies are effective for 
conducting large-scale screens, they can only produce mutations at random and thus 
are not useful for making precise, targeted alterations to the genome. A more recent 
technique, homologous recombination, makes targeted alterations to the genome 
possible, but it is inefficient and technically challenging (Gong & Golic 2003; Huang et 
al. 2009). Other genome editing technologies employ sequence-specific DNA-binding 
proteins, such as zinc finger nucleases (ZFNs) or transcription activator-like effector 
nucleases (TALENs). These approaches have the drawbacks that they require the 
generation of a customized protein for each targeting event, that the process is 
cumbersome, and that they generate undesired off-target effects in complex genomes 
(Wood et al. 2011; Gaj et al. 2013). 
More recently, the Clustered Regularly Interspaced Short Palindromic Repeats 
(CRISPR) technique has exploded in popularity in the scientific community (Doudna & 
Charpentier 2014; Sternberg & Doudna 2015; Mohr et al. 2016). CRISPR was originally 
identified in 1987 as a means by which E. coli defend against invading viral DNA. The 
system was later adapted by Jennifer Doudna and Emmanuelle Charpentier to precisely 
and efficiently edit the genome of other organisms (Ishino et al. 1987; Jinek et al. 2012). 
CRISPR genome editing, which I employ in the work described in this chapter, relies on 
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the Cas9 enzyme, an endonuclease that cleaves double stranded DNA. In order for 
genomic manipulations to be inherited, they must occur in the germline. In Drosophila, 
this is achieved by driving Cas9 expression in germ cells using promoter of the 
germline-specific gene vasa (Sebo et al. 2013). When injected into embryos, guide 
RNAs (gRNAs) will recruit the Cas9 nuclease to a region of the genome that is 
complementary to the gRNA sequence, producing a double-stranded break precisely at 
that location. Once Cas9 cuts the DNA, homologous recombination will occur between 
the freshly cut genomic DNA and another plasmid that was co-injected with the gRNAs 
carrying a replacement cassette. This replacement cassette contains two 1kb homology 
arms to facilitate recombination and create a freshly engineered locus. This technique 
has become extremely popular for its precision and efficiency, and seems to be very 
specific, as recent reports have shown that there are minimal off target effects using this 
technique (Bassett et al., 2013; Kim et al., 2015; Kleinstiver et al., 2016). I suspect 
CRISPR/Cas9 engineering will be as commonly used as Polymerase Chain Reaction 
(PCR) in the lab within just a few years. 
I have used CRISPR genome editing to alter two genes critical to Hh signaling: ci 
and patched. First, the ci locus was targeted because the field lacks an antibody 
sufficient to complete a successful ChIP-seq experiment. This major limitation has led 
researchers to employ less efficient workarounds, like the DamID technique to detect 
where Ci binds to genomic sequences (Vogel et al. 2007; Biehs et al. 2010). The results 
of that screen, however, predicted only 52 targets and these were not functionally 
validated by Ci binding site mutagenesis (see chapters 2 and 4 for more discussion). 
Therefore, I introduced a 3xFLAG epitope, which is recognized with high affinity and 
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specificity by a commercially available antibody, at the N-terminus of the ci coding 
sequence. To accomplish this, I examined the transcriptional landscape of ci to identify 
essential regulatory elements controlling ci expression. Published work by other groups 
have shown that the regulatory elements controlling ci in both the embryo and wing 
imaginal discs are located upstream of the gene (Schwartz et al. 1995); highlighted in 
yellow in Figure 5.1), so when I was forced to remove roughly 3kb of the large first 
intron because of highly repetitive sequence that was not specific enough to target with 
gRNA, I was not concerned with losing regulatory information (Figure 5.1). 
The second genomic manipulation I made targeted the patched locus so that I 
could more directly assess the function of the promoter and promoter-proximal 
regulatory elements discussed in Chapters 2 and 3. For this, I took advantage of site-
specific recombination to accurately and efficiently recombine sequences into the locus 
using already established technologies. Both of these projects are ongoing, but the 
CRISPR editing steps have been successful. Validation experiments and future 
directions are discussed below. 
5.3 Results 
5.3.1 Generation of a FLAG-tagged Ci allele 
To insert a 3xFLAG epitope at the N-terminus of ci, I injected a replacement 
cassette and two gRNAs into stage 2-3 Drosophila embryos expressing Cas9 in germ 
cells (Figure 5.2A).  These constructs were all transfected as circular DNA plasmids, 
with the gRNAs under the control of a U6 promoter (Gratz et al. 2014). Out of 600 
injected embryos, 97 survived. I outcrossed the survivors to wild type flies; of these 
crosses, 46 were fertile. Using a fluorescence dissecting stereomicroscope, I detected 
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fluorescent red eyes in at least one progeny in 6 crosses, indicating successful 
transformation. I then crossed these transformants into a line of flies that expresses Cre 
recombinase under the control of a constitutively active promoter to excise the dsRed 
cassette, leaving a single loxP scar in the intron of ci (Figure 5.2B-C). While I was then 
able to screen for the loss of red eyes, I still needed to genotype these flies to confirm 
proper recombination had taken place, so I extracted genomic DNA from a single wing 
of these flies for genotyping via PCR. I designed a forward primer (P1) upstream of 
homology region 1 and a reverse primer at the 3’ end of the intron (Figure 5.2C,D), 
which produced a ~1.6kb band, as expected. I then designed internal primers 
surrounding the 3xFLAG tag (P3 and P4), to easily screen wild type and FLAG tagged 
alleles (Figure 5.2C,E). All genotyping reactions yielded correct amplicon sizes, which 
were then sequenced to confirm successful targeting. 
The first clue that ci was still functional after this engineering came when I saw 
that flies homozygous for the ciFLAG allele were viable and phenotypically normal, as ci 
mutants have defects in embryonic, larval and pupal development (Méthot & Basler 
1999). I next sought to confirm that Ci protein was expressed in the correct cells during 
development. I accomplished this by comparing endogenous Ci antibody staining with 
anti-FLAG staining in the same samples. At time points in embryonic development when 
Ci is expressed, FLAG expression co-localized with that of Ci (Figure 5.3 A-C). 
Furthermore, I observed co-expression in larval tissues including the wing, leg and 
haltere imaginal discs (Figure 5.3D). Together, these results indicate that this CiFLAG 
allele successfully recapitulates endogenous Ci expression and will be useful for further 
downstream studies, as explained in the discussion section below.   
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5.3.2 An efficient strategy to target patched  
In order to generate an easily targetable allele of ptc, I replaced the first exon of 
ptc and approximately 1kb of flanking sequence in either direction with an attP 
recombination site using CRISPR/Cas9 replacement. For ptc, I chose to incorporate the 
attP site-specific recombination system because of its ability to swap sequences with 
extremely high efficiency (Thorpe & Smith 1998; Thorpe et al. 2000). By replacing the 
first exon of ptc with an attP recombination site, I created a targetable heterozygous ptc 
knockout (Figure 5.3A, ptcattP-dsRed/+). These flies still have one copy of wild type ptc, 
allowing them to survive, but can also be targeted by site specific recombination 
(Bischof et al. 2007). Using this strategy, recombination will be induced in the germ cells 
allowing us to quickly and efficiently make changes to the ptc locus (Figure 5.3B,C). 
Both experiments planned in Figure 5 have significant implications for better 
understanding the regulation of ptc. First, we will knock RFP into the first exon of ptc to 
generate a fluorescently marked line of flies, allowing us to easily assess ptc expression 
(Figure 5.4B). Second, we plan to re-introduce the wild type first exon of patched, but 
knock out the 3x GLI binding sites in the promoter-proximal patched enhancer to assess 
the functional contribution of these sites to ptc expression (Figure 5.4C). In both cases, 
the plasmid backbones will be removed by crossing flies into a Cre-expressing 
background (Figure 5.4B,C, bottom).   
I have successfully targeted ptc using CRISPR/Cas9 to insert the attP 
recombination site and have crossed this allele into the PhiC31 background for site-
specific recombination (Figure 5.4A). I confirmed this with the expression of dsRed in 
these flies as well as extensive PCR genotyping (Figure 5.5). The expression of dsRed 
confirmed that my construct was integrated into the genome. Primers P1, P2, P7 and 
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P8 were designed to anneal outside of the homology regions in order to confirm 
integration at the ptc locus. Internal primers (P3-P6) allowed smaller amplicons to 
facilitate efficient PCR. Genomic DNA was extracted and PCR completed using the 
primers in Figure 5.5B. While the expected products were generated, there were also 
smaller, additional bands in most of the reactions, most likely suggesting that PCR 
conditions were not optimized for each primer set, allowing for a more permissive 
environment in which the primers could recognize other regions of the genome (Figure 
5.5C). 
5.4 Discussion 
In this chapter, I have begun to address three major caveats to the first four 
chapters of my dissertation. The first is the lack of a high-quality Ci antibody that would 
allow us to complete critical in vivo analysis of Ci occupancy in the genome. Ci-FLAG 
addresses this major issue. The second and third critiques deal with the inherent 
limitation of GFP reporter constructs: examining each enhancer in a single, isolated 
reporter construct excludes the effects of other cis-regulatory elements on gene 
expression and by using GFP as a proxy for ptc, I am unable to see precisely how 
patterning contributes to developmental processes. I would like to know how these 
enhancers work together in their native genomic context to regulate patched 
expression. These last two problems will be addressed by ptcattP, which will allow highly 
efficient recombination into the ptc locus using the PhiC31 integration system. By 
examining sequences in their genomic contexts, I can address shortcomings of prior 
transgenic analyses. 
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The first experiment planned using these freshly generated alleles is to use 
CiFLAG to better understand the tissue-specific binding properties of Ci. By isolating 
tissues from different stages of development and then subjecting them to ChIP-seq 
experiments using the anti-FLAG antibody (Vokes et al. 2007), we can address this 
pressing issue. I suspect that many regions in the ptc locus will be constitutively bound 
by Ci, but that some of these sites will also change depending on the tissue examined, 
similar to the GLI2 binding in different mouse tissues and contexts (Figure 2.17) and as 
predicted by the low resolution DamID results (Biehs et al. 2010). We can also make 
specific predictions based on the reporter assays conducted in chapters 2-4. For 
example, enhancer DB responds to Hh signaling in the wing imaginal discs, but not the 
embryo. So, we would expect Ci to occupy enhancer DB in the larval context, but not in 
the embryonic context. Then, by doing bioinformatics analysis on the peaks generated 
by ChIP-seq, we can begin to characterize the affinity of Ci binding sites in each Ci-
occupied region to learn more about how Ci recognizes DNA. This analysis will also 
allow us to scan predicted regions for additional transcription factor inputs regulating Hh 
signaling in these contexts by searching for non-Ci binding sites using the tools already 
discussed in Chapter 3 (Figure 3.1). 
Even more broadly, by doing a global analysis of Ci occupancy in the genome, 
we can generate a more complete list of Hh target genes to better understand the 
mechanisms controlling patterning, morphogenesis and adult cell maintenance, 
depending on the context. We could then couple those ChIP-seq data to RNA-seq data 
to create lists of up- and down-regulated genes under conditions of increased or 
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decreased Hh signaling, using available genetic tools such as a temperature-sensitive 
allele of Hh (Ingham 1993; Figure 2.7). 
In addition to global analysis of Ci binding preferences, we will also perform more 
targeted experiments to identify sequence-specific binding preferences of Ci within a 
single enhancer. For example, does the in vitro affinity of Ci for a particular motif 
correlate with in vivo affinity? Previous work has demonstrated that the highest-affinity 
Ci binding site in vitro is GACCACCCA in luciferase assays and EMSA competition 
analyses (Hallikas et al. 2006; Parker et al. 2011). These experiments, however, have 
many caveats. First, the EMSA analysis is performed with the DNA binding domain of Ci 
alone; any other regions of the TF that may be important for binding are not included in 
the analysis. Second, no cofactors of Ci, which might impact its binding preferences, are 
present in this analysis. Third, both EMSAs and luciferase assays use a small DNA 
probe consisting mainly of the predicted Ci binding site, which may obscure the 
importance of flanking DNA sequences for Ci binding. All of these issues can be 
addressed by using already generated synthetic enhancers constructs (Ramos & Barolo 
2013; Figure 5.6). These enhancer-reporter constructs all contain a 3x multimer of a 
particular high- or low-affinity Ci binding site (Figure 5.6, left) and are integrated as 
single copy insertions into the same genomic position, so they experience the same 
position effects once they are integrated into the genome. To examine how well Ci binds 
these different GLI binding sites, we will cross our Ci-FLAG allele with these constructs 
and complete ChIP-qPCR using identical primers to yield an extremely well controlled 
analysis of Ci-binding in an in vivo context. Interestingly, the data presented in Figure 
5.6 suggest that, at least in the embryo, predicted lower affinity Ci binding sites 
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generate a stronger response to Hh signaling (Figure 5.6, right). With CiFLAG, we can 
now address how well Ci binds these sites in vivo with all of its appropriate cofactors. I 
suspect that we will see much stronger preference for Ci binding to lower affinity sites in 
the embryo, as compared to the larval tissues, because of the altered ratio of Ci 
activator:repressor, as discussed in Chapter 2. 
The second and third major issues to address relate to the design of our 
enhancer reporters. Because we are removing the enhancers from their native context 
in the ptc locus, they are no longer able to interact with other regulatory elements active 
in that tissue. While we do not know if this is happening, the evidence suggests there 
are multiple enhancers active in a single tissue at any particular time and raises this 
possibility (Figure 2.5, for example). In addition to this, we are also not addressing the 
functional contribution of these enhancers to ptc expression directly. For instance, if we 
removed any one of these enhancers in the context of all ptc regulatory elements, would 
ptc expression be changed even though there is potentially  a large amount of 
redundancy built in to the locus? Furthermore, would there be a change in the 
morphology of that tissue because of disrupted signaling? With the creation of the ptcattP 
allele, we can address both of these shortcomings (Figure 5.4C, for example). 
To address the issue of enhancer redundancy, I plan to knock in an RFP allele 
into the ptc locus. If we then use CRISPR/Cas9 to begin deleting enhancers in the 
ptcRFP allele (proposed in Figure 5.4B), we should be able to observe even subtle 
changes in expression. This CRISPR/Cas9 strategy should be highly efficient since we 
just need to create simple deletions, which will be achieved by using two gRNAs and 
Cas9 to create a Non-Homologous End Joining (NHEJ) deletion (Gratz et al. 2014). If 
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there are major effects on RFP expression, we will delete those enhancers in a wild 
type ptc locus using the same CRISPR/Cas9 NHEJ strategy, but this time will be able to 
see any change in phenotype associated with the mutation. I predict that these 
experiments will demonstrate individual enhancers, while sufficient to respond to Hh 
signaling, are not all required for the Hh response individually. Rather, since there are 
so many enhancers in the locus that are sufficient to respond to Hh signaling, we will 
need to remove multiple enhancers at once to see an effect. This is similar to the idea of 
redundant and shadow enhancers (Frankel et al. 2010; Perry et al. 2010; Barolo 2011a; 
Wunderlich et al. 2015; Staller et al. 2015). 
We can also use this ptcattP allele to examine the effect of removing the 3x Ci 
binding site cluster that responds to Hh signaling in the wing, but not in the embryo 
(Figure 5.4C, 2.1D-E) simply by creating a destination vector 
(pHD_ptc3xGBSko_destination, Figure 5.4C) using basic molecular biology techniques. 
Because we know that those 3 Ci binding sites are not sufficient to respond in the 
embryo, it suggests that removing those sites would not affect embryogenesis, since 
those sites seem to be important for larval development, a time point after 
embryogenesis. So, we might expect to see flies with morphologically deficient wings, 
but otherwise normal appendages. It would be interesting, however, if these flies are 
embryonic lethal, suggesting that there are signals being integrated through those 
binding sites, but they need input from other cis-regulatory sequences in the locus that 
are active in the embryo, such as enhancers 1EH, VT, or LK. There has been previous 
work published demonstrating that a LacZ reporter transgene carrying -12.5kb 
sequence from the ptc TSS recapitulates the embryonic Hh response (Forbes et al. 
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1993), but a version of this without those 3x Ci binding sites was never made. The 
proposed experiments here would be crucial to understanding how ptc is regulated 
using multiple enhancers in the context of the entire locus, which will add to our current 
knowledge of ptc regulation and how this regulation affects Hh signaling in different 
developmental contexts. 
The experiments described in this section are just a fraction of the work that 
could be done with these alleles. For example, instead of destroying the 3x Ci binding 
sites as depicted in Figure 5.4C, we could just as easily manipulate the binding sites 
within the ptc promoter, to examine how this Polycomb Response Element (PRE, 
described in Chapter 2) affects embryonic development. For this experiment, depending 
on how we manipulate the promoter sequence, I would expect disrupted development 
during embryogenesis, since we see PRE effects by then already in our GFP reporter 
assays (Figures 2.11-2.14). The generation of these alleles opens the door to an infinite 
number of experiments to functionally assess the role of cis-regulatory elements in the 
regulation of ptc and the corresponding effects of Hh signaling on the development of 
the organism. 
5.5 Materials and Methods 
 
DNA sequence alignments 
Sequences, DNAse hypersensitivity tracks, and multi-species alignments were obtained 




Homology directed repair cassettes were created by PCR amplification of each ~1kb 
homology region from Vasa-Cas9 genomic DNA and direct cloning into the 
pHD_dsRed_attP (Gratz et al., 2014) cassette via Aar1 (5’ homology arm) or Sap1 (3’ 
homology arm) restriction sites. Guide RNA were designed using Fly CRISPR Target 
finder (http://tools.flycrispr.molbio.wisc.edu/targetFinder/) using their highest stringency 
filters allowing 1 or less off target effects for each gRNA. These gRNAs were ordered as 
complimentary oligos and annealed by standard protocols for cloning into pU6-Bbs1-
chiRNA vector (Gratz et al., 2013). Primers can be found in Table 5.1. 
  
Genotyping 
Genomic DNA was isolated from either whole flies or single wings to keep flies alive for 
additional crosses (Carvalho et al. 2009). This DNA was subjected to PCR as previously 
described in Chapter 2, and examined on a 1-2% agarose gel. All amplicons were 
sequenced at the University of Michigan DNA Sequencing Core Facility. Primers can be 
found in Figure 5.7.  
  
Drosophila transgenesis and stocks 
Injection of gRNA and Homology Directed Repair cassette was performed as previously 
described (Gratz et al. 2014) into the Bloomington 55821 strain (y[1] M{vas-Cas9.RFP-
]ZH2A w[1118]/FM7a, P{w[+mC]=Tb[1]}FM7-A). The dsRed cassette was removed by 
crossing into the Cre-expression Bloomington Stock 766 (y[1] w[67c23] 
P{y[+mDint2]=Crey}1b;noc[Sco]/CyO). In the ptc-attP lines that were put in the 
background of PhiC31, this was done using Bloomington stock 24749 (y[1] M{vas-
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int.Dm}ZH-2A w[*]; M{3xP3-RFP.attP}ZH-86Fb). All synthetic enhancer reporters were 
made as previously described (Ramos & Barolo 2013). 
  
Immunohistochemistry and confocal microscopy 
Drosophila embryos and third-instar imaginal discs were fixed and stained using 
standard methods (D. S. Parker et al. 2011; Ramos & Barolo 2013; White et al. 2012). 
Primary antibodies used included rat anti-Ci (Developmental Studies Hybridoma Bank 
2A1, 1:10), mouse anti-FLAG (Sigma F1804, 1:50), rabbit anti-EGFP (Invitrogen 1:100), 
and mouse anti-Engrailed (Developmental Studies Hybridoma Bank 4D9, 1:50). 
Secondary Antibodies included goat anti-rat 568 (Invitrogen A11077, 1:2000), goat anti-
rabbit 488 (Invitrogen A11008) and goat anti-mouse 488 (Invitrogen A11001, 1:2000), 
Antibodies obtained from the Developmental Studies Hybridoma Bank were developed 
under the auspices of the National Institute of Child Health and Human Development 
and maintained by the Department of Biological Sciences, The University of Iowa (Iowa 
City, IA). Confocal images were captured on an Olympus FluoView 500 Laser Scanning 
Confocal Microscope mounted on an Olympus IX-71 inverted microscope, and on a 
Nikon A1 confocal microscope. Samples to be directly compared were fixed, prepared, 
and imaged under identical confocal microscopy conditions and settings. 
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Figure 5.1 Genomic landscape of ci annotated with data from the UCSC genome 
browser 
Known regulatory elements are highlighted in yellow upstream of the ci coding region 
(see bottom for UCSC identification of published enhancers in pink). Gray shading 
indicates homology regions used in CRISPR experiments. Conservation among 
Drosophilids is shown as black bars underneath ci gene map. Green, orange, red, blue, 
and purple tracks represent DNAse hypersensitivity, horizontal bars across peaks 
indicate significant peaks. Black horizontal bars indicating repetitive DNA sequences 




Figure 5.2 CRISPR/Cas9 strategy to tag ci with FLAG  
(A) Gene map of ci. Homology regions 1 and 2 are marked in gray. gRNAs are also 
shown. The homology cassette used to repair the locus after Cas9 cuts contains a 
3xFLAG inserted at the 5’end of the ci coding region (ATG added to 3xFLAG, the wild 
type ATG for Ci was preserved) and a floxed 3xP3-dsRed cassette. The 3xP3 is an eye 
specific promoter that will mark transgenic flies for easy screening. (B) Targeted allele 
of ci as marked by 3xP3-dsRed. (C) Genotyping strategy. Primers shown in pink. (D-E) 
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Genotyping results. W1118 flies are used as a control in all genotyping reactions. The 




Figure 5.3 - CiFLAG is co-expressed with Ci in embryos and larval tissues  
(A-C)  Similarly staged transgenic and wild type embryos stained for FLAG and Ci. (D) 




Figure 5.4 CRISPR/Cas9 strategy to target the ptc locus 
(A) The ptc gene map is shown and is focused on the first exon and about 3kb flanking 
sequence in either direction, at top. The homology directed repair cassette is shown 
immediately underneath the ptc locus and contains a floxed 3xP3-dsRed cassette 
(same as in Figure 5.2), and an attP recombination site to replace the first exon of ptc. 
(B) Strategy to knock in RFP into the ptc locus using site-specific recombination 
(Bischof et al., 2007). (C) Strategy to knock out three consensus, high affinity GLI 




Figure 5.5 Genotyping results suggest ptc locus was successfully targeted 
(A) A wild type and ptc-attP knockin allele are depicted. (B) Primers used for genotyping 
are shown as black arrows. Colored lines correspond to expected sizes of products. (C) 
Genotyping results, template DNA is from whole genomic preps of flies containing the 




Figure 5.6 Low affinity GLI binding site enhancers respond strongly to Hh signaling 
The grayscale chart on the left indicates Ci binding site quality (see Chapter 2 and 4 for 
more information). Synthetic enhancers each contained 3x binding sites for the broad 
transcriptional activator, Grainyhead, and 3x GLI binding sites of varying affinity, as 
predicted by shade of gray. Each reporter uses the hsp70 minimal promoter to drive 
GFP expression in transgenic animals. On the right, stage 12 embryos showing 












































Table 5.1 Primers used for CRISPR/Cas9 genomic engineering of ptc and ci 
All primers are written from 5’ to 3’ orientation. F refers to forward primer, R refers to 
reverse primer. Additional binding site to facilitate cloning are depicted in colors 








6.1 Summary of Findings 
Through an in-depth analysis of Hh dependent enhancers in flies and mice, I 
have significantly contributed to the fields of cellular, developmental, and molecular 
biology. I began by demonstrating that patched, a well studied Hh target gene and a 
constitutive target of Hh signaling, surprisingly requires a battery of context- and stage- 
specific enhancers to properly respond to signaling. By not relying on a single, master 
regulatory element, patched affords itself the ability to adapt to new situations and this 
helps to explain, at the cis-regulatory level, one way that this highly conserved cell 
signaling pathway is able to pattern such disparate tissues, like wings in flies and the 
neural tube in humans.  
I next showed that nearly all of these novel ptc enhancers are regulated by GLI 
through low affinity binding sites, and that the quality of GLI binding site is a key factor 
used for interpreting tissue specific responses of these enhancers – while low affinity 
sites might be critical for activation in the context of the embryonic ectoderm, they may 
not be preferred in the wing imaginal disc. Building on this theme of tissue specificity, I 
went on to identify novel regulatory inputs into these enhancers such as dGATAe and 
RFX, highlighting that there is much more to learn about tissue specific gene regulation.  
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I then applied this information about how GLI regulates ptc enhancers to the 
development of an algorithm that scanned the entire Drosophila genome for novel 
enhancers for other Hh target genes, besides ptc, and identified 8 additional GLI-
responsive enhancers. While this computational method of enhancer prediction was 
useful for finding some new enhancers, it still produced many false positives, mainly 
because many sequences might look like binding sites at a sequence level, but not all of 
them are functional.  
Lingering questions about enhancer identification, lack of in vivo analysis of Ci 
binding at the ptc locus, and limited information about how enhancers might cooperate 
to regulate gene expression led me to employ the powerful genome editing technique of 
CRISPR/Cas9 to address these questions at the actual genomic loci in question. To 
these ends, I generated a FLAG tagged allele of Ci to do tissue specific ChIP analyses 
to better understand how Ci binds to enhancers and regulates target gene expression. 
These experiments will yield valuable insights into how the quality of Ci binding sites 
influences tissue specific gene responses. To better address the question of enhancer 
function, I generated an easily targetable allele of ptc to learn more about how the more 
than 30 newly identified enhancers contribute to morphogenetic changes during 
development and to cellular homeostasis into adulthood to prevent misregulation of 
cellular processes that lead to disease.  
6.2 Implications 
My in depth dissection of ptc regulation has contributed a great deal of insight 
into how genes are controlled at the cis-regulatory level. While not all genes are 
regulated with such a complex assortment of enhancers like ptc, these results highlight 
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that we should still consider the entire locus when asking how an enhancer contributes 
to gene expression. This is especially true in cases where genes are expressed in more 
than one tissue or timepoint throughout development, since there might be more than 
one enhancer controlling context specific expression. We have known that multiple 
regulatory elements control precise patterns of gene expression for many years and 
their placement in the gene locus is critically important; see the story about the Locus 
Control Region of the human β-globin gene (Tanimoto et al., 1999; Tolhuis et al., 2002). 
Enhancers most likely function by looping to their promoter in order to act at a distance 
to the gene they regulate, but they can also interact with other enhancers active at the 
same developmental timepoints (Ghavi-Helm et al., 2014; Whalen et al., 2016). We do 
not know exactly how these processes occur, but are able to visualize such events 
using the Chromatin Conformation Capture technique, which has led to the widespread 
ability to recognize Topological Activation Domains, or TADs, which provide insight into 
the 3D architecture of the genome and strongly suggest that this architecture plays a 
role in regulating gene expression (Dixon et al., 2012). The idea of non-coding regions 
of the genome being considered junk DNA has been thoroughly debunked, and gene 
regulation experts are constantly identifying new ways that DNA is able to code for key 
information to control gene expression. In order to fully understand these mechanisms, 
we must look at gene regulation from many angles: the bird’s eye view of genome 
architecture is just as important as the nucleotides making up each enhancer.  
My analysis of ptc and other Hh target genes has also made it clear that there is 
no all encompassing enhancer identification method able to accurately predict a 
complete list of enhancers. There are caveats and shortcomings to each enhancer-
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detection method discussed, from a lack of functional data from ChIP-seq binding 
regions, to the misidentification of binding sites using purely sequence based analysis. 
My work suggests that the best way to identify enhancers is by using a combination of 
approaches. There is a wealth of genomic transcription factor binding data and 
enhancer signatures available, and this can easily be mistaken for a comprehensive list 
of all known enhancers. These immense datasets should be the starting point to 
identifying a regulatory element, not the end. Predicted enhancers should be examined 
both as stably integrated transgenic reporters and in their native contexts, by deletion 
using genomic engineering techniques, as it is most likely not the only enhancer 
regulating gene expression.  
One specific implication of my characterization of the ptc locus deals with the 
non-Hh regulated expression of ptc. In order for Hh signaling to remain off, Ptc must 
inhibit Smo, even in the absence of Hh ligand (Figure 1.1). The only known mechanism 
by which ptc is activated, however, is by Hh signaling. As already extensively discussed 
in this work, this negative feedback mechanism is essential for maintaining proper levels 
of signaling across timepoints and tissues in all Hh-regulated tissues. By examining the 
locus in such detail, I was able to locate a promoter proximal region, termed ptcB, that 
did not contain predicted Ci binding sites and was distinct from the promoter, which was 
identified by its core promoter elements like the initiator sequence and downstream 
promoter element (Figure 2.11). ptcB was able to drive low-level expression when 
examined on the core ptc promoter (Figure 2.11), which might account for the non-GLI 
regulated expression of ptc necessary to keep the pathway off in the absence of Hh.  
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A broader interpretation of these data offers several evolutionary implications as 
well. While I spent much time and effort demonstrating that the patched loci in mice and 
flies are regulated similarly, it is extremely important to note that the actual enhancers 
for each gene are not conserved by sequence. This was demonstrated on an 
experimental level when Peak2, the mouse Ptch1 enhancer, was examined in flies and 
did not recapitulate a Hh response in any imaginal discs (Chapter 3). Furthermore, 
when I searched vertebrate genomes for similar sequences using my Drosophila 
enhancers as templates, there were no matches, demonstrating that these enhancers 
are not conserved by sequence or position. Completing this same screen using the 
mouse DNA sequences as templates against the fly genome similarly produced no 
matches. So, while the sequences in these enhancers themselves are not strictly 
conserved by sequence, I was able to demonstrate that overall cis-regulatory logic of 
patched regulation is conserved; in both animals, the constitutive response of patched 
to Hh signaling is regulated by a battery of context specific enhancers rather than a 
single, master regulatory element. The enhancers themselves are probably not explicitly 
conserved since each organism has different requirements for gene expression – from 
different TF inputs into the enhancers to different morphological outcomes: flies need 
wings and humans need hands. In addition to this insight, my data bring up an 
interesting idea about how to think about TFs recognizing their cognate binding sites. 
While we know that binding sites can vary quite a bit in sequence, this is why they are 
represented as positional weight matrices, perhaps TFs do not care as much about the 
exact sequence they recognize as they do about the overall binding site affinity. For 
example, GACCACCCA is considered a consensus GLI binding site in all genomes 
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based on exhaustive EMSA and luciferase analysis (Chapter 2). Once nucleotide 
substitutions are made in this sequence, the affinity is lowered, and we consider the 
new sequence a low affinity binding site. Perhaps instead of thinking of these binding 
sites individually, we should be thinking about them as “affinity groups”, meaning they 
are not just important because of the nucleotide sequence, but for the affinity by which a 
TF can bind. Many different arrangements of nucleotides could achieve any particular 
affinity, rendering the exact sequences less important. This logic allows for greater 
evolutionary discretion – binding sites become more malleable and far less rigid. So, 
any mutation to a binding site would be less detrimental to changes in gene expression, 
especially when multiple enhancers regulate gene expression in a particular context. 
Since evolution usually cannot change the coding sequence of a gene without creating 
a drastic, and often detrimental, effect on the organism, fine scale changes made at the 
level of cis-regulatory elements can be an important tool for explaining how changes to 
gene expression occur over time. 
6.3 Future Directions 
While I have made several contributions to understanding gene regulation during 
my graduate career, there are many experiments and future projects that are needed to 
address these implications and to complete a more thorough analysis of ptc regulation 
during development and into adulthood. 
I have mainly focused on two main tissues in my analysis of ptc regulation: the 
embryonic ectoderm and the wing imaginal disc. Perhaps the lowest hanging fruit left 
out of this dissertation is the characterization of how ptc responds to Hh signaling in 
additional developmental and adult contexts. I demonstrated that low affinity Ci binding 
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sites are critical in both wings and the embryonic ectoderm, and that the affinity of these 
sites helps tune signaling. In my initial screen of ptc enhancers, I identified elements 
that were active in nearly every single developmental context that relies on Hh signaling 
(Figure 2.3) including adult stem-cell dependent contexts like the testis and ovary 
(Michel et al., 2012; Sahai-Hernandez and Nystul, 2013). In the testis, Hh is secreted 
from hub cells, considered the signaling center of this tissue, and received by nearby 
somatic cyst cells, where ptc is known to be active (Michel et al., 2012). Interestingly, 
the Ptc antibody stain detects expression in the hub, where Hh is expressed as well. 
Our analysis confirmed that expression driven by the GC enhancer is also found in both 
the somatic cells and the hub itself (Figure 2.3G). This is unique from most other Hh 
responsive tissues like the wing or embryonic ectoderm because normally ptc is most 
active in cells responding to the ligand, not in cells secreting it. It would be interesting to 
more fully investigate this expression pattern and see if that unexpected expression is 
dependant on Ci binding sites or other factors. Similar to the testis, the adult ovary 
contains populations of stem cells. Hh signaling is essential for maintaining both ovarian 
germ and follicle stem cells (FSCs) (Sahai-Hernandez and Nystul, 2013; Zhang and 
Kalderon, 2001). In relation to my analysis, FSCs are found in the region where 
enhancer 1AC is most strongly activate, making it a prime candidate for an FSC 
enhancer (Figure 2.3H). Scrutinizing this additional adult context of the ovary would be 
very important to help us better understand how ptc responds to Hh signaling to learn 
more about how Hh is maintaining these distinct populations of adult stem cells. 
Furthermore, a functional analysis of these enhancers at the endogenous ptc locus 
would be extremely informative to understanding the ptc response, Hh regulation, and 
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role in maintaining these stem cell dependent contexts. These contexts might also 
provide new, non-canonical sites of Hh signaling in Drosophila.  
Another direction this project should take is derived from results presented in 
Chapter 3, which suggest that Hh signaling might also regulate salivary gland 
development in flies and this regulation might be augmented by the ciliary factor RFX. 
There is not much known about Hh signaling in the Drosophila salivary gland, so the 
first steps would be to characterize expression of all the pathway components, like Hh, 
Ptc, Smo, Cos2, Fused and Ci to show that the required components are present. There 
are either antibodies or LacZ knock-in alleles for all of these key proteins, so detection 
should be possible. Next, we should be able to augment signaling to demonstrate a 
change in signaling or development. We could achieve this by removing any Hh 
signaling components genetically and measuring expression of a target gene, like ptc, 
and also examine the phenotypic consequences of disrupting signaling. If we could 
establish that Hh signaling is important for salivary gland development, then we can ask 
if this tissue is ciliated and how this might also be important for development. Most cell 
types in Drosophila are not ciliated, although there is one notable exception: the 
olfactory sensory neurons, which require cilia for normal development (Vieillard et al., 
2015) and references therein).  Interestingly, Hh signaling occurs in these cell types and 
many of the components of the pathway are processed in cilia suggesting a possible 
non-canonical path for Hh signaling in the fly (Kuzhandaivel et al., 2014). To then apply 
this to my work, we would need to demonstrate that Drosophila salivary glands are 
ciliated by using any number of cilia markers available to the fly community such as 
Arl13b::GFP or CBY::GFP, both GFP tagged versions of ciliary proteins expressed in 
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the proximal ciliary segment and transition zone, respectively (Enjolras et al., 2012). 
Using these lines to examine expression in salivary glands would help us determine if 
cilia are present in this tissue. We could then merge these two experiments to see if Hh 
pathway components are being processed in salivary gland cilia, and begin asking how 
this potential cilia-mediated Hh signaling contributes to salivary gland development and 
function. It is also of note to mention that mammalian salivary glands are ciliated 
(Bernfield et al., 1972) and also require SHH signaling for branching morphogenesis 
during development (Jaskoll et al., 2004). This suggests that Drosophila salivary glands 
might be another evolutionary link between signaling in flies, mice and humans, since 
cilia play a significant role in Hh signaling in most mammalian contexts. It is also a 
potential opportunity to characterize another non-canonical pathway for Hh signaling in 
Drosophila.  
One of the most significant (and I believe most important) future directions of my 
work is to explore the function of all of these newly identified enhancers in their native 
genomic context. This is absolutely critical to understanding how Hh signaling 
contributes to development and adult tissue maintenance. To address these essential 
questions, I have adapted the CRISPR/Cas9 genome editing technology for use in the 
Barolo lab and started several critical experiments using the technique (see Chapter 5 
for a longer discussion). The first experiment in progress is tagging Ci with a 3xFLAG 
epitope to better understand where and how Ci binds to enhancers in different 
developmental contexts. Nearly all of what is known about how Ci binds to DNA has 
been extrapolated from luciferase assays and EMSA analyses. While these provide 
critical information, they do not tell us the whole story of how Ci regulates Hh signaling 
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and need to be complemented with ChIP-seq analyses to give us more information 
about co-factors and binding conditions in Ci’s native genomic context in flies (Chapter 
5). I also have enlisted the expertise of the Kassis Lab at the NIH for a collaboration 
using this allele for tissue specific ChIP-seq analysis. The second experiment that I 
have started is the generation of the ptcattP allele, which contains an attP recombination 
site in place of exon1 of ptc. This allele will allow us to address several lingering 
questions about how ptc is regulated by the enhancers I have characterized in this 
dissertation and provide insights into how these enhancers work together to contribute 
to morphogenesis of different tissues (Figure 5.4). By manipulating the cis-regulatory 
elements that control ptc regulation at the native locus, we will be able to see how 
enhancers are working together to regulate expression, how they interact with the 
promoter, and be able to better address the role of Polycomb and Trithorax regulation at 
this locus. Most importantly, we can finally address the functional contribution these 
elements make to the development of the organism.  
While there is still much to learn about how the Hh pathway regulates its target 
genes, this in-depth analysis of gene regulation has uncovered a highly evolutionarily 
conserved mechanism by which GLI is able to transduce its signal in many different 
tissues and cell types using an array of highly context specific enhancers. The future 
directions discussed here, and throughout the rest of my thesis, will significantly 
contribute to our understanding of how cells communicate via transcriptional cues to 
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